A method for enhancing biomass in plants via RuBP regeneration and enhanced electron transport
Genetic modification of plants to enhance RuBP regeneration and electron transfer through overexpression of specific proteins improves energy conversion efficiency, leading to increased biomass and water use efficiency.
Patent Information
- Application Number
- JP2021556527
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2019-03-21
- Filing Date
- 2020-03-18
- Publication Date
- 2024-11-11
- Estimated Expiration
- 2040-03-18
AI Technical Summary
The energy conversion efficiency of crop species is limited by internal plant processes such as photosynthesis and respiration, which hampers productivity improvement despite optimal agricultural management and environmental conditions.
Genetically modify plants to enhance RuBP regeneration and electron transfer by overexpressing Calvin-Benson cycle proteins like FBPase/SBPase and photosynthetic electron transfer proteins like cytochrome c6, localized to specific plant compartments with appropriate transit peptides and promoters.
Enhances biomass production and water use efficiency in genetically modified plants, improving photosynthetic carbon assimilation and electron transfer rates.
Smart Images

Figure 0007580388000004 
Figure 0007580388000005 
Figure 0007580388000006
Abstract
Description
Detailed Description of the Invention
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS This application claims the benefit of U.S. Provisional Application No. 62 / 821,786, filed March 21, 2019, which is incorporated by reference herein in its entirety.
[0002] [Submission of sequence listing as an ASCII text file] The contents of the following submission regarding an ASCII text file are incorporated herein by reference in their entirety: Computer Readable Form (CRF) of Sequence Listing (Filename: 794542000640SEQLIST.TXT, Recorded on: March 16, 2020, Size: 316KB).
[0003] [Technical field] The present disclosure relates to genetically modified plants. In particular, the present disclosure relates to genetically modified plants with enhanced biomass, including genetic modifications that promote RuBP regeneration, including through overexpression of Calvin-Benson cycle (CB) proteins such as FBPase / SBPase or SBPase, and genetic modifications that stimulate electron transport, including through overexpression of photosynthetic electron transport proteins such as cytochrome c6 and Rieske iron-sulfur (Rieske FeS).
[0004] 〔background〕 The productivity of crop species is limited by multiple external factors, including agricultural management and environmental conditions. However, even under optimal management and conditions, the energy conversion efficiency of crop species can still limit yield. Energy conversion efficiency is the ratio of biomass energy produced divided by light energy intercepted by the crop canopy over a period of time, and is determined by plant internal processes such as photosynthesis and respiration. Modeling has shown that the energy conversion efficiency of major crop species lags behind other productivity improvement components and represents a major obstacle in crop species productivity improvement (Zhu, et al., Annu. Rev. Plant. Biol. (2010)61:235-261).
[0005] The Calvin-Benson Cycle (CB) is a promising target for improving photosynthesis because it is involved in the assimilation of carbon, i.e., the generation of biomass energy. Early studies showed that even a small reduction in individual CB enzymes was sufficient to reduce carbon assimilation and plant growth. Although some enzymes have a greater effect than others, investigations have shown that overexpressing different individual CB enzymes results in increased photosynthetic carbon assimilation and improved plant growth. Thus, there is no single limiting step in photosynthetic carbon assimilation. This means that although CB enzyme activity can be manipulated to increase productivity, developing effective engineering strategies for major crop species has to date proven to be not as simple as changing one component.
[0006] Photosynthetic electron transport is another possible target for improving photosynthesis, since it is involved in the utilization of light energy intercepted by the crop canopy. It has been shown that individual components of the photosynthetic electron transport chain can increase the electron transport rate. For example, overexpression of the plant Riske iron-sulfur protein resulted in increased electron transport rate and increased plant biomass (Simkin, et al., Plant Physiol. (2017) 175:134-145). Although individual components provided promising results, studies as a whole showed that the efficiency of photosynthetic electron transport in higher plants is limited by photosynthetic electron transport proteins of higher plants (e.g., plastocyanin) (Chida, et al., Plant Cell Physiol. (2007) 48:948-957; Finazzi, et al., Proc. Natl. Acad. Sci. US A. (2005) 102:7031-7036).
[0007] There is a clear need for improved energy conversion efficiency to achieve optimal productivity in crop species. To develop plants with improved energy conversion efficiency, multi-component engineering that incorporates different aspects of photosynthesis is required.
[0008] 〔overview〕 To meet these demands, the present disclosure provides a method for enhancing plant biomass by promoting RuBP regeneration and electron transport. In particular, the present disclosure relates to genetically modified plants having enhanced biomass through overexpression of CB proteins (e.g., FBPase / SBPase or SBPase) and overexpression of photosynthetic electron transport proteins (e.g., cytochrome c6 and Riske iron-sulfur).
[0009] Aspects of the present disclosure include genetically modified plants, plant parts, or plant cells, where the plant, plant parts, or cells include one or more genetic modifications that improve RuBP regeneration and one or more genetic modifications that improve photosynthetic electron transport, which increase the activity of CB protein. Further embodiments of this aspect include the one or more genetic modifications that improve photosynthetic electron transport are overexpression of one or more photosynthetic electron transport proteins. Yet another embodiment of this aspect includes one or more photosynthetic electron transport proteins selected from the group of cytochrome c6 protein, Liske iron-sulfur protein, or cytochrome c6 protein and Liske iron-sulfur protein. Further embodiments of this aspect include the one or more photosynthetic electron transport proteins are cytochrome c6 protein. Yet another embodiment of this aspect includes the cytochrome c6 protein is an algal cytochrome c6 protein. In further embodiments of this aspect, the algal cytochrome c6 protein comprises an amino acid sequence having at least 70% sequence identity, at least 75% sequence identity, at least 80% sequence identity, at least 85% sequence identity, at least 90% sequence identity, at least 95% sequence identity, or at least 99% sequence identity to SEQ ID NO:49, SEQ ID NO:50, SEQ ID NO:51, SEQ ID NO:52, SEQ ID NO:53, SEQ ID NO:54, SEQ ID NO:55, SEQ ID NO:56, SEQ ID NO:57, SEQ ID NO:58, SEQ ID NO:59, SEQ ID NO:60, SEQ ID NO:61, SEQ ID NO:62, SEQ ID NO:63, SEQ ID NO:64, SEQ ID NO:65, SEQ ID NO:66, SEQ ID NO:67, SEQ ID NO:68, SEQ ID NO:69, SEQ ID NO:95, or SEQ ID NO:102. In further embodiments of this aspect, the algal cytochrome c6 protein comprises an amino acid sequence having at least 70% sequence identity, at least 75% sequence identity, at least 80% sequence identity, at least 85% sequence identity, at least 90% sequence identity, at least 95% sequence identity, or at least 99% sequence identity to SEQ ID NO: 95. Further embodiments of this aspect include where the one or more photosynthetic electron transport proteins are Riske iron-sulfur proteins.In further embodiments of this aspect, the Riske iron-sulfur protein comprises an amino acid sequence having at least 70% sequence identity, at least 75% sequence identity, at least 80% sequence identity, at least 85% sequence identity, at least 90% sequence identity, at least 95% sequence identity, or at least 99% sequence identity to SEQ ID NO:70, SEQ ID NO:71, SEQ ID NO:72, SEQ ID NO:73, SEQ ID NO:74, SEQ ID NO:75, SEQ ID NO:76, SEQ ID NO:77, SEQ ID NO:78, SEQ ID NO:79, SEQ ID NO:80, or SEQ ID NO: 101. Further embodiments of this aspect include where the one or more photosynthetic electron transport proteins are a cytochrome c6 protein and a Riske iron-sulfur protein. In a further embodiment of this aspect, the cytochrome c6 protein has at least 70% sequence identity, at least 75% sequence identity, at least 80% sequence identity, at least 85% sequence identity, at least 90% sequence identity, to SEQ ID NO:49, SEQ ID NO:50, SEQ ID NO:51, SEQ ID NO:52, SEQ ID NO:53, SEQ ID NO:54, SEQ ID NO:55, SEQ ID NO:56, SEQ ID NO:57, SEQ ID NO:58, SEQ ID NO:59, SEQ ID NO:60, SEQ ID NO:61, SEQ ID NO:62, SEQ ID NO:63, SEQ ID NO:64, SEQ ID NO:65, SEQ ID NO:66, SEQ ID NO:67, SEQ ID NO:68, SEQ ID NO:69, SEQ ID NO:95, or SEQ ID NO:102. and the Rieske iron sulfur protein comprises an amino acid sequence having at least 70% sequence identity, at least 75% sequence identity, at least 80% sequence identity, at least 85% sequence identity, at least 90% sequence identity, at least 95% sequence identity, or at least 99% sequence identity to SEQ ID NO:70, SEQ ID NO:71, SEQ ID NO:72, SEQ ID NO:73, SEQ ID NO:74, SEQ ID NO:75, SEQ ID NO:76, SEQ ID NO:77, SEQ ID NO:78, SEQ ID NO:79, SEQ ID NO:80, or SEQ ID NO:101.
[0010] In yet another embodiment of this aspect, which can be combined with any of the previous embodiments having cytochrome c6, the cytochrome c6 protein is localized to the thylakoid lumen of at least one chloroplast in the cell of the genetically modified plant. A further embodiment of this aspect includes a cytochrome c6 protein that includes a transit peptide that localizes the cytochrome c6 protein to the thylakoid lumen. A further embodiment of this aspect includes a cytochrome c6 transit peptide selected from the group of chlorophyll a / b binding protein 6 transit peptide, light-harvesting complex I chlorophyll a / b binding protein 1 transit peptide, or plastocyanin signal peptide. In yet another embodiment of this aspect, which can be combined with any of the previous embodiments having Liske iron sulfur, the Liske iron sulfur protein includes a transit peptide that localizes the Liske iron sulfur protein to the thylakoid membrane. Further embodiments of this aspect include a Liske iron sulfur transport peptide selected from the group of cytochrome f transport peptide, cytochrome b6 transport peptide, PetD transport peptide, PetG transport peptide, PetL transport peptide, PetN transport peptide, PetM transport peptide, and plastoquinone transport peptide. Yet another embodiment of this aspect, which may be combined with any of the previous embodiments having cytochrome c6, further includes a cytochrome c6 protein coding nucleic acid sequence operably linked to a plant promoter. Further embodiments of this aspect include a promoter selected from a constitutive promoter, an inducible promoter, a tissue or cell type specific promoter, or an inducible tissue or cell type specific promoter. Yet another embodiment of this aspect, which may be combined with any of the previous embodiments having Liske iron sulfur, further includes a Liske iron sulfur protein coding nucleic acid sequence operably linked to a plant promoter. Further embodiments of this aspect include a promoter selected from a constitutive promoter, an inducible promoter, a tissue or cell type specific promoter, or an inducible tissue or cell type specific promoter.
[0011] In yet another embodiment of this aspect that can be combined with any of the previous embodiments, the one or more genetic modifications that improve RuBP regeneration include overexpression of a CB protein. Further embodiments of this aspect include a CB protein selected from the group of sedoheptulose-1,7-bisphosphatase (SBPase), fructose-1,6-bisphosphate aldolase (FBPA), chloroplast fructose-1,6-bisphosphatase (FBPase), bifunctional fructose-1,6-bisphosphatase / sedoheptulose-1,7-bisphosphatase (FBP / SBPase), or transketolase (TK). Further embodiments of this aspect include a CB protein that is an SBPase. In yet another embodiment of this aspect, the SBPase comprises an amino acid sequence having at least 70% sequence identity, at least 75% sequence identity, at least 80% sequence identity, at least 85% sequence identity, at least 90% sequence identity, at least 95% sequence identity, or at least 99% sequence identity to SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, or SEQ ID NO:96. A further embodiment of this aspect comprises an SBPase localized to the chloroplast stroma of at least one chloroplast in a cell of a genetically modified plant. In yet another embodiment of this aspect, the SBPase comprises a transit peptide that localizes the SBPase to the chloroplast stroma. Yet another embodiment of this aspect, which can be combined with any of the previous embodiments having an SBPase, further comprises an SBPase encoding nucleic acid sequence operably linked to a plant promoter. Further embodiments of this aspect include a promoter selected from a constitutive promoter, an inducible promoter, a tissue or cell type specific promoter, or an inducible tissue or cell type specific promoter. Further embodiments of this aspect include a CB protein that is an FBPA.In yet another embodiment of this aspect, the FBPA comprises an amino acid sequence having at least 70% sequence identity, at least 75% sequence identity, at least 80% sequence identity, at least 85% sequence identity, at least 90% sequence identity, at least 95% sequence identity, or at least 99% sequence identity to SEQ ID NO:15, SEQ ID NO:16, SEQ ID NO:17, SEQ ID NO:18, SEQ ID NO:19, SEQ ID NO:20, SEQ ID NO:21, SEQ ID NO:22, SEQ ID NO:23, SEQ ID NO:24, SEQ ID NO:25, SEQ ID NO:26, or SEQ ID NO:97. A further embodiment of this aspect comprises the FBPA localized to the chloroplast stroma of at least one chloroplast in a cell of the genetically modified plant. In yet another embodiment of this aspect, the FBPA comprises a transit peptide that localizes the FBPA to the chloroplast stroma. Yet another embodiment of this aspect, which can be combined with any of the previous embodiments having an FBPA, further comprises an FBPA encoding nucleic acid sequence operably linked to a plant promoter. Further embodiments of this aspect include a promoter selected from a constitutive promoter, an inducible promoter, a tissue or cell type specific promoter, or an inducible tissue or cell type specific promoter. Further embodiments of this aspect include a CB protein that is an FBPase. In yet another embodiment of this aspect, the FBPase comprises an amino acid sequence having at least 70% sequence identity, at least 75% sequence identity, at least 80% sequence identity, at least 85% sequence identity, at least 90% sequence identity, at least 95% sequence identity, or at least 99% sequence identity to SEQ ID NO:27, SEQ ID NO:28, SEQ ID NO:29, SEQ ID NO:30, SEQ ID NO:31, SEQ ID NO:32, SEQ ID NO:33, SEQ ID NO:34, SEQ ID NO:35, SEQ ID NO:36, SEQ ID NO:37, or SEQ ID NO:98. Further embodiments of this aspect include an FBPase that is localized in the chloroplast stroma of at least one chloroplast in a cell of a genetically modified plant. In yet another embodiment of this aspect, the FBPase comprises a transit peptide that localizes the FBPase to the chloroplast stroma.Yet another embodiment of this aspect, which may be combined with any of the preceding embodiments having an FBPase, further comprises an FBPase encoding nucleic acid sequence operably linked to a plant promoter. Further embodiments of this aspect include a promoter selected from a constitutive promoter, an inducible promoter, a tissue or cell type specific promoter, or an inducible tissue or cell type specific promoter. Further embodiments of this aspect include a CB protein that is an FBP / SBPase. Further embodiments of this aspect include an FBP / SBPase that is a cyanobacterial FBP / SBPase. In yet another embodiment of this aspect, the cyanobacterial FBP / SBPase comprises an amino acid sequence having at least 70% sequence identity, at least 75% sequence identity, at least 80% sequence identity, at least 85% sequence identity, at least 90% sequence identity, at least 95% sequence identity, or at least 99% sequence identity to SEQ ID NO:38, SEQ ID NO:39, SEQ ID NO:40, or SEQ ID NO:99. Yet another embodiment of this aspect, which can be combined with any of the previous embodiments having an FBP / SBPase, comprises an FBP / SBPase localized in the chloroplast stroma of at least one chloroplast in a cell of a genetically modified plant. In a further embodiment of this aspect, the FBP / SBPase comprises a transport peptide that localizes the FBP / SBPase to the chloroplast stroma. A further embodiment of this aspect comprises a transport peptide selected from the group of geraniol synthase transport peptide, SBPase transport peptide, FBPA transport peptide, FBPase transport peptide, transketolase transport peptide, PGK transport peptide, GAPDH transport peptide, AGPase transport peptide, RPI transport peptide, RPE transport peptide, PRK transport peptide, or Rubisco transport peptide. Yet another embodiment of this aspect, which can be combined with any of the previous embodiments having an FBP / SBPase, further comprises an FBP / SBPase encoding nucleic acid sequence operably linked to a plant promoter.Further embodiments of this aspect include a promoter selected from a constitutive promoter, an inducible promoter, a tissue or cell type specific promoter, or an inducible tissue or cell type specific promoter. Further embodiments of this aspect include a CB protein that is a transketolase. In yet another embodiment of this aspect, the transketolase comprises an amino acid sequence having at least 70% sequence identity, at least 75% sequence identity, at least 80% sequence identity, at least 85% sequence identity, at least 90% sequence identity, at least 95% sequence identity, or at least 99% sequence identity to SEQ ID NO:41, SEQ ID NO:42, SEQ ID NO:43, SEQ ID NO:44, SEQ ID NO:45, SEQ ID NO:46, SEQ ID NO:47, SEQ ID NO:48, or SEQ ID NO:100. Further embodiments of this aspect include a transketolase that is localized in the chloroplast stroma of at least one chloroplast in a cell of a genetically modified plant. Yet another embodiment of this aspect, which can be combined with any of the previous embodiments having a transketolase, further includes a transketolase encoding nucleic acid sequence operably linked to a plant promoter. Further embodiments of this aspect include a promoter selected from a constitutive promoter, an inducible promoter, a tissue or cell type specific promoter, or an inducible tissue or cell type specific promoter.
[0012] Further embodiments of this aspect, which may be combined with any of the preceding embodiments having a CB protein that may be endogenous to the plant, include a nucleic acid encoding a CB protein that is endogenous. Further embodiments of this aspect include a promoter operably linked to the nucleic acid encoding the CB protein that is engineered to overexpress, inducibly express, express in a particular tissue or cell type, inducibly overexpress, or inducibly express in a particular tissue or cell type. Yet another embodiment of this aspect, which may be combined with any of the preceding embodiments having a CB protein, includes a nucleic acid encoding a CB protein that is heterologous.
[0013] Yet another embodiment of this aspect, which can be combined with any of the preceding embodiments having a Liske iron-sulfur protein encoding nucleic acid sequence, includes a nucleic acid encoding a Liske iron-sulfur protein that is endogenous. Further embodiments of this aspect include a promoter operably linked to the Liske iron-sulfur protein encoding nucleic acid that is engineered to overexpress, inducibly express, express in a particular tissue or cell type, inducibly overexpress, or inducibly express in a particular tissue or cell type. Yet another embodiment of this aspect, which can be combined with any of the preceding embodiments having a Liske iron-sulfur protein encoding nucleic acid sequence, includes a nucleic acid encoding a CB protein that is heterologous.
[0014] In yet another embodiment of this aspect that may be combined with any of the preceding embodiments, the plant has an increased biomass compared to an unmodified wild-type (WT) plant. -2 s -1 The present invention also includes plants that have improved water use efficiency compared to unmodified WT plants when grown under conditions having a light intensity greater than 100 nm. Further embodiments of this aspect include plants selected from the group of cowpea, soybean, cassava, rice, wheat, barley, tomato, potato, tobacco, canola, or other C3 crop plants. Yet another embodiment of this aspect includes plants selected from the group of cowpea, soybean, cassava, rice, wheat, barley, and tobacco.
[0015] Further embodiments of this aspect that may be combined with any of the preceding embodiments with respect to plant parts include plant parts that are leaves, stems, roots, tubers, flowers, seeds, kernels, grains, fruits, cells, or parts thereof, and parts of genetically modified plants that include one or more genetic modifications. Further embodiments of this aspect include plant parts that are fruits, tubers, kernels, or grains. Further embodiments of this aspect that may be combined with any of the preceding embodiments with respect to pollen grains or ovules include genetically modified pollen grains or genetically modified ovules of a plant of any one of the preceding embodiments, wherein the genetically modified pollen grains or genetically modified ovules include one or more genetic modifications. Further embodiments of this aspect that may be combined with any of the preceding embodiments include genetically modified protoplasts produced from a genetically modified plant of any of the preceding embodiments, wherein the genetically modified protoplasts include one or more genetic modifications. Further embodiments of this aspect, which may be combined with any of the preceding embodiments, include a genetically modified tissue culture produced from a protoplast or cell from a genetically modified plant of any one of the preceding embodiments, wherein the cell or protoplast is produced from a part of a plant selected from the group of leaves, mesophyll cells, anthers, pistils, stems, petioles, roots, root tips, tubers, fruits, seeds, kernels, grains, flowers, cotyledons, hypocotyls, embryos, or meristematic cells, and the genetically modified tissue culture comprises one or more genetic modifications. Further embodiments of this aspect include a genetically modified plant regenerated from the genetically modified tissue culture comprising one or more genetic modifications. Yet another embodiment of this aspect, which may be combined with any of the preceding embodiments, includes a genetically modified plant seed produced from a genetically modified plant of any one of the preceding embodiments.
[0016] Further aspects of the present disclosure include methods of producing a genetically modified plant of any of the foregoing embodiments, including: (a) introducing one or more genetic modifications that improve RuBP regeneration to increase the activity of a CB protein, one or more genetic modifications that improve photosynthetic electron transport, or both one or more genetic modifications that improve RuBP regeneration to increase the activity of a CB protein and one or more genetic modifications that improve photosynthetic electron transport into a plant cell, tissue, or other explant; (b) regenerating the plant cell, tissue, or other explant into a genetically modified plantlet; and (c) breeding the genetically modified plantlet into a genetically modified plant having one or more genetic modifications that improve RuBP regeneration to increase the activity of a CB protein, one or more genetic modifications that improve photosynthetic electron transport, or both one or more genetic modifications that improve RuBP regeneration to increase the activity of a CB protein and one or more genetic modifications that improve photosynthetic electron transport. Further embodiments of this aspect further include confirming successful introduction of one or more genetic modifications by screening or selecting plant cells, tissues, or other explants before step (b); screening or selecting plantlets between steps (b) and (c); or screening or selecting plants after step (c). In yet another embodiment of this aspect, which can be combined with any of the previous embodiments, the transformation is performed using a transformation method selected from the group of particle bombardment (i.e., biolistic, gene gun), Agrobacterium-mediated transformation, Rhizobium-mediated transformation, or protoplast transfection or transformation.
[0017] Yet another embodiment of this aspect, which can be combined with any of the previous embodiments, comprises a genetic modification introduced using a vector. In a further embodiment of this aspect, the vector comprises a promoter operably linked to nucleotides encoding one or more photosynthetic electron transport proteins, nucleotides encoding one or more CB proteins, or nucleotides encoding one or more photosynthetic electron transport proteins and one or more CB proteins. Yet another embodiment of this aspect comprises a promoter selected from the group of constitutive promoters, inducible promoters, tissue or cell type specific promoters, or inducible tissue or cell type specific promoters. In a further embodiment of this aspect, which can be combined with any of the previous embodiments, the photosynthetic electron transport protein is selected from the group of cytochrome c6 protein, Liske iron sulfur protein, or cytochrome c6 protein and Liske iron sulfur protein. In yet another embodiment of this aspect, the cytochrome c6 protein comprises an amino acid sequence having at least 70% sequence identity, at least 75% sequence identity, at least 80% sequence identity, at least 85% sequence identity, at least 90% sequence identity, at least 95% sequence identity, or at least 99% sequence identity to SEQ ID NO:49, SEQ ID NO:50, SEQ ID NO:51, SEQ ID NO:52, SEQ ID NO:53, SEQ ID NO:54, SEQ ID NO:55, SEQ ID NO:56, SEQ ID NO:57, SEQ ID NO:58, SEQ ID NO:59, SEQ ID NO:60, SEQ ID NO:61, SEQ ID NO:62, SEQ ID NO:63, SEQ ID NO:64, SEQ ID NO:65, SEQ ID NO:66, SEQ ID NO:67, SEQ ID NO:68, SEQ ID NO:69, SEQ ID NO:95, or SEQ ID NO:102.In yet another embodiment of this aspect, the Riske iron-sulfur protein comprises an amino acid sequence having at least 70% sequence identity, at least 75% sequence identity, at least 80% sequence identity, at least 85% sequence identity, at least 90% sequence identity, at least 95% sequence identity, or at least 99% sequence identity to SEQ ID NO:70, SEQ ID NO:71, SEQ ID NO:72, SEQ ID NO:73, SEQ ID NO:74, SEQ ID NO:75, SEQ ID NO:76, SEQ ID NO:77, SEQ ID NO:78, SEQ ID NO:79, SEQ ID NO:80, or SEQ ID NO: 101. In a further embodiment of this aspect, the vector comprises one or more gene editing components targeting a nuclear genomic sequence operably linked to a nucleic acid encoding a CB protein. In yet another embodiment of this aspect, the one or more gene editing components are selected from the group of: a ribonucleoprotein complex targeted to a nuclear genomic sequence; a vector comprising a sequence encoding a TALEN protein (wherein the TALEN protein targets a nuclear genomic sequence); a vector comprising a sequence encoding a ZFN protein (wherein the ZFN protein targets a nuclear genomic sequence); an oligonucleotide donor (ODN) (wherein the ODN targets a nuclear genomic sequence); or a vector comprising a sequence encoding a CRISPR / Cas enzyme and a targeting sequence (wherein the targeting sequence targets a nuclear genomic sequence).
[0018] In further embodiments of this aspect that may be combined with any of the preceding embodiments having a vector containing nucleotides encoding one or more CB proteins, the CB protein is selected from the group of sedoheptulose-1,7-bisphosphatase (SBPase), fructose-1,6-bisphosphate aldolase (FBPA), chloroplast fructose-1,6-bisphosphatase (FBPase), bifunctional fructose-1,6-bisphosphatase / sedoheptulose-1,7-bisphosphatase (FBP / SBPase), or transketolase (TK). In a further embodiment of this aspect, the CB protein is an SBPase, and the SBPase comprises an amino acid sequence having at least 70% sequence identity, at least 75% sequence identity, at least 80% sequence identity, at least 85% sequence identity, at least 90% sequence identity, at least 95% sequence identity, or at least 99% sequence identity to SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, or SEQ ID NO:96. In another embodiment of this aspect, the CB protein is FBPA, and the FBPA comprises an amino acid sequence having at least 70% sequence identity, at least 75% sequence identity, at least 80% sequence identity, at least 85% sequence identity, at least 90% sequence identity, at least 95% sequence identity, or at least 99% sequence identity to SEQ ID NO:15, SEQ ID NO:16, SEQ ID NO:17, SEQ ID NO:18, SEQ ID NO:19, SEQ ID NO:20, SEQ ID NO:21, SEQ ID NO:22, SEQ ID NO:23, SEQ ID NO:24, SEQ ID NO:25, SEQ ID NO:26, or SEQ ID NO:97.In yet another embodiment of this aspect, the CB protein is an FBPase, and the FBPase comprises an amino acid sequence having at least 70% sequence identity, at least 75% sequence identity, at least 80% sequence identity, at least 85% sequence identity, at least 90% sequence identity, at least 95% sequence identity, or at least 99% sequence identity to SEQ ID NO:27, SEQ ID NO:28, SEQ ID NO:29, SEQ ID NO:30, SEQ ID NO:31, SEQ ID NO:32, SEQ ID NO:33, SEQ ID NO:34, SEQ ID NO:35, SEQ ID NO:36, SEQ ID NO:37, or SEQ ID NO:98. In a further embodiment of this aspect, the CB protein is an FBP / SBPase, wherein the FBP / SBPase comprises an amino acid sequence having at least 70% sequence identity, at least 75% sequence identity, at least 80% sequence identity, at least 85% sequence identity, at least 90% sequence identity, at least 95% sequence identity, or at least 99% sequence identity to SEQ ID NO:38, SEQ ID NO:39, SEQ ID NO:40, or SEQ ID NO:99. In yet another embodiment of this aspect, the CB protein is a transketolase, wherein the transketolase comprises an amino acid sequence having at least 70% sequence identity, at least 75% sequence identity, at least 80% sequence identity, at least 85% sequence identity, at least 90% sequence identity, at least 95% sequence identity, or at least 99% sequence identity to SEQ ID NO:41, SEQ ID NO:42, SEQ ID NO:43, SEQ ID NO:44, SEQ ID NO:45, SEQ ID NO:46, SEQ ID NO:47, SEQ ID NO:48, or SEQ ID NO:100.
[0019] Further aspects of the present disclosure include a method of cultivating the genetically modified plant of any of the preceding embodiments having a genetically modified plant, the method comprising planting a genetically modified seedling, a genetically modified plantlet, a genetically modified cutting, a genetically modified tuber, a genetically modified root, or a genetically modified seed in soil to produce a genetically modified plant, or grafting the genetically modified seedling, the genetically modified plantlet, or the genetically modified cutting to a rootstock or a second plant grown in soil to produce a genetically modified plant; cultivating the plant to produce a harvestable seed, a harvestable leaf, a harvestable root, a harvestable cutting, a harvestable tree, a harvestable fruit, a harvestable kernel, a harvestable tuber, and / or a harvestable grain; and harvesting the harvestable seed, the harvestable leaf, the harvestable root, the harvestable cutting, the harvestable tree, the harvestable fruit, the harvestable kernel, the harvestable tuber, and / or the harvestable grain.
[0020] BRIEF DESCRIPTION OF THE DRAWINGS This patent or application contains at least one drawing executed in color. Copies of this patent or patent application publication with color drawing(s) will be provided by the Office upon request and payment of the necessary fee.
[0021] Figures 1A-1B show schematic diagrams of constructs used to generate transgenic N. tabacum lines. Figure 1A shows the constructs used to express FBP / SBPase (SynFBP / SBPase) in N. tabacum cv. Petit Havana (top, EC23083) and Porphyra umbilicalis cytochrome c6 (PuCytc6) (bottom, EC23028). Figure 1B shows the constructs (B2-C6) used to express cytochrome c6 (PuCytc6) in N. tabacum cv. Samsun. RB = T-DNA right border; pFMV = Figwort mosaic virus promoter; tNOS = nopaline synthase terminator; 35S = Cauliflower mosaic virus 35S promoter; HPT = A. thaliana heat shock protein 18.2 (HSP) terminator; LB = T-DNA left border; p2x35S = 2x Cauliflower mosaic virus 35S promoter; tHSP = A. thaliana heat shock protein 18.2 (HSP) terminator; pNos = nopaline synthase promoter; NPT II = neomycin phosphotransferase gene.
[0022] 2A-2E show the screening of transgenic plants overexpressing FBP / SBPase, SBPase, and cytochrome c6. B line (N. tabacum cultivar Petit Havana line expressing FBP / SBPase; S B lines 03, 06, 21, and 44), C6 lines (N. tabacum cultivar Petit Havana line expressing cytochrome c6; C6 lines 15, 41, 47, and 50), S B C6 line (N. tabacum cultivar Petit Havana line expressing FBP / SBPase and cytochrome c6; S BFigure 2B shows the transcript levels in S lines (SBPase-expressing N. tabacum cv. Samsun lines; S lines 30 and 60), SC6 lines (SBPase- and cytochrome c6-expressing N. tabacum cv. Samsun lines; SC6 lines 1, 2, and 3), and control lines (CN; both WT and azygous plants). Figure 2C ... B Lineage and S B Figures 2D-2E show FBPase activity in the C6 strain. -2 s -1 F in (PPFD) q ' / F m Figure 2D shows chlorophyll fluorescence imaging of plants grown under controlled environmental conditions, which was used to measure the maximum PSII operation efficiency (PSII- ... B lineage, C6 lineage and S B Figure 2C-2E shows the maximum PSII actuation efficiency of the C6 line (6 plants per line; 3-4 lines per manipulation). Figure 2E shows the maximum PSII actuation efficiency of the control (CN; WT plants), S line and SC6 line (CN = 11 plants per manipulation; S and SC6 lines = 6-7 plants per manipulation) at 650 PPFD. In Figures 2C-2E, asterisks indicate lines that are statistically different from the control group ( * P<0.05).
[0023] 3A-3B show biochemical analysis of transgenic N. tabacum cv. Petit Havana and N. tabacum cv. Samsun plants. FIG. 3A shows the FBP / SBPase (SBPase) activity in the extracts of transgenic N. tabacum cv. Petit Havana and N. tabacum cv. Samsun plants compared to the wild-type (WT) control plants (CN). B lines 03, 06, 21, and 44) and FBP / SBPase + cytochrome c6 (S BImmunoblot analysis of protein extracts representative of multiple experiments from mature leaves of N. tabacum cv. Petit Havana expressing SBPase (S lines S30 and S60) and SBPase + cytochrome c6 (SC6 lines 1, 2, and 3) compared to extracts from WT control plants (CN) and blotted against SBPase antibody. In Figures 3A-3B, expression of H protein from the glycine cleavage system (H protein), transketolase (TK), and Rubisco was used as loading control. Immunoblot analysis was repeated for multiple sets of plants and results shown are representative of a typical blot.
[0024] Figure 4 shows the complete data set of FBPase enzyme assays in the analyzed N. tabacum cv. Petit Havana plants shown in Figure 2C. The bars represent the FBPase activity in the tested transgenic lines relative to the FBPase activity in the controls (both WT and azygous plants). Each bar represents the FBPase activity in the SBPase expressing FBP / SBPase. B System (S B 03, S B 06, S B 21, S B 44; appears in the center and "S B "), which expresses FBP / SBPase + cytochrome c6 B C6 system (S B C1, S B C2, S B C3; displayed on the right side, "S BFigure 1. Individual plants from the control line (CN; both WT and azygous plants; shown in black on the left) and the control line (CN; both WT and azygous plants; shown in black on the left). The average control activity is shown as a black bar at 1.0 relative FBPase activity and labeled "CN."
[0025] Figures 5A-5B show biochemical analysis of transgenic N. tabacum cv. Petit Havana plants expressing cytochrome c6. Figure 5A shows immunoblot analysis of protein extracts from pools of developing leaves of C6 lines (C15, C41, and C47), a WT control line, and a null segregant (A) control line, as well as Porphyra umbilicalis crude protein extract (P). Figure 5B shows Ponceau staining of the immunoblot membrane in Figure 5A, revealing similar loading levels as the plant leaf extracts in Figure 5A.
[0026] 6A-6B show the average environmental conditions during the 2017 field experiments (i.e., experiments evaluating field-grown plants). Figure 6A shows the average daily light intensity (μmol m -2 s -1 ) are shown. Figure 6B shows air temperatures (°C) from the 2017 field experiments. In Figures 6A-6B, black = 2017 experiment 1, and grey = 2017 experiment 2.
[0027] 7A-7B show the photosynthetic response of transgenic plants grown under controlled conditions (i.e., greenhouse (GH)). Figures 7A-7B show the photosynthetic carbon fixation rate (A (μmol m -2 s -1 )), and the actual efficiency of PSII in light (F q ' / F m '), electron sinks derived from PSII (F q ' / F v '), and maximum efficiency of PSII (F v ' / F mThe parameters are saturation light level (400 μmol m -2 s -1 to 1000 μmol m -2 s -1 Natural light level in the greenhouse oscillated between 400 μmol m -2 s -1 Supplemental light was provided as needed to maintain a minimum irradiance level of 100 mC. i (μmol m -2 ) was determined as a function of FBP / SBPase (S B ), cytochrome c6 (C6), FBP / SBPase + cytochrome c6 (S B Figure 7B shows the photosynthetic response of mature leaves (i.e., 11-13 cm long; right column) of N. tabacum cv. Petit Havana lines expressing SBPase (S), SBPase + cytochrome c6 (SC6), and the control (CN; both WT and azygous plants). Figure 7C shows the photosynthetic response of mature leaves (left column) and developing leaves (i.e., 11-13 cm long; right column) of N. tabacum cv. Samsun lines expressing SBPase (S), SBPase + cytochrome c6 (SC6), and the control (CN; both WT and azygous plants). In Figures 7A-7B, three to four individual plants from three to four independent transgenic lines were evaluated. Asterisks indicate significance between transgenic and control groups as determined using a linear mixed-effects model and type III ANOVA, * P < 0.05, ** P < 0.01, *** P<0.001.
[0028] FIG. 8 shows that increasing expression of SBPase or increasing expression of FBP / SBPase + cytochrome c6 increases biomass in plants grown under controlled conditions (i.e., greenhouse (GH)). The left column of the graph shows the expression of FBP / SBPase (S B ), cytochrome c6 (C6), and FBP / SBPase + cytochrome c6 (S BFigure 1 shows the mean ± SE of plant height, leaf area, and aboveground biomass dry weight expressed as a percentage of control values for 40-day-old N. tabacum cv. Petit Havana lines expressing SBPase (S) and SBPase + cytochrome c6 (SC6). The right column of the graph shows the mean ± SE of plant height, leaf area, and aboveground biomass dry weight expressed as a percentage of control values for 56-day-old N. tabacum cv. Samsun lines expressing SBPase (S) and SBPase + cytochrome c6 (SC6). Five to six individual plants from two to four independent transgenic lines were evaluated. Values obtained for the control group, containing both WT and azygous plants, are shown as shades of grey set at 100% and are overlaid on the graph. Asterisks indicate significance between transgenic and control groups or between genotypes, determined using ANOVA with Tukey's post-hoc test. * P < 0.05, ** P < 0.01, *** P<0.001.
[0029] FIG. 9 shows that increased expression of SBPase or increased expression of FBP / SBPase + cytochrome c6 leads to increased biomass in GH-grown plants. The left column of the graph shows the expression of FBP / SBPase (S B ), cytochrome c6 (C6), and FBP / SBPase + cytochrome c6 (S BThe right column of the graphs shows the mean ± SE of leaf number, leaf dry weight, and stem dry weight expressed as a percentage of the control value for 40-day-old N. tabacum cv. Petit Havana lines expressing SBPase (S) and SBPase + cytochrome c6 (SC6). The right column of the graphs shows the mean ± SE of leaf number, leaf dry weight, and stem dry weight expressed as a percentage of the control value for 56-day-old N. tabacum cv. Samsun lines expressing SBPase (S) and SBPase + cytochrome c6 (SC6). Five to six individual plants from two to four independent transgenic lines were evaluated. Values obtained for the control group, containing both WT and azygous plants, are shown as grey shades set at 100% and are overlaid on the graphs. Asterisks indicate significance between transgenic and control groups or between genotypes, determined using ANOVA with Tukey's post-hoc test. * P < 0.05, ** P < 0.01, *** P<0.001.
[0030] 10A-10C show that co-expression of FBP / SBPase + cytochrome c6 increases biomass in field-grown plants. B 10A shows the mean ± SE of plant height, leaf area, and aboveground biomass dry weight expressed as a percentage of control values for 40-day-old (i.e., young) 2016 field-grown N. tabacum cv. Petit Havana plants expressing FBP / SBPase (S B Figure 10C shows the mean ± SE of plant height, leaf area, and aboveground biomass dry weight expressed as percentage of control values for 57-day-old field-grown N. tabacum cv. Petit Havana plants expressing cytochrome c6 (C6 line; light grey bars) or cytochrome c6 (C6 line; dark grey bars). Figure 10D shows the mean ± SE of plant height, leaf area, and aboveground biomass dry weight expressed as percentage of control values for 57-day-old field-grown N. tabacum cv. Petit Havana plants expressing cytochrome c6 (C6 line; dark grey bars) or FBP / SBPase + cytochrome c6 (S BFigure 10 shows the mean ± SE of plant height, leaf area, and aboveground biomass dry weight, expressed as a percentage of control values for 61-day-old (i.e., flowering stage) field-grown N. tabacum cv. Petit Havana plants expressing the WT-C6 line; white bars. Six individual plants from 2–3 independent transgenic lines (Figure 10A) or 24 individual plants from 2–3 independent transgenic lines (Figures 10B–10C) were evaluated. Values obtained for the control group, containing both WT and azygous plants, are shown as grey shades set at 100% and overlaid on the graphs. Asterisks indicate significance between transgenic and control groups or between genotypes using ANOVA with Tukey's post-hoc test, * P < 0.05, ** P < 0.01, *** P<0.001.
[0031] 11A-11B show the photosynthetic capacity of field-grown transgenic plants. B ), cytochrome c6 (C6), and control plants (CN; both WT and azygous plants) from field-grown N. tabacum cultivar Petit Havana line expressing C6 at saturating light levels. i (μmol m -2 Photosynthetic carbon fixation rate (A(μmol m )) as a function of -2 s -1 )) and PSII operating efficiency (F q ' / F m The inset bar graph shows the results for field-grown S B and C6N.tabacum cultivar Petit Havana line, and the maximum carbon fixation rate (A max ) Figure 11B shows the results of the analysis of cytochrome c6 (C6), FBP / SBPase + cytochrome c6 (S BC6), and control plants (CN; both WT and azygous plants) from field-grown N. tabacum cultivar Petit Havana line expressing increased CO2 concentration at saturating light levels (C i (μmol m -2 ) as a function of photosynthetic carbon fixation rate (A(μmol m -2 s -1 )) and PSII operating efficiency (Fq' / F m The inset bar shows the results for field-grown C6 and S B The maximum carbon fixation rate (A) of mature leaves from C6N.tabacum cultivars Petit Havana and CN max 11A-11B show the mean ± SE of 4-5 individual plants from 2-3 independent transgenic lines. Asterisks indicate significance between transgenic and control groups as determined by linear mixed-effects model and type III ANOVA. * P<0.05.
[0032] Figures 12A-12D show that co-expression of FBP / SBPase + cytochrome c6 increases water use efficiency under field conditions. Figure 12A shows the mean ± SE net CO2 assimilation rate (A (μmol m -2 s -1 ) and FIG. 12B shows the mean ± SE stomatal conductance (g s (mol m -2 s -1 )), and FIG. 12C shows the mean ± SE intercellular CO2 concentration (C i (μmol m -2 )), and FIG. 12D shows the mean ± SE potential water use efficiency (iWUE (A / g s )). The parameters shown in Figures 12A to 12D are cytochrome c6 (C6), FBP / SBPase + cytochrome c6 (S B C6), and control plants (CN; both WT and azygous plants) in the field-grown N. tabacum cultivar Petit Havana expressing light (PPFD (μmol m -2 s -1) are provided as a function of . Four to five individual plants from two to three independent transgenic lines were evaluated. Asterisks indicate significance between transgenic lines and control groups, determined using a linear mixed-effects model and type III ANOVA. * P < 0.05, ** P < 0.01, *** P<0.001.
[0033] Figures 13A-13D show the response of gas exchange parameters to absorbed light intensity in N. tabacum cv. Petit Havana plants expressing FBP / SBPase or cytochrome c6 in field experiment 1 in 2017. Figure 13A shows the response of gas exchange parameters to absorbed light intensity in N. tabacum cv. Petit Havana plants expressing FBP / SBPase or cytochrome c6 in field experiment 1 in 2017. -2 s -1 ) and FIG. 13B shows the stomatal conductance (g s (mol m -2 s -1 )), and FIG. 13C shows the intercellular CO2 concentration (C i (μmol m -2 ) and FIG. 13D shows the potential water use efficiency (iWUE(A / g s The parameters shown in Figures 13A to 13D are FBP / SBPase (S B ), cytochrome c6 (C6), and control plants (CN; both WT and azygous plants) in the field-grown N. tabacum cultivar Petit Havana line expressing PPFD (μmol m -2 s -1 ) are provided as a function of . Four to five individual plants from two to three independent transgenic lines were evaluated and the mean ± SE is shown. Asterisks indicate significance between groups as determined using a linear mixed-effects model and type III ANOVA. * P < 0.05, ** P < 0.01, *** P<0.001.
[0034] 14A to 14D show the enzyme activities of Chlamydomonas reinhardtii (C_reinhardtii_SBPase_XP_001691997.1 (SEQ ID NO: 13); C reinhardtii_SBPase_P46284.1 (SEQ ID NO: 14)), Zea mays (Z_mays_SBPase_NP_001148402.1 (SEQ ID NO: 10); Z_mays_SBPase_ONM36378.1 SEQ ID NO: 11)), Brachypodium distachyon (SEQ ID NO: 9), Triticum aestivum (T_aestivum_SBPase_P46285.1 (SEQ ID NO: 7); T_aestivum_SBPase_CBH32512.1 (SEQ ID NO: 8)), Arabidopsis thaliana (SEQ ID NO: 1), Brassica napus (SEQ ID NO: 2), Ananas comosus (SEQ ID NO: 6), Glycine max (SEQ ID NO: 12), Solanum lycopersicum (SEQ ID NO: 3), and Nicotiana tabacum (N_tabacum_SBPase_016455125.1 (SEQ ID NO: 4); N_tabacum_SBPase_016497321.1 (SEQ ID NO: 5)). FIG. 14A shows an alignment of the N-terminal parts of the SBPase polypeptides. FIG. 14B shows an alignment of the first part of the central part of the SBPase polypeptides (box indicates the cysteine residue to be mutated to produce a plant with a non-TRx (redox)-activated SBPase). FIG. 14C shows an alignment of the second part of the central part of the SBPase polypeptides. FIG. 14D shows the C-terminal part of the SBPase polypeptides.
[0035] 15A-15D show Chlamydomonas reinhardtii (SEQ ID NO:26), Arabidopsis thaliana (SEQ ID NO:17), Brassica napus (SEQ ID NO:18), Solanum lycopersicum (SEQ ID NO:15), Nicotiana tabacum (SEQ ID NO:16), Glycine max (G_max_FBPA_NP_001347079.1 (SEQ ID NO:22), G_max_FBPA1_XP_003522841.1 (SEQ ID NO:23)), Ananas comosus (SEQ ID NO:24), Zea mays (Z_mays_FBPA_ACG36798.1 (SEQ ID NO:19), Z_mays_FBPA_PWZ45921.1 (SEQ ID NO:20)), Triticum aestivum (SEQ ID NO:21), and Brachypodium Figure 15A shows an alignment of the N-terminal portions of the FBPA polypeptides. Figure 15B shows an alignment of a first portion of the central portions of the FBPA polypeptides. Figure 15C shows an alignment of a second portion of the central portions of the FBPA polypeptides. Figure 15D shows an alignment of the C-terminal portions of the FBPA polypeptides.
[0036] Figures 16A-16D show alignments of FBPase polypeptide sequences from Chlamydomonas reinhardtii (SEQ ID NO: 37), Zea mays (SEQ ID NO: 35), Brachypodium distachyon (SEQ ID NO: 33), Triticum aestivum (SEQ ID NO: 36), Arabidopsis thaliana (SEQ ID NO: 27), Brassica napus (SEQ ID NO: 34), Glycine max (G_max_FBPase_NP_001238269.2 (SEQ ID NO: 28); G_max_FBPase_XP_003552216.1 (SEQ ID NO: 29)), Nicotiana tabacum (SEQ ID NO: 30), and Solanum lycopersicum (SEQ ID NO: 32). Figure 16A shows an alignment of the N-terminal parts of the FBPase polypeptides. Figure 16B shows an alignment of the first part of the central part of the FBPase polypeptides. Figure 16C shows an alignment of the central second portion of the FBPase polypeptides. Figure 16D shows an alignment of the C-terminal portion of the FBPase polypeptides. In Figures 16B-16C, the boxes indicate the cysteine residues that should be mutated to produce plants with non-TRx (redox)-activated FBPase.
[0037] Figures 17A-17B show an alignment of FBP / SBPase polypeptide sequences from Synechocystis sp. PCC6803 (SEQ ID NO: 38), Synechocystis sp. PCC6714 (SEQ ID NO: 39) and Microcystis aeruginosa (SEQ ID NO: 40). Figure 17A shows an alignment of the N-terminal parts of the FBP / SBPase polypeptides. Figure 17B shows an alignment of the C-terminal parts of the FBP / SBPase polypeptides.
[0038] Figures 18A-18E show alignments of transketolase polypeptide sequences from Brachypodium distachyon (B_distachyon_TK_XP_003557240.1 (SEQ ID NO: 46); B_distachyon_TK_XP_003581128.1 (SEQ ID NO: 47)), Zea mays (SEQ ID NO: 45), Nicotiana tabacum (SEQ ID NO: 43), Solanum lycopersicum (SEQ ID NO: 44), Arabidopsis thaliana (A_thaliana_TK1 (SEQ ID NO: 41); A_thaliana_TK2 (SEQ ID NO: 48)), and Brassica napus (SEQ ID NO: 42). Figure 18A shows an alignment of the N-terminal parts of the transketolase polypeptides. Figure 18B shows an alignment of the first part of the central part of the transketolase polypeptides. Figure 18C shows an alignment of the second part of the central portion of the transketolase polypeptide. Figure 18D shows an alignment of the third part of the central portion of the transketolase polypeptide. Figure 18E shows an alignment of the C-terminal part of the transketolase polypeptide.
[0039] Figures 19A-19B show an alignment of the Liske iron-sulfur polypeptide sequences from Chlamydomonas reinhardtii (SEQ ID NO: 80), Ananas comosus (SEQ ID NO: 74), Zea mays (SEQ ID NO: 78), Oryza sativa (SEQ ID NO: 76), Triticum aestivum (SEQ ID NO: 75), Brachypodium distachyon (SEQ ID NO: 77), Arabidopsis thaliana (SEQ ID NO: 70), Brassica napus (SEQ ID NO: 71), Glycine max (SEQ ID NO: 79), Solanum lycopersicum (SEQ ID NO: 72), and Nicotiana tabacum (SEQ ID NO: 73). Figure 19A shows an alignment of the N-terminal portions of the Liske iron-sulfur polypeptides. Figure 19B shows an alignment of the C-terminal portions of the transketolase polypeptides.
[0040] 20A-20C show Chlamydomonas reinhardtii (SEQ ID NO: 49), Oscillatoria acuminata (SEQ ID NO: 68), Chamaesiphon polymorphus (SEQ ID NO: 69), Pyropia tenera (SEQ ID NO: 53), Porphyra umbilicalis (SEQ ID NO: 95), Porphyra purpurea (SEQ ID NO: 51), Bangia fuscopurpurea (SEQ ID NO: 50), Pyropia pulchra (SEQ ID NO: 52), Ulva fasciata (SEQ ID NO: 64), Thorea hispida (SEQ ID NO: 55), Gracilaria ferox (SEQ ID NO: 58), Gracilariopsis mclachlanii (SEQ ID NO: 62), Ahnfeltia plicata (SEQ ID NO: 56), Porolithon onkodes (SEQ ID NO: 57), Saccharina japonica (SEQ ID NO: 67), Sargassum confusum (SEQ ID NO: 59), Fucus vesiculosus var. FIG. 20A shows an alignment of the cytochrome c6 polypeptide sequences from Pseudomonas spiralis (SEQ ID NO: 65), Porphyridium purpureum (SEQ ID NO: 54), Trachydiscus minutus (SEQ ID NO: 60), Nannochloropsis oculata (SEQ ID NO: 66), Vischeria species CAUP Q (SEQ ID NO: 61), and Monodopsis species MarTras21 (SEQ ID NO: 63). FIG. 20A shows an alignment of the N-terminal part of the cytochrome c6 polypeptide. FIG. 20B shows an alignment of the central part of the cytochrome c6 polypeptide. FIG. 20C shows an alignment of the C-terminal part of the cytochrome c6 polypeptide.
[0041] Detailed Description The following description sets forth example methods, parameters, etc. However, it should be recognized that such description is not intended as a limitation on the scope of the present disclosure, but instead is provided as a description of example embodiments.
[0042] (Genetically modified plants and seeds)Aspects of the present disclosure include genetically modified plants, plant parts, or plant cells, where the plant, plant parts, or cells include one or more genetic modifications that increase the activity of CB protein, improve RuBP regeneration, and one or more genetic modifications that improve photosynthetic electron transport. Further embodiments of this aspect include one or more genetic modifications that improve photosynthetic electron transport, which are overexpression of one or more photosynthetic electron transport proteins. Yet another embodiment of this aspect includes one or more photosynthetic electron transport proteins selected from the group of cytochrome c6 protein, Liske iron-sulfur protein, or cytochrome c6 protein and Liske iron-sulfur protein. Further embodiments of this aspect include one or more photosynthetic electron transport proteins that are cytochrome c6 protein. Yet another embodiment of this aspect includes a cytochrome c6 protein that is an algal cytochrome c6 protein. In a further embodiment of this aspect, the algal cytochrome c6 protein has at least 70% sequence identity, at least 71% sequence identity, at least 72% sequence identity, at least 73% sequence identity, at least 74% sequence identity, at least 75% sequence identity, at least 76% sequence identity, or at least 77% sequence identity to SEQ ID NO:49, SEQ ID NO:50, SEQ ID NO:51, SEQ ID NO:52, SEQ ID NO:53, SEQ ID NO:54, SEQ ID NO:55, SEQ ID NO:56, SEQ ID NO:57, SEQ ID NO:58, SEQ ID NO:59, SEQ ID NO:60, SEQ ID NO:61, SEQ ID NO:62, SEQ ID NO:63, SEQ ID NO:64, SEQ ID NO:65, SEQ ID NO:66, SEQ ID NO:67, SEQ ID NO:68, SEQ ID NO:69, SEQ ID NO:95, or SEQ ID NO:102. at least 77% sequence identity, at least 78% sequence identity, at least 79% sequence identity, at least 80% sequence identity, at least 81% sequence identity, at least 82% sequence identity, at least 83% sequence identity, at least 84% sequence identity, at least 85% sequence identity, at least 86% sequence identity, at least 87% sequence identity, at least 88% sequence identity, at least 89% sequence identity, at least 90% sequence identity, at least 91% sequence identity, at least 92% sequence identity, at least 93% sequence identity, at least 94% sequence identity, at least 95% sequence identity, at least 96% sequence identity, at least 97% sequence identity, at least 98% sequence identity,or at least 99% sequence identity to SEQ ID NO:95. In a further embodiment of this aspect, the algal cytochrome c6 protein comprises an amino acid sequence having at least 70% sequence identity, at least 71% sequence identity, at least 72% sequence identity, at least 73% sequence identity, at least 74% sequence identity, at least 75% sequence identity, at least 76% sequence identity, at least 77% sequence identity, at least 78% sequence identity, at least 79% sequence identity, at least 80% sequence identity, at least 81% sequence identity, at least 82% sequence identity, at least 83% sequence identity, at least 84% sequence identity, at least 85% sequence identity, at least 86% sequence identity, at least 87% sequence identity, at least 88% sequence identity, at least 89% sequence identity, at least 90% sequence identity, at least 91% sequence identity, at least 92% sequence identity, at least 93% sequence identity, at least 94% sequence identity, at least 95% sequence identity, at least 96% sequence identity, at least 97% sequence identity, at least 98% sequence identity, at least 9 ... The present invention includes amino acid sequences having at least 84% sequence identity, at least 85% sequence identity, at least 86% sequence identity, at least 87% sequence identity, at least 88% sequence identity, at least 89% sequence identity, at least 90% sequence identity, at least 91% sequence identity, at least 92% sequence identity, at least 93% sequence identity, at least 94% sequence identity, at least 95% sequence identity, at least 96% sequence identity, at least 97% sequence identity, at least 98% sequence identity, or at least 99% sequence identity. In yet another embodiment of this aspect, the algal cytochrome c6 protein has at least 70% sequence identity, at least 71% sequence identity, at least 72% sequence identity, at least 73% sequence identity, at least 74% sequence identity, at least 75% sequence identity, at least 76% sequence identity, at least 77% sequence identity, at least 78% sequence identity, at least 79% sequence identity, at least 80% sequence identity, at least 81% sequence identity, at least 82% sequence identity to SEQ ID NO: 102. , at least 83% sequence identity, at least 84% sequence identity, at least 85% sequence identity, at least 86% sequence identity, at least 87% sequence identity, at least 88% sequence identity, at least 89% sequence identity, at least 90% sequence identity, at least 91% sequence identity, at least 92% sequence identity, at least 93% sequence identity, at least 94% sequence identity, at least 95% sequence identity, at least 96% sequence identity, at least 97% sequence identity, at least 98% sequence identity,or at least 99% sequence identity to SEQ ID NO:70, SEQ ID NO:71, SEQ ID NO:72, SEQ ID NO:73, SEQ ID NO:74, SEQ ID NO:75, SEQ ID NO:76, SEQ ID NO:77, SEQ ID NO:78, SEQ ID NO:79, SEQ ID NO:80, or SEQ ID NO:101. In a further embodiment of this aspect, the Riske iron-sulfur protein comprises an amino acid sequence having at least 70% sequence identity, at least 71% sequence identity, at least 72% sequence identity, at least 73% sequence identity, at least 74% sequence identity, at least 75% sequence identity, at least 76% sequence identity, at least 77% sequence identity, at least 78% sequence identity, at least 79% sequence identity, at least 80% sequence identity, at least 82% sequence identity, at least 83% sequence identity, at least 84% sequence identity, at least 85% sequence identity, at least 86% sequence identity, at least 87% sequence identity, at least 88% sequence identity, at least 89% sequence identity, at least 90% sequence identity, at least 91% sequence identity, at least 92% sequence identity, at least 93% sequence identity, at least 94% sequence identity, at least 95% sequence identity, at least 96% sequence identity, at least 97% sequence identity, at least 98% sequence identity, at least 9 ... The amino acid sequences include those having 1% sequence identity, at least 82% sequence identity, at least 83% sequence identity, at least 84% sequence identity, at least 85% sequence identity, at least 86% sequence identity, at least 87% sequence identity, at least 88% sequence identity, at least 89% sequence identity, at least 90% sequence identity, at least 91% sequence identity, at least 92% sequence identity, at least 93% sequence identity, at least 94% sequence identity, at least 95% sequence identity, at least 96% sequence identity, at least 97% sequence identity, at least 98% sequence identity, or at least 99% sequence identity. In yet another embodiment of this aspect, the Riske iron sulfur protein has at least 70% sequence identity, at least 71% sequence identity, at least 72% sequence identity, at least 73% sequence identity, at least 74% sequence identity, at least 75% sequence identity, at least 76% sequence identity, at least 77% sequence identity, at least 78% sequence identity, at least 79% sequence identity, at least 80% sequence identity, at least 81% sequence identity, at least 82% sequence identity, at least 83% sequence identity, at least 84% sequence identity, at least 85% sequence identity, at least 86% sequence identity, at least 87% sequence identity, at least 88% sequence identity, to SEQ ID NO:101.The present invention includes an amino acid sequence having at least 89% sequence identity, at least 90% sequence identity, at least 91% sequence identity, at least 92% sequence identity, at least 93% sequence identity, at least 94% sequence identity, at least 95% sequence identity, at least 96% sequence identity, at least 97% sequence identity, at least 98% sequence identity, or at least 99% sequence identity. Further embodiments of this aspect include one or more photosynthetic electron transport proteins that are cytochrome c6 protein and Riske iron-sulfur protein. In further embodiments of this aspect, the cytochrome c6 protein has at least 70% sequence identity, at least 71% sequence identity, at least 72% sequence identity, at least 73% sequence identity, at least 74% sequence identity, at least 75% sequence identity, at least 76% sequence identity, at least 77% sequence identity, at least 78% sequence identity, at least 79% sequence identity, at least 80% sequence identity, at least 81% sequence identity, to SEQ ID NO:49, SEQ ID NO:50, SEQ ID NO:51, SEQ ID NO:52, SEQ ID NO:53, SEQ ID NO:54, SEQ ID NO:55, SEQ ID NO:56, SEQ ID NO:57, SEQ ID NO:58, SEQ ID NO:59, SEQ ID NO:60, SEQ ID NO:61, SEQ ID NO:62, SEQ ID NO:63, SEQ ID NO:64, SEQ ID NO:65, SEQ ID NO:66, SEQ ID NO:67, SEQ ID NO:68, SEQ ID NO:69, SEQ ID NO:95, or SEQ ID NO:102. or at least 82% sequence identity, at least 83% sequence identity, at least 84% sequence identity, at least 85% sequence identity, at least 86% sequence identity, at least 87% sequence identity, at least 88% sequence identity, at least 89% sequence identity, at least 90% sequence identity, at least 91% sequence identity, at least 92% sequence identity, at least 93% sequence identity, at least 94% sequence identity, at least 95% sequence identity, at least 96% sequence identity, at least 97% sequence identity, at least 98% sequence identity, or at least 99% sequence identity; Riske iron-sulfur proteins include SEQ ID NO:70, SEQ ID NO:71, SEQ ID NO:72, SEQ ID NO:73, SEQ ID NO:74, SEQ ID NO:75, SEQ ID NO:76, SEQ ID NO:77, SEQ ID NO:78, SEQ ID NO:79,At least 70% sequence identity, at least 71% sequence identity, at least 72% sequence identity, at least 73% sequence identity, at least 74% sequence identity, at least 75% sequence identity, at least 76% sequence identity, at least 77% sequence identity, at least 78% sequence identity, at least 79% sequence identity, at least 80% sequence identity, at least 81% sequence identity, at least 82% sequence identity, at least 83% sequence identity, at least 84% sequence identity to SEQ ID NO:80 or SEQ ID NO:101 The amino acid sequences include those having at least 85% sequence identity, at least 86% sequence identity, at least 87% sequence identity, at least 88% sequence identity, at least 89% sequence identity, at least 90% sequence identity, at least 91% sequence identity, at least 92% sequence identity, at least 93% sequence identity, at least 94% sequence identity, at least 95% sequence identity, at least 96% sequence identity, at least 97% sequence identity, at least 98% sequence identity, or at least 99% sequence identity.
[0043] In yet another embodiment of this aspect, which may be combined with any of the previous embodiments having cytochrome c6, the cytochrome c6 protein is localized to the thylakoid lumen of at least one chloroplast in the cell of the genetically modified plant. A further embodiment of this aspect includes a cytochrome c6 protein comprising a transport peptide that localizes the cytochrome c6 protein to the thylakoid lumen. A further embodiment of this aspect includes a cytochrome c6 transport peptide selected from the group of chlorophyll a / b binding protein 6 transport peptide, light-harvesting complex I chlorophyll a / b binding protein 1 transport peptide, or plastocyanin signal peptide. In yet another embodiment of this aspect, which may be combined with any of the previous embodiments having Liske iron sulfur, the Liske iron sulfur protein comprises a transport peptide that localizes the Liske iron sulfur protein to the thylakoid membrane. Another embodiment of this aspect includes a Liske iron sulfur transport peptide that is a cytochrome b6f complex protein transport peptide. Further embodiments of this aspect include a Liske iron sulfur transport peptide selected from the group of cytochrome f transport peptide, cytochrome b6 transport peptide, PetD transport peptide, PetG transport peptide, PetL transport peptide, PetN transport peptide, PetM transport peptide, and plastoquinone transport peptide. Yet another embodiment of this aspect, which may be combined with any of the previous embodiments having cytochrome c6, further includes a nucleic acid sequence encoding a cytochrome c6 protein operably linked to a plant promoter. Further embodiments of this aspect include a promoter selected from a constitutive promoter, an inducible promoter, a tissue or cell type specific promoter, or an inducible tissue or cell type specific promoter. Yet another embodiment of this aspect, which may be combined with any of the previous embodiments having Liske iron sulfur, further includes a nucleic acid sequence encoding a Liske iron sulfur protein operably linked to a plant promoter. Further embodiments of this aspect include a promoter selected from a constitutive promoter, an inducible promoter, a tissue or cell type specific promoter, or an inducible tissue or cell type specific promoter.
[0044] In yet another embodiment of this aspect that can be combined with any of the previous embodiments, the one or more genetic modifications that improve RuBP regeneration include overexpression of a CB protein.A further embodiment of this aspect includes a CB protein selected from the group of sedoheptulose-1,7-bisphosphatase (SBPase), fructose-1,6-bisphosphate aldolase (FBPA), chloroplast fructose-1,6-bisphosphatase (FBPase), bifunctional fructose-1,6-bisphosphatase / sedoheptulose-1,7-bisphosphatase (FBP / SBPase), or transketolase (TK).A further embodiment of this aspect includes a CB protein that is an SBPase. In yet another embodiment of this aspect, the SBPase has at least 70% sequence identity, at least 71% sequence identity, at least 72% sequence identity, at least 73% sequence identity, at least 74% sequence identity, at least 75% sequence identity, at least 76% sequence identity, at least 77% sequence identity, at least 78% sequence identity, at least 79% sequence identity, at least 80% sequence identity, at least 82% sequence identity, at least 83% sequence identity, at least 84% sequence identity, at least 85% sequence identity, at least 86% sequence identity, at least 87% sequence identity, at least 88% sequence identity, at least 89% sequence identity, at least 90% sequence identity, at least 92% sequence identity, at least 94% sequence identity, at least 96% sequence identity, to SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, or SEQ ID NO:96. Any of the above amino acid sequences may have at least 81% sequence identity, at least 82% sequence identity, at least 83% sequence identity, at least 84% sequence identity, at least 85% sequence identity, at least 86% sequence identity, at least 87% sequence identity, at least 88% sequence identity, at least 89% sequence identity, at least 90% sequence identity, at least 91% sequence identity, at least 92% sequence identity, at least 93% sequence identity, at least 94% sequence identity, at least 95% sequence identity, at least 96% sequence identity, at least 97% sequence identity, at least 98% sequence identity, or at least 99% sequence identity.In yet another embodiment of this aspect, the SBPase has at least 70% sequence identity, at least 71% sequence identity, at least 72% sequence identity, at least 73% sequence identity, at least 74% sequence identity, at least 75% sequence identity, at least 76% sequence identity, at least 77% sequence identity, at least 78% sequence identity, at least 79% sequence identity, at least 80% sequence identity, at least 81% sequence identity, at least 82% sequence identity, at least 83% sequence identity, at least 84% sequence identity, at least 85% sequence identity, at least 86% sequence identity, at least 87% sequence identity, at least 88% sequence identity, at least 89% sequence identity, at least 90% sequence identity, at least 91% sequence identity, at least 92% sequence identity, at least 93% sequence identity, at least 94% sequence identity, at least 95% sequence identity, at least 96% sequence identity, at least 97% sequence identity, at least 98% sequence identity, at least 99% sequence identity, at least 100% sequence identity, at least 101% sequence identity, at least 102% sequence identity, at least 103% sequence identity, at least 104% sequence identity, at least 105% sequence identity, at least 106% sequence identity, at least 107% sequence identity, at least 108% sequence identity, at least 109% sequence identity, at least 110% sequence identity, at least 111% sequence identity, at least 112% sequence identity, at least 113% sequence identity, at least 114% sequence identity, at least 115% sequence identity, at least 116% sequence identity, at least 117% sequence identity, at least 118% sequence identity, at least 119% sequence identity, at least 120% sequence identity, at least 122% sequence identity, at least 123% sequence The SBPase comprises an amino acid sequence having at least 84% sequence identity, at least 85% sequence identity, at least 86% sequence identity, at least 87% sequence identity, at least 88% sequence identity, at least 89% sequence identity, at least 90% sequence identity, at least 91% sequence identity, at least 92% sequence identity, at least 93% sequence identity, at least 94% sequence identity, at least 95% sequence identity, at least 96% sequence identity, at least 97% sequence identity, at least 98% sequence identity, or at least 99% sequence identity. A further embodiment of this aspect includes the SBPase being localized to the chloroplast stroma of at least one chloroplast in the cell of the genetically modified plant. In yet another embodiment of this aspect, the SBPase comprises a transit peptide that localizes the SBPase to the chloroplast stroma. Yet another embodiment of this aspect, which can be combined with any of the previous embodiments having an SBPase, further comprises a nucleic acid sequence encoding an SBPase operably linked to a plant promoter. Further embodiments of this aspect include a promoter selected from a constitutive promoter, an inducible promoter, a tissue or cell type specific promoter, or an inducible tissue or cell type specific promoter. Further embodiments of this aspect include a CB protein that is an FBPA.In yet another embodiment of this aspect, the FBPA has at least 70% sequence identity, at least 71% sequence identity, at least 72% sequence identity, at least 73% sequence identity, at least 74% sequence identity, at least 75% sequence identity, at least 76% sequence identity, at least 77% sequence identity, at least 78% sequence identity, at least 79% sequence identity, at least 80% sequence identity, at least 82% sequence identity, or at least 83% sequence identity to SEQ ID NO:15, SEQ ID NO:16, SEQ ID NO:17, SEQ ID NO:18, SEQ ID NO:19, SEQ ID NO:20, SEQ ID NO:21, SEQ ID NO:22, SEQ ID NO:23, SEQ ID NO:24, SEQ ID NO:25, SEQ ID NO:26, or SEQ ID NO:97. The amino acid sequences include those having 1% sequence identity, at least 82% sequence identity, at least 83% sequence identity, at least 84% sequence identity, at least 85% sequence identity, at least 86% sequence identity, at least 87% sequence identity, at least 88% sequence identity, at least 89% sequence identity, at least 90% sequence identity, at least 91% sequence identity, at least 92% sequence identity, at least 93% sequence identity, at least 94% sequence identity, at least 95% sequence identity, at least 96% sequence identity, at least 97% sequence identity, at least 98% sequence identity, or at least 99% sequence identity.In yet another embodiment of this aspect, the FBPA has at least 70% sequence identity, at least 71% sequence identity, at least 72% sequence identity, at least 73% sequence identity, at least 74% sequence identity, at least 75% sequence identity, at least 76% sequence identity, at least 77% sequence identity, at least 78% sequence identity, at least 79% sequence identity, at least 80% sequence identity, at least 81% sequence identity, at least 82% sequence identity, at least 83% sequence identity, or at least 84% sequence identity, to SEQ ID NO:97. The FBPA comprises an amino acid sequence having 84% sequence identity, at least 85% sequence identity, at least 86% sequence identity, at least 87% sequence identity, at least 88% sequence identity, at least 89% sequence identity, at least 90% sequence identity, at least 91% sequence identity, at least 92% sequence identity, at least 93% sequence identity, at least 94% sequence identity, at least 95% sequence identity, at least 96% sequence identity, at least 97% sequence identity, at least 98% sequence identity, or at least 99% sequence identity. A further embodiment of this aspect comprises an FBPA localized to the chloroplast stroma of at least one chloroplast in a cell of a genetically modified plant. In yet another embodiment of this aspect, the FBPA comprises a transit peptide that localizes the FBPA to the chloroplast stroma. Yet another embodiment of this aspect, which can be combined with any of the previous embodiments having an FBPA, further comprises a nucleic acid sequence encoding the FBPA operably linked to a plant promoter. Further embodiments of this aspect include a promoter selected from a constitutive promoter, an inducible promoter, a tissue or cell type specific promoter, or an inducible tissue or cell type specific promoter. Further embodiments of this aspect include a CB protein that is an FBPase.In yet another embodiment of this aspect, the FBPase has at least 70% sequence identity, at least 71% sequence identity, at least 72% sequence identity, at least 73% sequence identity, at least 74% sequence identity, at least 75% sequence identity, at least 76% sequence identity, at least 77% sequence identity, at least 78% sequence identity, at least 79% sequence identity, at least 80% sequence identity, at least 81% sequence identity, or a combination thereof to SEQ ID NO:27, SEQ ID NO:28, SEQ ID NO:29, SEQ ID NO:30, SEQ ID NO:31, SEQ ID NO:32, SEQ ID NO:33, SEQ ID NO:34, SEQ ID NO:35, SEQ ID NO:36, SEQ ID NO:37, or SEQ ID NO:98. sequence identity, at least 82% sequence identity, at least 83% sequence identity, at least 84% sequence identity, at least 85% sequence identity, at least 86% sequence identity, at least 87% sequence identity, at least 88% sequence identity, at least 89% sequence identity, at least 90% sequence identity, at least 91% sequence identity, at least 92% sequence identity, at least 93% sequence identity, at least 94% sequence identity, at least 95% sequence identity, at least 96% sequence identity, at least 97% sequence identity, at least 98% sequence identity, or at least 99% sequence identity.In yet another embodiment of this aspect, the FBPase has at least 70% sequence identity, at least 71% sequence identity, at least 72% sequence identity, at least 73% sequence identity, at least 74% sequence identity, at least 75% sequence identity, at least 76% sequence identity, at least 77% sequence identity, at least 78% sequence identity, at least 79% sequence identity, at least 80% sequence identity, at least 81% sequence identity, at least 82% sequence identity, at least 83% sequence identity, at least 84% sequence identity, at least 85% sequence identity, at least 86% sequence identity, at least 87% sequence identity, at least 88% sequence identity, at least 89% sequence identity, at least 90% sequence identity, at least 91% sequence identity, at least 92% sequence identity, at least 93% sequence identity, at least 94% sequence identity, at least 95% sequence identity, at least 96% sequence identity, at least 97% sequence identity, at least 98% sequence identity, at least 99% sequence identity, at least 100% sequence identity, at least 101% sequence identity, at least 102% sequence identity, at least 103% sequence identity, at least 104% sequence identity, at least 105% sequence identity, at least 106% sequence identity, at least 107% sequence identity, at least 108% sequence identity, at least 109% sequence identity, at least 110% sequence identity, at least 111% sequence identity, at least 112% sequence identity, at least 113% sequence identity, at least 114% sequence identity, at least 115% sequence identity, at least 116% sequence identity, at least 117% sequence identity, at least 118% sequence identity, at least 119% sequence identity, at least 120% sequence identity, at least 122% sequence identity, at least 123% sequence The FBPase comprises an amino acid sequence having at least 84% sequence identity, at least 85% sequence identity, at least 86% sequence identity, at least 87% sequence identity, at least 88% sequence identity, at least 89% sequence identity, at least 90% sequence identity, at least 91% sequence identity, at least 92% sequence identity, at least 93% sequence identity, at least 94% sequence identity, at least 95% sequence identity, at least 96% sequence identity, at least 97% sequence identity, at least 98% sequence identity, or at least 99% sequence identity. A further embodiment of this aspect comprises an FBPase localized to the chloroplast stroma of at least one chloroplast in a cell of a genetically modified plant. In yet another embodiment of this aspect, the FBPase comprises a transit peptide that localizes the FBPase to the chloroplast stroma. Yet another embodiment of this aspect, which may be combined with any of the preceding embodiments having an FBPase, further comprises a nucleic acid sequence encoding an FBPase operably linked to a plant promoter. Further embodiments of this aspect include a promoter selected from a constitutive promoter, an inducible promoter, a tissue or cell type specific promoter, or an inducible tissue or cell type specific promoter. Further embodiments of this aspect include a CB protein that is an FBP / SBPase. Further embodiments of this aspect include an FBP / SBPase that is a cyanobacterial FBP / SBPase.In yet another embodiment of this aspect, the cyanobacterial FBP / SBPase has at least 70% sequence identity, at least 71% sequence identity, at least 72% sequence identity, at least 73% sequence identity, at least 74% sequence identity, at least 75% sequence identity, at least 76% sequence identity, at least 77% sequence identity, at least 78% sequence identity, at least 79% sequence identity, or a combination thereof to SEQ ID NO:38, SEQ ID NO:39, SEQ ID NO:40, or SEQ ID NO:99. sequence identity, at least 80% sequence identity, at least 81% sequence identity, at least 82% sequence identity, at least 83% sequence identity, at least 84% sequence identity, at least 85% sequence identity, at least 86% sequence identity, at least 87% sequence identity, at least 88% sequence identity, at least 89% sequence identity, at least 90% sequence identity, at least 91% sequence identity, at least 92% sequence identity, at least 93% sequence identity. In yet another embodiment of this aspect, the cyanobacterial FBP / SBPase comprises an amino acid sequence having at least 70% sequence identity, at least 71% sequence identity, at least 72% sequence identity, at least 73% sequence identity, at least 74% sequence identity, at least 75% sequence identity, at least 76% sequence identity, at least 77% sequence identity, at least 78% sequence identity, at least 79% sequence identity, at least 80% sequence identity, at least 81% sequence identity, at least 82% sequence identity, at least 83% sequence identity, to SEQ ID NO:99. The FBP / SBPase comprises an amino acid sequence having at least 84% sequence identity, at least 85% sequence identity, at least 86% sequence identity, at least 87% sequence identity, at least 88% sequence identity, at least 89% sequence identity, at least 90% sequence identity, at least 91% sequence identity, at least 92% sequence identity, at least 93% sequence identity, at least 94% sequence identity, at least 95% sequence identity, at least 96% sequence identity, at least 97% sequence identity, at least 98% sequence identity, or at least 99% sequence identity. Yet another embodiment of this aspect, which may be combined with any of the previous embodiments having an FBP / SBPase, comprises an FBP / SBPase that is localized to the chloroplast stroma of at least one chloroplast in a cell of a genetically modified plant. In a further embodiment of this aspect, the FBP / SBPase comprises a transit peptide that localizes the FBP / SBPase to the chloroplast stroma. Yet another embodiment of this aspect includes a transit peptide that is a plant chloroplast stroma protein transit peptide.Further embodiments of this aspect include a transport peptide selected from the group of geraniol synthase transport peptide, SBPase transport peptide, FBPA transport peptide, FBPase transport peptide, transketolase transport peptide, PGK transport peptide, GAPDH transport peptide, AGPase transport peptide, RPI transport peptide, RPE transport peptide, PRK transport peptide, or Rubisco transport peptide. Yet another embodiment of this aspect, which can be combined with any of the previous embodiments having an FBP / SBPase, further includes a nucleic acid sequence encoding an FBP / SBPase operably linked to a plant promoter. Further embodiments of this aspect include a promoter selected from a constitutive promoter, an inducible promoter, a tissue or cell type specific promoter, or an inducible tissue or cell type specific promoter. Further embodiments of this aspect include a CB protein that is a transketolase. In yet another embodiment of this aspect, the transketolase has at least 70% sequence identity, at least 71% sequence identity, at least 72% sequence identity, at least 73% sequence identity, at least 74% sequence identity, at least 75% sequence identity, at least 76% sequence identity, at least 77% sequence identity, at least 78% sequence identity, at least 79% sequence identity, at least 80% sequence identity, at least 81% sequence identity, at least 82% sequence identity, at least 83% sequence identity, at least 84% sequence identity, at least 85% sequence identity, at least 86% sequence identity, at least 87% sequence identity, at least 88% sequence identity, at least 89% sequence identity, at least 90% sequence identity, at least 91% sequence identity, at least 92% sequence identity, at least 93% sequence identity, at least 94% sequence identity, at least 95% sequence identity, at least 96% sequence identity, at least 97% sequence identity, at least 98% sequence identity, at least 99% sequence identity, at least 99% sequence identity, at least 98% sequence identity, at least 99% sequence identity, at least 99% sequence identity, at least 10 ... The present invention includes amino acid sequences having at least 82% sequence identity, at least 83% sequence identity, at least 84% sequence identity, at least 85% sequence identity, at least 86% sequence identity, at least 87% sequence identity, at least 88% sequence identity, at least 89% sequence identity, at least 90% sequence identity, at least 91% sequence identity, at least 92% sequence identity, at least 93% sequence identity, at least 94% sequence identity, at least 95% sequence identity, at least 96% sequence identity, at least 97% sequence identity, at least 98% sequence identity, or at least 99% sequence identity.In yet another embodiment of this aspect, the transketolase has at least 70% sequence identity, at least 71% sequence identity, at least 72% sequence identity, at least 73% sequence identity, at least 74% sequence identity, at least 75% sequence identity, at least 76% sequence identity, at least 77% sequence identity, at least 78% sequence identity, at least 79% sequence identity, at least 80% sequence identity, at least 81% sequence identity, at least 82% sequence identity, at least 83% sequence identity, at least The present invention relates to a method for producing a transketolase comprising the steps of: (a) detecting a transketolase gene in a plant cell; (b) detecting a transketolase gene in a plant cell; and (c) detecting a transketolase gene in a plant cell. The present invention relates to a method for producing ... Further embodiments of this aspect include a promoter selected from a constitutive promoter, an inducible promoter, a tissue or cell type specific promoter, or an inducible tissue or cell type specific promoter.
[0045] Further embodiments of this aspect, which may be combined with any of the preceding embodiments having a CB protein that is not an FBP / SBPase, include a nucleic acid encoding a CB protein that is endogenous. Further embodiments of this aspect include a promoter operably linked to a nucleic acid encoding a CB protein that has been engineered to overexpress, inducibly express, express in a particular tissue or cell type, inducibly overexpress, or inducibly express in a particular tissue or cell type. Yet another embodiment of this aspect, which may be combined with any of the preceding embodiments having a CB protein, includes a nucleic acid encoding a CB protein that is heterologous.
[0046] In yet another embodiment of this aspect that may be combined with any of the preceding embodiments, the plant has increased biomass compared to an unmodified wild-type (WT) plant. Further embodiments of this aspect include an increased biomass of 1000 μmol m -2 s -1The present invention includes plants that have improved water use efficiency compared to unmodified WT plants when grown under conditions with light levels greater than 100 nm. Further embodiments of this aspect include cowpea (e.g., black-eyed pea, catjang, yardlong bean, Vigna unguiculata), soybean (e.g., Glycine max, Glycine soja), cassava (e.g., manioc, yucca, Manihot esculenta), rice (e.g., indica rice, japonica rice, aromatic rice, glutinous rice, Oryza sativa, Oryza glaberrima), wheat (e.g., common wheat, spelt, durum, einkorn, emmer, kamut, Triticum aestivum, Triticum spelta, Triticum durum, Triticum urartu, Triticum monococcum, Triticum turanicum, Triticum species), barley (e.g., Hordeum vulgare), tomato (e.g., Solanum lycopersicum), potato (e.g., russet potato, yellow potato, red potato, Solanum tuberosum), tobacco (e.g., Nicotiana tabacum), canola (e.g., Brassica rapa, Brassica napus, Brassica juncea), or other C3 crop plants.Yet another embodiment of this aspect includes a plant selected from the group of cowpea (e.g., Vigna unguiculata), soybean (e.g., Glycine max, Glycine soja), cassava (e.g., manioc, yucca, Manihot esculenta), rice (e.g., Indica rice, Japonica rice, aromatic rice, glutinous rice, Oryza sativa, Oryza glaberrima), wheat (e.g., common wheat, spelt, durum, einkorn, emmer, kamut, Triticum aestivum, Triticum spelta, Triticum durum, Triticum urartu, Triticum monococcum, Triticum turanicum, Triticum species), barley (e.g., Hordeum vulgare), and tobacco (e.g., Nicotiana tabacum).
[0047] Further embodiments of this aspect, which may be combined with any of the preceding embodiments with respect to the plant part, include a plant part that is a leaf, stem, root, tuber, flower, seed, kernel, grain, fruit, cell, or part thereof, and a genetically modified plant part that contains one or more genetic modifications. Further embodiments of this aspect include a plant part that is a fruit, tuber, kernel, or grain. Further embodiments of this aspect, which may be combined with any of the preceding embodiments with respect to the pollen grain or ovule, include a genetically modified pollen grain or genetically modified ovule of a plant of any one of the preceding embodiments, wherein the genetically modified pollen grain or genetically modified ovule contains one or more genetic modifications. Further embodiments of this aspect, which may be combined with any of the preceding embodiments, include a genetically modified protoplast produced from a genetically modified plant of any of the preceding embodiments, wherein the genetically modified protoplast contains one or more genetic modifications. Further embodiments of this aspect, which may be combined with any of the preceding embodiments, include a genetically modified tissue culture produced from a protoplast or cell from a genetically modified plant of any one of the preceding embodiments, wherein the cell or protoplast is produced from a part of a plant selected from the group consisting of leaves, mesophyll cells, anthers, pistils, stems, petioles, roots, root tips, tubers, fruits, seeds, kernels, grains, flowers, cotyledons, hypocotyls, embryos, or meristematic cells, and the genetically modified tissue culture comprises one or more genetic modifications. Further embodiments of this aspect include a genetically modified plant regenerated from the genetically modified tissue culture comprising one or more genetic modifications. Yet another embodiment of this aspect, which may be combined with any of the preceding embodiments, includes a genetically modified plant seed produced from a genetically modified plant of any one of the preceding embodiments.
[0048] (Methods of Producing and Cultivating Genetically Modified Plants) Further aspects of the present disclosure include a method of producing a genetically modified plant of any of the preceding embodiments, comprising: (a) introducing into a plant cell, tissue, or other explant one or more genetic modifications that improve RuBP regeneration, that increase the activity of a CB protein, one or more genetic modifications that improve photosynthetic electron transport, or both one or more genetic modifications that improve RuBP regeneration and one or more genetic modifications that improve photosynthetic electron transport, that increase the activity of a CB protein; (b) regenerating the plant cell, tissue, or other explant into a genetically modified plantlet; and (c) growing the genetically modified plantlet into a genetically modified plant having one or more genetic modifications that improve RuBP regeneration, that increase the activity of a CB protein, one or more genetic modifications that improve photosynthetic electron transport, or both one or more genetic modifications that improve RuBP regeneration and one or more genetic modifications that improve photosynthetic electron transport that increase the activity of a CB protein. Further embodiments of this aspect further include confirming successful introduction of one or more genetic modifications by screening or selecting plant cells, tissues, or other explants prior to step (b); screening or selecting plantlets between steps (b) and (c); or screening or selecting plants after step (c). In yet another embodiment of this aspect, which can be combined with any of the preceding embodiments, the transformation is performed using a transformation method selected from the group of particle bombardment (i.e., biolistic, gene gun), Agrobacterium-mediated transformation, Rhizobium-mediated transformation, or protoplast transfection or transformation.
[0049] Yet another embodiment of this aspect, which can be combined with any of the previous embodiments, comprises a genetic modification introduced using a vector. In a further embodiment of this aspect, the vector comprises a promoter operably linked to nucleotides encoding one or more photosynthetic electron transport proteins, nucleotides encoding one or more CB proteins, or nucleotides encoding one or more photosynthetic electron transport proteins and one or more CB proteins. Yet another embodiment of this aspect comprises a promoter selected from the group of constitutive promoters, inducible promoters, tissue or cell type specific promoters, or inducible tissue or cell type specific promoters. In a further embodiment of this aspect, which can be combined with any of the previous embodiments, the photosynthetic electron transport protein is selected from the group of cytochrome c6 protein, Liske iron sulfur protein, or cytochrome c6 protein and Liske iron sulfur protein.In yet another embodiment of this aspect, the cytochrome c6 protein has at least 70% sequence identity, at least 71% sequence identity, at least 72% sequence identity, at least 73% sequence identity, at least 74% sequence identity, at least 75% sequence identity, at least 76% sequence identity, at least 77% sequence identity, at least 78% sequence identity to SEQ ID NO:49, SEQ ID NO:50, SEQ ID NO:51, SEQ ID NO:52, SEQ ID NO:53, SEQ ID NO:54, SEQ ID NO:55, SEQ ID NO:56, SEQ ID NO:57, SEQ ID NO:58, SEQ ID NO:59, SEQ ID NO:60, SEQ ID NO:61, SEQ ID NO:62, SEQ ID NO:63, SEQ ID NO:64, SEQ ID NO:65, SEQ ID NO:66, SEQ ID NO:67, SEQ ID NO:68, SEQ ID NO:69, SEQ ID NO:95, or SEQ ID NO:102. The present invention includes amino acid sequences having at least 79% sequence identity, at least 80% sequence identity, at least 81% sequence identity, at least 82% sequence identity, at least 83% sequence identity, at least 84% sequence identity, at least 85% sequence identity, at least 86% sequence identity, at least 87% sequence identity, at least 88% sequence identity, at least 89% sequence identity, at least 90% sequence identity, at least 91% sequence identity, at least 92% sequence identity, at least 93% sequence identity, at least 94% sequence identity, at least 95% sequence identity, at least 96% sequence identity, at least 97% sequence identity, at least 98% sequence identity, or at least 99% sequence identity. Figures 20A-20C show an alignment of exemplary cytochrome c6 protein polypeptide sequences.In yet another embodiment of this aspect, the Riske iron-sulfur protein has at least 70% sequence identity, at least 71% sequence identity, at least 72% sequence identity, at least 73% sequence identity, at least 74% sequence identity, at least 75% sequence identity, at least 76% sequence identity, at least 77% sequence identity, at least 78% sequence identity, at least 79% sequence identity, at least 80% sequence identity, at least 82% sequence identity, or at least 83% sequence identity to SEQ ID NO:70, SEQ ID NO:71, SEQ ID NO:72, SEQ ID NO:73, SEQ ID NO:74, SEQ ID NO:75, SEQ ID NO:76, SEQ ID NO:77, SEQ ID NO:78, SEQ ID NO:79, SEQ ID NO:80, or SEQ ID NO:101. The vector may comprise an amino acid sequence having at least 1% sequence identity, at least 82% sequence identity, at least 83% sequence identity, at least 84% sequence identity, at least 85% sequence identity, at least 86% sequence identity, at least 87% sequence identity, at least 88% sequence identity, at least 89% sequence identity, at least 90% sequence identity, at least 91% sequence identity, at least 92% sequence identity, at least 93% sequence identity, at least 94% sequence identity, at least 95% sequence identity, at least 96% sequence identity, at least 97% sequence identity, at least 98% sequence identity, or at least 99% sequence identity. Figures 19A-19B show an alignment of exemplary Liske iron-sulfur polypeptide sequences. In a further embodiment of this aspect, the vector comprises one or more gene editing components targeting a nuclear genomic sequence operably linked to a nucleic acid encoding a CB protein. In yet another embodiment of this aspect, the one or more gene editing components are selected from the group of: a ribonucleoprotein complex targeted to a nuclear genomic sequence; a vector comprising a sequence encoding a TALEN protein, where the TALEN protein targets a nuclear genomic sequence; a vector comprising a sequence encoding a ZFN protein, where the ZFN protein targets a nuclear genomic sequence; an oligonucleotide donor (ODN), where the ODN targets a nuclear genomic sequence; or a vector comprising a sequence encoding a CRISPR / Cas enzyme and a targeting sequence, where the targeting sequence targets a nuclear genomic sequence.
[0050] In further embodiments of this aspect that may be combined with any of the preceding embodiments having a vector comprising nucleotides encoding one or more CB proteins, the CB protein is selected from the group of sedoheptulose-1,7-bisphosphatase (SBPase), fructose-1,6-bisphosphate aldolase (FBPA), chloroplast fructose-1,6-bisphosphatase (FBPase), bifunctional fructose-1,6-bisphosphatase / sedoheptulose-1,7-bisphosphatase (FBP / SBPase), or transketolase (TK). In a further embodiment of this aspect, the CB protein is an SBPase and the SBPase has at least 70% sequence identity, at least 71% sequence identity, at least 72% sequence identity, at least 73% sequence identity, at least 74% sequence identity, at least 75% sequence identity, at least 76% sequence identity, at least 77% sequence identity, at least 78% sequence identity, at least 79% sequence identity, at least 80% sequence identity, to SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, or SEQ ID NO:96. The SBPase polypeptides include amino acid sequences having at least 81% sequence identity, at least 82% sequence identity, at least 83% sequence identity, at least 84% sequence identity, at least 85% sequence identity, at least 86% sequence identity, at least 87% sequence identity, at least 88% sequence identity, at least 89% sequence identity, at least 90% sequence identity, at least 91% sequence identity, at least 92% sequence identity, at least 93% sequence identity, at least 94% sequence identity, at least 95% sequence identity, at least 96% sequence identity, at least 97% sequence identity, at least 98% sequence identity, or at least 99% sequence identity. Figures 14A-14D show an alignment of exemplary SBPase polypeptide sequences.In another embodiment of this aspect, the CB protein is FBPA, and the FBPA has at least 70% sequence identity, at least 71% sequence identity, at least 72% sequence identity, at least 73% sequence identity, at least 74% sequence identity, at least 75% sequence identity, at least 76% sequence identity, at least 77% sequence identity, at least 78% sequence identity, at least 79% sequence identity, at least 80% sequence identity, at least 82% sequence identity, at least 83% sequence identity, at least 84% sequence identity, at least 85% sequence identity, at least 86% sequence identity, at least 87% sequence identity, at least 88% sequence identity, at least 89% sequence identity, at least 90% sequence identity, at least 92% sequence identity, at least 93% sequence identity, at least 94% sequence identity, at least 95% sequence identity, at least 96% sequence identity, at least 97% sequence identity, at least 98% sequence identity, at least 99% sequence identity, at least 98% sequence identity, at least 99% sequence identity, at least 99% sequence identity, at least 99% sequence identity, at least 99% sequence identity, at least 10 ... FBPA polypeptide sequences include amino acid sequences having at least 81% sequence identity, at least 82% sequence identity, at least 83% sequence identity, at least 84% sequence identity, at least 85% sequence identity, at least 86% sequence identity, at least 87% sequence identity, at least 88% sequence identity, at least 89% sequence identity, at least 90% sequence identity, at least 91% sequence identity, at least 92% sequence identity, at least 93% sequence identity, at least 94% sequence identity, at least 95% sequence identity, at least 96% sequence identity, at least 97% sequence identity, at least 98% sequence identity, or at least 99% sequence identity. Figures 15A-15D show alignments of exemplary FBPA polypeptide sequences.In yet another embodiment of this aspect, the CB protein is an FBPase and the FBPase has at least 70% sequence identity, at least 71% sequence identity, at least 72% sequence identity, at least 73% sequence identity, at least 74% sequence identity, at least 75% sequence identity, at least 76% sequence identity, at least 77% sequence identity, at least 78% sequence identity, at least 79% sequence identity, at least 80% sequence identity, at least 82% sequence identity, at least 83% sequence identity, at least 84% sequence identity, at least 85% sequence identity, at least 86% sequence identity, at least 87% sequence identity, at least 88% sequence identity, at least 89% sequence identity, at least 90% sequence identity, at least 91% sequence identity, at least 92% sequence identity, at least 93% sequence identity, at least 94% sequence identity, at least 95% sequence identity, at least 96% sequence identity, at least 97% sequence identity, at least 98% sequence identity, at least 99% sequence identity, at least 99% sequence identity, at least 98% sequence identity, at least 99% sequence identity, at least 99% sequence identity, at least 10 ... The FBPase polypeptides include amino acid sequences having at least 81% sequence identity, at least 82% sequence identity, at least 83% sequence identity, at least 84% sequence identity, at least 85% sequence identity, at least 86% sequence identity, at least 87% sequence identity, at least 88% sequence identity, at least 89% sequence identity, at least 90% sequence identity, at least 91% sequence identity, at least 92% sequence identity, at least 93% sequence identity, at least 94% sequence identity, at least 95% sequence identity, at least 96% sequence identity, at least 97% sequence identity, at least 98% sequence identity, or at least 99% sequence identity. Figures 16A-16D show an alignment of exemplary FBPase polypeptide sequences.In a further embodiment of this aspect, the CB protein is an FBP / SBPase and the FBP / SBPase has at least 70% sequence identity, at least 71% sequence identity, at least 72% sequence identity, at least 73% sequence identity, at least 74% sequence identity, at least 75% sequence identity, at least 76% sequence identity, at least 77% sequence identity, at least 78% sequence identity, at least 79% sequence identity, at least 80% sequence identity, at least 81% sequence identity, at least 82% sequence identity, to SEQ ID NO:38, SEQ ID NO:39, SEQ ID NO:40, or SEQ ID NO:99. The FBP / SBPase polypeptides include amino acid sequences having at least 83% sequence identity, at least 84% sequence identity, at least 85% sequence identity, at least 86% sequence identity, at least 87% sequence identity, at least 88% sequence identity, at least 89% sequence identity, at least 90% sequence identity, at least 91% sequence identity, at least 92% sequence identity, at least 93% sequence identity, at least 94% sequence identity, at least 95% sequence identity, at least 96% sequence identity, at least 97% sequence identity, at least 98% sequence identity, or at least 99% sequence identity. Figures 17A-17B show an alignment of exemplary FBP / SBPase polypeptide sequences.In yet another embodiment of this aspect, the CB protein is a transketolase, and the transketolase has at least 70% sequence identity, at least 71% sequence identity, at least 72% sequence identity, at least 73% sequence identity, at least 74% sequence identity, at least 75% sequence identity, at least 76% sequence identity, at least 77% sequence identity, at least 78% sequence identity, at least 79% sequence identity, at least 80% sequence identity, at least 81% sequence identity, to SEQ ID NO:41, SEQ ID NO:42, SEQ ID NO:43, SEQ ID NO:44, SEQ ID NO:45, SEQ ID NO:46, SEQ ID NO:47, SEQ ID NO:48, or SEQ ID NO:100. % sequence identity, at least 82% sequence identity, at least 83% sequence identity, at least 84% sequence identity, at least 85% sequence identity, at least 86% sequence identity, at least 87% sequence identity, at least 88% sequence identity, at least 89% sequence identity, at least 90% sequence identity, at least 91% sequence identity, at least 92% sequence identity, at least 93% sequence identity, at least 94% sequence identity, at least 95% sequence identity, at least 96% sequence identity, at least 97% sequence identity, at least 98% sequence identity, or at least 99% sequence identity. Figures 18A-18E show alignments of exemplary transketolase sequences.
[0051] Further aspects of the present disclosure include a method of cultivating the genetically modified plant of any of the preceding embodiments having the genetically modified plant, comprising planting the genetically modified seedling, genetically modified plantlet, genetically modified cutting, genetically modified tuber, genetically modified root, or genetically modified seed in soil to produce a genetically modified plant, or grafting the genetically modified seedling, genetically modified plantlet, or genetically modified cutting to a rootstock or a second plant grown in soil to produce a genetically modified plant; cultivating the plant to produce harvestable seeds, harvestable leaves, harvestable roots, harvestable cuttings, harvestable trees, harvestable fruits, harvestable kernels, harvestable tubers, and / or harvestable grains; and harvesting the harvestable seeds, harvestable leaves, harvestable roots, harvestable cuttings, harvestable trees, harvestable fruits, harvestable kernels, harvestable tubers, and / or harvestable grains.
[0052] (Molecular biological methods for producing genetically modified plants, plant parts, and plant cells) One aspect of the present invention provides a genetically modified plant, plant part, or plant cell having one or more CB proteins with modified expression and one or more photosynthetic electron transport proteins with modified expression compared to an unmodified plant, plant part, or plant cell. For example, the present disclosure provides a genetically modified plant, plant part, or plant cell having one or more CB proteins operably linked to a constitutive promoter, an inducible promoter, a tissue or cell type specific promoter, or an inducible tissue or cell type specific promoter, and one or more photosynthetic electron transport proteins, wherein a nucleic acid encoding one or more CB proteins and / or one or more photosynthetic electron transport proteins has been introduced by genetic modification of the plant, a promoter has been introduced by genetic modification of the plant, or both a nucleic acid encoding one or more CB proteins and / or one or more photosynthetic electron transport proteins and a promoter have been introduced by genetic modification of the plant.
[0053] The transformation and production of genetically modified monocotyledonous and dicotyledonous plant cells are well known in the art.See, for example, Weising et al., Ann. Rev. Genet. 22:421-477 (1988); U.S. Patent No. 5,679,558; Agrobacterium Protocols, ed.: Gartland, Humana Press Inc. (1995); Wang, et al. Acta Hort. 461:401-408 (1998), and Broothaerts, et al. Nature 433:629-633 (2005). The choice of method varies depending on the type of plant to be transformed, the specific application, and / or the desired result. The appropriate transformation technique can be easily selected by those skilled in the art.
[0054] Any methodology known in the art for deleting, inserting or otherwise modifying cellular DNA (e.g., genomic DNA and organelle DNA) can be used in the practice of the present invention disclosed herein.As an example, CRISPR / Cas-9 system and related systems (e.g., TALEN, ZFN, ODN, etc.) can be used to insert heterologous genes into target sites in genomic DNA, or to substantially edit endogenous genes to express heterologous genes, or to modify promoters to increase or otherwise change the expression of endogenous genes, for example, by removing repressor binding sites or introducing enhancer binding sites. For example, a disarmed Ti plasmid containing a genetic construct for target gene deletion or insertion in Agrobacterium tumefaciens can be used to transform plant cells, and transformed plants can then be regenerated from the transformed plant cells using means described in the art, for example, in EP 0116718, EP 0270822, PCT Application WO 84 / 02913, and published European Patent Application ("EP") 0242246. The Ti plasmid vectors each contain a gene located between the border sequences, or at least to the left of the right border sequence, of the T-DNA of the Ti plasmid.Of course, other types of vectors can be used for direct gene transfer (e.g., as described in EP 0233247), pollen-mediated transformation (e.g., as described in EP 0270356, PCT Application WO 85 / 01856, and U.S. Pat. No. 4,684,611), plant RNA virus-mediated transformation (e.g., as described in EP 0067553 and U.S. Pat. No. 4,407,956), liposome-mediated transformation (e.g., as described in U.S. Pat. No. 4,536,475), and methods for transforming certain strains of maize (e.g., U.S. Pat. No. 6,140,553; Fromm et al., Bio / Technology (1990) 8, 833-839; Gordon-Kamm et al., The Plant Cell, (1990) 2, 603-618), rice (Shimamoto et al., Nature, (1989) 338, 274-276; Datta et al., Bio / Technology, (1990) 8, 736-740), as well as other methods such as methods for transforming monocotyledonous plants in general (PCT Application WO 92 / 09696). For the transformation of cotton, the method described in PCT Application WO 00 / 71733 can be used. For the transformation of soybean, reference is made to methods known in the art, such as, for example, the methods of Hinchee et al., (Bio / Technology, (1988) 6, 915) and Christou et al., (Trends Biotech, (1990) 8, 145) or the method of WO 00 / 42207.
[0055] The genetically modified plants of the present invention can be used in conventional plant breeding schemes to produce more genetically modified plants with the same characteristics, or to introduce the genetic modification into other varieties of the same or related plant species. The seeds obtained from the modified plants preferably contain the genetic modification as a stable insertion in chromosomal DNA or as a modification to an endogenous gene or promoter. Plants containing a genetic modification according to the present invention include plants that contain or are derived from the rootstock of a plant containing the genetic modification of the present invention, such as fruit trees, or ornamental plants. Thus, any non-transgenic plant part that is grafted with a transformed plant or part of a plant is included in the present invention.
[0056] The genetic modifications of the present disclosure, including expression vectors or expression cassettes that result in expression of an introduced gene or modified expression of an endogenous gene, typically utilize a plant-expressible promoter. As used herein, a "plant-expressible promoter" refers to a promoter that ensures expression of the genetic modifications of the present invention in plant cells. Examples of constitutive promoters frequently used in plant cells include the cauliflower mosaic (CaMV) 35S promoter (KAY et al., Science, 236, 4805, 1987), the minimal CaMV 35S promoter (Benfey & Chua, Science, (1990)250, 959-966), various other derivatives of the CaMV 35S promoter, the Striga mosaic virus (FMV) promoter (Richins, et al., Nucleic Acids Res. (1987) 15:8451-8466), the maize ubiquitin promoter (CHRISTENSEN & QUAIL, Transgenic Res, 5, 213-8, 1996), the white clover promoter (Ljubql, MAEKAWA et al. Mol Plant Microbe Interact. 21, 375-82, 2008), the vein mosaic cassava virus promoter (International Application WO 97 / 48819), and the Arabidopsis UBQ10 promoter, Norris et al. Plant Mol. Biol. 21,895-906,1993).
[0057] Further examples of promoters that direct constitutive expression in plants are known in the art, including the strong constitutive 35S promoter ("35S promoter") of the cauliflower mosaic virus (CaMV), e.g., isolates CM 1841 (Gardner et al., Nucleic Acids Res, (1981) 9, 2871-2887), CabbB S (Franck et al., Cell (1980) 21, 285-294), and CabbB JI (Hull and Howell, Virology, (1987) 86, 482-493); promoters from the ubiquitin family (e.g., the maize ubiquitin promoter, Christensen et al., Plant Mol Biol, (1992) 18,675-689), the gos2 promoter (de Pater et al., The Plant J (1992) 2, 834-844), the emu promoter (Last et al., Theor Appl Genet, (1990) 81, 581-588), actin promoters such as the promoter described by An et al. (The Plant J, (1996) 10 107), the rice actin promoter described by Zhang et al. (The Plant Cell, (1991) 3, 1155-1165); the promoter of Scrophulariaceous mosaic virus (FMV) (Richins et al., Nucleic Acids Res. (1987) 15:8451-8466), the cassava vein mosaic virus promoter (WO97 / 48819; Verdaguer et al., Plant Mol Biol, (1998) 37, 1055-1067), the pPLEX series of promoters from Subterranean clover stunt virus (WO96 / 06932, particularly the S4 or S7 promoters), the alcohol dehydrogenase promoter, e.g., pAdh1S (GenBank Accession Nos. X04049, X00581), and the TR1' and TR2' promoters (the "TR1' promoter" and "TR2' promoter", respectively) which drive expression of the 1' and 2' genes of T DNA, respectively (Velten et al., EMBO J, (1984) 3, 2723-2730).
[0058] Alternatively, the plant-expressible promoter can be a tissue-specific promoter, i.e., a promoter that directs higher levels of expression in some cells or tissues of a plant, for example, green tissues (such as the promoter of chlorophyll a / b binding protein (Cab)). The plant Cab promoter (Mitra et al., Planta, (2009) 5:1015-1022) has been described as a strong bidirectional promoter for expression in green tissues (e.g., leaves and stems) and is useful in one embodiment of the present invention. These plant-expressible promoters can be combined with enhancer elements, they can be combined with minimal promoter elements, or they can contain repetitive elements to ensure the desired expression profile.
[0059] Further non-limiting examples of tissue specific promoters include the maize allothionein promoter (DE FRAMOND et al, FEBS 290, 103-106, 1991; European Patent Application Publication No. 452269), the chitinase promoter (SAMAC et al. Plant Physiol 93, 907-914, 1990), the maize ZRP2 promoter (U.S. Pat. No. 5,633,363), the tomato LeExtl promoter (Bucher et al. Plant Physiol. 128, 911-923, 2002), the glutamine synthetase soybean root promoter (HIREL et al. Plant Mol. Biol. 20, 207-218, 1992), the RCC3 promoter (PCT Application Publication No. WO 2009 / 016104), the rice antiquitine promoter (R. promoter) (PCT Application WO 2007 / 076115), LRR receptor kinase promoter (PCT Application WO 02 / 46439), and Arabidopsis pCO2 promoter (HEIDSTRA et al, Genes Dev. 18, 1964-1969, 2004). Further non-limiting examples of tissue-specific promoters include the RbcS2B promoter, the RbcS1B promoter, the RbcS3B promoter, the LHB1B1 promoter, the LHB1B2 promoter, the cab1 promoter, and other promoters described in Engler et al., ACS Synthetic Biology, DOI:10.1021 / sb4001504, 2014. These plant promoters can be combined with enhancer elements, which can be combined with minimal promoter elements, or can contain repetitive elements to ensure the desired expression profile.
[0060] In some embodiments, additional genetic modifications can be utilized to increase expression in plant cells.For example, introns at the 5' or 3' end of the introduced gene, or introns in the coding sequence of the introduced gene, such as the hsp70 intron.Other such genetic elements include, but are not limited to, promoter enhancer elements, duplicated or triple promoter regions, 5' leader sequences that are different from other introduced genes or different from endogenous (plant host) gene leader sequences, 3' trailer sequences that are different from other introduced genes or different from endogenous (plant host) trailer sequences used in the same plant.
[0061] The introduced genes of the present disclosure may be inserted into the host cell DNA such that the inserted gene portion is upstream (i.e., 5') of appropriate 3'-end transcriptional regulatory signals (i.e., transcript formation and polyadenylation signals). This is preferably accomplished by inserting the gene into the plant cell genome (nucleus or chloroplast). Preferred polyadenylation and transcript formation signals include the nopaline synthase gene (Depicker et al., J. Molec Appl Gen, (1982) 1, 561-573), the octopine synthase gene (Gielen et al., EMBO J, (1984) 3:835-845), the SCSV or Malic enzyme terminator (Schunmann et al., Plant Funct Biol, (2003) 30:453-460), and the T DNA gene 7, which acts as a 3' non-translated DNA sequence in transformed plant cells (Velten and Schell, Nucleic Acids Res, (1985) 13, 6981-6998). In some embodiments, one or more introduced genes are stably integrated into the nuclear genome. Stable integration exists when the nucleic acid sequence remains integrated into the nuclear genome and continues to be expressed (i.e., detectable mRNA transcripts or proteins are produced) throughout the subsequent generation of the plant. Stable integration into the nuclear genome can be achieved by any method known in the art (e.g., microparticle bombardment, Agrobacterium-mediated transformation, CRISPR / Cas9, electroporation of protoplasts, microinjection, etc.).
[0062] The term recombinant or modified nucleic acid refers to a polynucleotide created by the combination of two otherwise separate segments of sequence, accomplished by the artificial manipulation of isolated segments of polynucleotides, by genetic engineering techniques or chemical synthesis, whereby polynucleotide segments of desired functions can be ligated together to produce a desired combination of functions.
[0063] As used herein, the term "overexpression" refers to increased expression as a result of genetic modification (e.g., mRNA, polypeptide, etc.) compared to expression in a wild-type organism (e.g., a plant), and may refer to expression of a heterologous gene at a level sufficient to achieve a desired result, such as increased yield. In some embodiments, the increase in expression is a slight increase, about 10% more than expression in the wild-type. In some embodiments, the increase in expression is an increase of 50% or more (e.g., 60%, 70%, 80%, 100%, etc.) compared to expression in the wild-type. In some embodiments, an endogenous gene is upregulated. In some embodiments, an exogenous gene is upregulated by the potency with which it is expressed. Upregulation of genes in plants can be achieved through any method known in the art, including, but not limited to, constitutive promoters with added inducible response elements, inducible promoters, high expression promoters with added inducible response elements (e.g., the PsaD promoter), enhancers, transcriptional and / or translational regulatory sequences, codon optimization, modified transcription factors, and / or mutant or modified genes that control the expression of genes that are upregulated in response to stimuli such as cytokinin signaling.
[0064] When a recombinant nucleic acid is intended for the expression, cloning, or replication of a particular sequence, the DNA construct prepared for introduction into a host cell typically includes a replication system (e.g., a vector) that is recognized by the host, containing the intended DNA fragment encoding the desired polypeptide, and may also include transcription and translation initiation regulatory sequences operably linked to the polypeptide-encoding segment. In addition, such a construct may include a cellular localization signal (e.g., a plasma membrane localization signal). In a preferred embodiment, such a DNA construct is introduced into the genomic DNA, chloroplast DNA, or mitochondrial DNA of the host cell.
[0065] In some embodiments, non-integrated expression systems can be used to induce the expression of one or more introduced genes. Expression systems (expression vectors) can include, for example, origins of replication, or autonomously replicating sequences (ARS) and expression control sequences, promoters, enhancers, and necessary processing information sites (e.g., ribosome binding sites, RNA splice sites, polyadenylation sites, transcription terminator sequences, and mRNA stabilization sequences). Signal peptides can also be included from secreted polypeptides of the same or related species, where appropriate, that allow the protein to cross and / or remain in the cell membrane, cell wall, or secreted from the cell.
[0066] The selection marker that is effective in carrying out the methodology of the invention disclosed herein can be a positive selection marker. Typically, positive selection refers to the case where genetically modified cells can survive in the presence of toxic substances only when the recombinant polynucleotide of interest is present in the cells. Negative selection markers and screenable markers are also well known in the art and are contemplated by the present invention. Those skilled in the art will recognize that any relevant marker available can be utilized in carrying out the invention disclosed herein.
[0067] Screening and molecular analysis of the recombinant lines of the present invention can be performed using nucleic acid hybridization techniques. Hybridization procedures are useful for identifying polynucleotides (e.g., polynucleotides modified using the techniques described herein) with sufficient homology to the subject regulatory sequences to be utilized as taught herein. A particular hybridization technique is not essential to the subject invention. As improvements in hybridization techniques are made, they can be readily applied by those of skill in the art. Hybridization probes can be labeled with any suitable label known to those of skill in the art. Hybridization and washing conditions (e.g., temperature and concentration) can be altered to change the stringency of detection threshold. For further guidance regarding hybridization conditions, see, for example, Sambrook et al. (1989) vide infra, or Ausubel et al. (1995) Current Protocols in Molecular Biology, John Wiley & Sons, NY, NY.
[0068] Furthermore, screening and molecular analysis of genetically modified strains, as well as the production of desired isolated nucleic acids, can be carried out using polymerase chain reaction (PCR). PCR is the repeated, enzymatic, preparatory synthesis of nucleic acid sequences. This means is well known and commonly used by those skilled in the art (see Mullis, U.S. Pat. Nos. 4,683,195, 4,683,202, and 4,800,159; Saiki et al. (1985) Science 230:1350-1354). PCR is based on the enzymatic amplification of a DNA fragment of interest that is flanked by two oligonucleotide primers that hybridize to opposite strands of the target sequence. The primers are oriented with their 3' ends pointing towards each other. Repeated cycles of thermal denaturation of the template, annealing of the primers to their complementary sequences, and extension of the annealed primers with DNA polymerase result in the amplification of the segment defined by the 5' ends of the PCR primers. Since the extension product of each primer can serve as a template for the other primer, each cycle essentially doubles the amount of DNA template produced in the previous cycle. This results in an exponential accumulation of specific target fragments, up to millions of times in a few hours. The amplification process can be fully automated by using a thermostable DNA polymerase, such as Taq polymerase, which is isolated from the thermophilic bacterium Thermus aquaticus. Other enzymes that can be used are known to those skilled in the art.
[0069] The nucleic acids and proteins of the present invention can also encompass homologues of the specifically disclosed sequences. Homology (e.g., sequence identity) can be 50% to 100%. In some instances, such homology is greater than 80%, greater than 85%, greater than 90%, or greater than 95%. The degree of homology or identity required for any intended use of the sequence is easily identified by one of skill in the art. As used herein, the percentage of sequence identity of two nucleic acids is determined using algorithms known in the art, such as those disclosed by Karlin and Altschul (1990) Proc. Natl. Acad. Sci. USA 87:2264-2268, and modified as in Karlin and Altschul (1993) Proc. Natl. Acad. Sci. USA 90:5873-5877. Such algorithms are incorporated into the programs BLASTN, BLASTP, and BLASTX of Altschul et al. (1990) J. Mol. Biol. 215:402-410. BLAST nucleotide searches are performed using the BLASTN program (score=100, word length=12) to obtain nucleotide sequences with a desired percentage of sequence identity. To obtain gapped alignments for comparison purposes, Gapped BLAST is utilized as described in Altschul et al. (1997) Nucl. Acids. Res. 25:3389-3402. When utilizing BLAST and Gapped BLAST programs, the default parameters of each program (BLASTN and BLASTX) are used. See www.ncbi.nih.gov.Those skilled in the art can easily determine the sequence of interest where positions corresponding to amino acids or nucleic acids in the reference sequence occur by aligning the sequence of interest with the reference sequence using a suitable BLAST program with default settings (e.g., for BLASTP: gap opening penalty: 11, gap extension penalty: 1, expectation: 10, word size: 3, maximum score: 25, maximum alignment: 15, and matrix: blosum62; and for BLASTN: gap opening penalty: 5, gap extension penalty: 2, kernel match: 1, kernel mismatch -3, expectation: 10, word size: 11, maximum score: 25, and maximum alignment: 15).
[0070] The preferred host cell is a plant cell. A recombinant host cell, in this context, is one that is genetically modified and contains an isolated nucleic acid molecule, or contains one or more deleted or otherwise non-functional genes that are normally present and functional in the host cell, or contains one or more genes for producing at least one recombinant protein. The nucleic acid encoding the protein of the present invention can be introduced by any means known to those skilled in the art that is suitable for the particular type of cell, including, but not limited to, transformation, lipofection, electroporation, or any other method known to those skilled in the art.
[0071] Having generally described the invention, the invention will be better understood by reference to certain specific examples which are included herein to further illustrate the invention and are not intended to limit the scope of the invention as defined by the claims.
[0072] [Example] The present disclosure will be described in more detail in the following examples.These examples are not intended to limit the scope of the present disclosure in any way.The accompanying drawings are intended to be considered as an integral part of the specification and description of the present disclosure.The following examples are provided for illustrative purposes, but do not limit the present disclosure.
[0073] Example 1: Generation of constructs and transgenic N. tabacum plants To test the combination of manipulation of genes involved in RuBP regeneration with manipulation of genes involved in electron transport, the following examples describe the generation of constructs and transgenic N. tabacum plants. Nicotiana tabacum cv. Petit Havana and Nicotiana tabacum cv. Samsun were used, as two different tobacco varieties with very different growth habits.
[0074] (material and method) Construct generation: Constructs were generated using Golden Gate cloning (Engler et al., Plos One (2009)4; Engler et al., Plos One (2008)3:e3647) or Gateway cloning technology (Nakagawa et al., J. Biosci. Bioeng. (2007)104:34-41). Transgenes were expressed under the control of CaMV35S and FMV constitutive promoters.
[0075] For the Nicotiana tabacum cv. Petit Havana transgenic lines, a cyanobacterial bifunctional fructose-1,6-bisphosphatase / sedoheptulose-1,7-bisphosphatase (FBP / SBPase; slr2094 Synechocystis sp. PCC 7942 (Miyagawa et al., Nat. Biotechnol. (2001)19:965-969)) linked to a geraniol synthase transit peptide (Simkin et al., Phytochemistry (2013)85:36-43) was codon optimized, and P. umbilicalis cytochrome c6 (AFC39870) with a chlorophyll a / b binding protein 6 transit peptide from Arabidopsis thaliana (AT3G54890) was codon optimized using FMV (Richins et al., Nucleic Acids Res. (1987)15;8451-8466) and CaMV 35S promoters, respectively, were used to generate Golden Gate (Engler et al., Plos One (2008)3:e3647) overexpression constructs (EC23083 and EC23028) (Figure 1A).
[0076] For the N. tabacum cultivar Samsun transgenic line, the full-length P. umbilicalis cytochrome c6 gene linked to a transit peptide from light-harvesting complex I chlorophyll a / b-binding protein 6 (AT3G54890), driven by the CaMV 35S promoter, was used in vector pGWB2 (Nakagawa et al., J. Biosci. Bioeng. (2007)104:34-41) to generate overexpression constructs B2–C6 (Figure 1B).
[0077] Production of tobacco transformants: 60 lines of N. tabacum cv. Petit Havana and 12–14 lines of N. tabacum cv. Samsun were generated for each construct. Recombinant plasmids EC23083 and EC23028 were introduced into WT N. tabacum cv. Petit Havana by leaf disc transformation (Horsch et al., Abstr. Pap. Am. Chem. S. (1985)190:67) using Agrobacterium tumefaciens strain LBA4404. Shoots were cultured for 10 min at 4°C for 1 h under 5% CO2 with hygromycin (20 mg L−1). -1 ) and cefotaxime (400 mg L -1 The primary transformants (T0 generation) with established root systems were transferred to soil and self-pollinated. T0 and T1 lines expressing the integrated transgene were screened using semi-quantitative RT-PCR. FBP / SBPase (S B N. tabacum cultivar Petit Havana T2 / T3 progeny expressing either cytochrome c6 (C6 lines: 03, 06, 21, 44) or cytochrome c6 (C6 lines: C15, C41, C47, C50) were selected from the primary transformants produced as described above. B N. tabacum cv. Petit Havana plants expressing both S B System (S B 06, S B 44, S B 21) was generated by crossing with C6 strains (C15, C47, and C50), and S B C1(S B 06×C47), S B C2(S B 06×C50), S B C3(S B 44×C47), and S B C6(S B 21×C15) four independent S B These four independent lines were then self-pollinated.
[0078] The recombinant plasmid B2-C6 was introduced into the SBPase-overexpressing N. tabacum cultivar Samsun T4 line described in Lefebvre et al., Plant Physiol. (2005)138:451-460, by leaf disc transformation (Horsch et al., Abstr. Pap. Am. Chem. S. (1985)190:67) using Agrobacterium tumefaciens strain AGL1. Primary transformants (T0 generation, 39 plants) were cultured with kanamycin (100 mg L -1 ), hygromycin (20 mg L -1 ) and Augmentin (500 mg L -1 ) on MS medium. Plants expressing the integrated transgene were screened using semi-quantitative RT-PCR. N. tabacum cultivar Samsun lines expressing SBPase+cytochrome c6 (SC6 lines: 1, 2 and 3) were self-pollinated and the progeny used in subsequent experiments were checked for the presence and expression of the transgene by semi-quantitative RT-PCR.
[0079] The control plants used in this study were a composite group of WT and null segregants (i.e., azygous lines) derived from transgenic lines, and the transgene was confirmed to be non-integrated by PCR and semi-quantitative RT-PCR. A complete list of the transgenic and control lines used in the experiments described in the Examples below is provided in Table 1. [Table 1]
[0080] Selection of tobacco transformants: Using semi-quantitative RT-PCR (described in Example 2), S B Lineage and S B Presence of FBP / SBPase transcripts in C6 lineages, C6 lineage, S BWe detected the presence of cytochrome c6 transcripts in the C6 and SC6 lines, and the presence of SBPase transcripts in the S and SC6 lines (Figures 2A-2B). B Lineage and S B It was shown that the C6 line accumulated FBP / SBPase protein, and the S and SC6 lines overexpressed SBPase protein (Figures 3A-3B, immunoblot analysis described in Example 4). In addition to the immunoblot analysis, the S of N. tabacum cultivar Petit Havana was also overexpressed. B lineage and C6 lineage (T2 / T4 generation) and S B Total extractable FBPase activity in leaves of C6 lines (F3 homozygous generation; F1 is the first seed from the cross) was measured. B Lineage and S B C6 strain showed increased FBPase activity levels ranging from 34% to 47% more activity than the control (Fig. 2B). B Plants and S B A full set of assays showing the variation in FBPase activity from C6 plants can be seen in Figure 4. Additionally, cytochrome c6 protein expression in C6 lines was measured by immunoblotting using an antibody raised against P. umbilicalis cytochrome c6 protein. As shown in Figure 5A, unique bands appeared in P. umbilicalis crude protein extracts (P), and in the complex protein mixtures of C6 lines 15, 41 and 47 (C6). No bands were observed in wild-type (WT) or azygous (A) controls (Figures 5A-5B).
[0081] 600 μmol m -2 s -1 Petit Havana S. at different irradiances B lineage, C6 lineage and S B C6 lineage, or 650 μmol m -2 s -1Chlorophyll fluorescence analysis of N. tabacum cv. Samsun at irradiance of 100 nm showed that in young plants, photosystem 2 (PSII) photochemistry (F q ' / F m The efficiency of S' activation was significantly higher in all transgenic lines compared to either the WT or null segregant controls (Figures 2C-2D). B F of C6 and SC6 strains q ' / F m 'The value is FBP / SBPase(S B ), cytochrome c6 (C6), or SBPase (S)-expressing plants q ' / F m was not significantly different from the values.
[0082] Example 2: cDNA generation and semi-quantitative RT-PCR cDNA generation: The leaves used for cDNA generation were the same leaves used for photosynthesis measurements (see Example 7). Total RNA was extracted from tobacco leaf disks (sampled from greenhouse-grown plants and quickly frozen in liquid nitrogen) using the NucleoSpin® RNA Plant Kit (Macherey-Nagel, Fisher Scientific, UK). cDNA was synthesized using 1 μg of total RNA in 20 μl with oligo-dT primers according to the protocol of the RevertAid Reverse Transcriptase Kit (Fermentas, Life Sciences, UK). cDNA was synthesized using 12.5 ng μL -1 The solution was diluted 4-fold to a final concentration of
[0083] RT-PCR: For semi-quantitative RT-PCR, 2 μL of RT reaction mixture (100 ng RNA) in a total volume of 25 μL was used with DreamTaq DNA polymerase (Thermo Fisher Scientific, UK) according to the manufacturer's recommendations. PCR products were fractionated on a 1.0% agarose gel. The primers used for semi-quantitative RT-PCR are provided in Table 2 below. [Table 2]
[0084] <Example 3: Plant Cultivation> (Generation of transgenic plant lines) Wild-type tobacco plants and T1 progeny resulting from self-pollination of transgenic plants were sown and grown in soil (Levington F2, Fisons, Ipswich, UK). For experiments in N. tabacum cv. Samsun, null segregants were selected from the transformed lines as described in Example 1. For experiments in N. tabacum cv. Petit Havana, null segregants were selected from the transformed lines as described in Example 1. B The selection was made from the C6 lineage. Seeds used in the experimental studies were germinated as described below and the resulting plants were grown under controlled conditions.
[0085] (Management conditions) For experimental studies, T2–T4 and F1–F3 progeny seeds were cultured at 130 μmol photons m -2 s -1 Plants were germinated on soil in a controlled environmental chamber with an irradiance of 100 μmol photons m−1, a temperature of 22°C, 60% relative humidity, and a 16-h photoperiod (16 h light:8 h dark). Plants were transferred to individual 8 cm pots and grown under the same conditions (130 μmol photons m−1). -2 s -1 The plants were then grown for 2 weeks at 100°C for 12 min at a constant irradiance of 100000000000000000 μmol photons m−1, 22°C temperature, 60% relative humidity, and 16-h photoperiod. The plants were then transferred to 4 L pots and grown in an environmentally controlled greenhouse (16-h photoperiod; temperature between 25°C–30°C during the day and 20°C at night). During periods of low natural light induced by cloud cover, natural light was supplemented with high-pressure sodium light bulbs, delivering 380–1000 μmol photons m−1 from the height of the pot to the top tip of the plant, respectively. -2 s -1(highlights) were provided with a minimum irradiance of 1000 nm. The plants were changed three times weekly and watered regularly with nutrients (Hoagland et al., The College of Agriculture (1950)1). The plants were positioned so that at maturity, a nearly closed crown was achieved and the temperature range was maintained to resemble the surrounding external environment.
[0086] (Field) Plants were grown as described in Lopez-Calcagno et al., Plant Biotechnol. J. (2018). The field site was located at the University of Illinois Energy Farm (Urbana, IL, USA, 40.11°N, 88.21°W). Two different experimental designs were used in two different years.
[0087] Figure 6A shows the replicate control design used in 2016. Plants were grown in rows spaced 30 cm apart with the outer border being a border of wild-type plants. The entire experiment was surrounded by a border of two rows of wild-type plants. Plants were irrigated as needed using a rain tower. T2 seeds were germinated and seedlings were transferred to individual pots (350 mL) after 11 days. Seedlings were grown for an additional 15 days in the greenhouse before being transferred to the field. Plants were grown in the field for 14 days before harvesting.
[0088] Figure 6B shows the block within row design used in 2017 when two experiments were performed two weeks apart. In this design, one block contains one independent transgenic line of each of the five conflicts, with each row having all the lines. The central 20 plants of each block are divided into five rows of four plants per genotype. Experiment 1 in 2017 included controls (WT and null segregants), FBP / SBPase expressing lines (S B ) and cytochrome c6 expressing line (C6). Experiment 2 in 2017 included controls (WT and null segregants), cytochrome c6 expressing line (C6) and FBP / SBPase + cytochrome c6 expressing line (S BIn the 2017 experiment, we also investigated lines overexpressing the H protein of the glycine cleavage system (G lines) and null segregants derived from these lines (aG lines) (data published in Lopez-Calcagno et al., Plant Biotechnol. J. (2019)17(1):141-151), as well as lines expressing the B and C proteins and overexpressing the H protein (S B CG lineages) and null segregants derived from these lineages (aS B Some lines were evaluated alone (CG line) (data not published). Seeds were germinated and transferred 12 days later to hydroponic trays (Trans-plant Tray GP009 6912 cells; Speedling Inc., Ruskin, FL). Seedlings were grown in the greenhouse for 31–33 days before being transferred to the field. Plants were grown in the field until flowering (another 24–30 days) before harvest.
[0089] Fields were prepared in both years as described in Kromdijk et al., Science (2016) 354:857-861. Light (LI-quantum sensor; LI-COR) and temperature (Model 109 temperature probe; Campbell Scientific Inc., Logan, UT) were measured near the same field locations and recorded 15-min averages (Figures 6A-6B) using a data logger (CR1000; Campbell Scientific).
[0090] Example 4: Protein extraction and immunoblot analysis Leaf disks (0.8 cm diameter) were taken from the same area of the leaves used for photosynthesis measurements (see Example 7), immediately immersed in liquid N2, and stored at -80°C. Leaf disks were crushed in dry ice. Protein extraction was performed as described in Lopez-Calcagno, et al., J. Exp. Bot. (2017)68:2285-2298 or using the Nucleospin RNA / Protein Kit (Macherey-Nagel; www.mn-net.com) during RNA preparation. Protein quantification was performed using a protein quantification kit from Macherey-Nagel. Samples were loaded equally with protein standards, separated using 12% (w / v) SDS-PAGE, transferred to nitrocellulose membranes (GE Healthcare Life science, Germany), and probed using antibodies raised against SBPase and FBP / SBPase. Proteins were detected using horseradish peroxidase conjugated to secondary antibodies and ECL chemiluminescence detection reagents (Amersham, Buckinghamshire, UK). SBPase antibodies were previously characterized (Lefebvre et al., Plant Physiol. (2005)138:451-460; Dunford et al., Protein Expr. Purif. (1998)14:139-145). FBP / SBPase antibodies were raised against a peptide derived from a conserved region of the protein [C]-DRPRHKELIQEIRNAG-amide (SEQ ID NO: 93), and cytochrome c6 antibodies were raised against the peptide [C]-[Nle]-PDKTLKKDVLEANS-amide (SEQ ID NO: 94) (Cambridge Research Biochemicals, Cleveland, UK). In addition to the aforementioned antibodies, samples were probed with antibodies raised against transketolase (Henkes, et al., Plant Cell (2001)13:535-551; Khozaei, et al., Plant Cell (2015)27:432-447) and glycine decarboxylase H protein to use as a loading control.Glycine decarboxylase H protein antibodies were previously characterized in Timm et al., Febs Lett. (2012) 586:3692-3697.
[0091] (Cytochrome c6 protein extraction) Whole leaves were harvested from 8-week-old plants, washed in cold water, then wiped with a cloth soaked in 80% ethanol to remove most of the leaf debris. The leaves were then washed two more times in cold water, the midrib removed, and 50 g of the remaining tissue was placed in a sealed plastic bag and stored overnight at 4°C in the dark. Proteins were extracted as in Hiyama, Methods Mol. Biol. (2004) 274:11-17, with some modifications. Leaf tissue was homogenized for 30 seconds in 250 ml of chilled chloroplast preparation buffer (50 mM sodium phosphate buffer, pH 7, 10 mM NaCl). The solution was then filtered through four layers of muslin cloth and centrifuged at 10,000×g for 5 minutes. The resulting precipitate was then gently resuspended in 50 mL of chilled chloroplast preparation buffer and the chlorophyll concentration was measured, which was approximately 2 mg ml -1 The resulting mixture was then added to two volumes of pre-warmed (45°C) solubilization solvent (50 mM Tris-HCl, pH 8.8, and 3% triton X-100) and incubated at 45°C for 30 min. It was then cooled in an ice bath for another 30 min before being centrifuged at 12000g for 30 min. The supernatant was stored at -80°C for use in the next step. To purify the cytochrome c6 protein, a Biorad Econo-Pac High-Q 5 ml format wash column was used, with a 1 ml min -1 A flow rate of 1 mL min was used. The column was first prepared by washing with 100 mL of starting buffer (10 mM Tris-HCl pH 8.8, 0.2% triton X-100, and 20% sucrose). The protein mixture from the previous step was then diluted with an equal volume of chilled starting buffer and run at 1 mL min -1After all the protein was loaded onto the column, it was then washed with 1000 ml of starting buffer supplemented with 10 mM NaCl. The column was then washed with 300 ml of starting buffer supplemented with 50 mM NaCl, and finally the column was washed with a linear gradient of starting buffer supplemented with NaCl concentrations from 50 mM to 200 mM at 1 ml min -1 The solution was eluted at a flow rate of 0.01 ml for 4 h and multiple aliquots were collected. Samples were mixed with 300 μl of loading buffer (50% glycerol, 25% β-mercaptoethanol, 25% EDTA), loaded at equal protein standards, separated using 18% (w / v) SDS-PAGE, transferred to nitrocellulose membranes, and probed with an antibody raised against cytochrome c6.
[0092] <Example 5: Measurement of FBPase activity by phosphate release> FBPase activity was determined by phosphate release, with slight modifications from previous descriptions of SBPase (Simkin et al., J. Exp. Bot. (2015)66:4075-4090). Leaf discs were obtained from the same leaves used for photosynthesis measurements (see Example 7), and after photosynthesis measurements were completed, the discs were isolated and frozen in liquid nitrogen. Leaf discs were ground to a fine powder in liquid nitrogen, immersed in extraction buffer (50 mM HEPES, pH 8.2; 5 mM MgCl; 1 mM EDTA; 1 mM EGTA; 10% glycerol; 0.1% triton X-100; 2 mM benzamidine; 2 mM aminocaproic acid; 0.5 mM phenylmethylsulfonyl fluoride; 10 mM dithiothreitol), and centrifuged at 14,000×g for 1 min at 4° C. The resulting supernatant (1 ml) was desalted through a NAP-10 column (Amersham) and stored in liquid nitrogen. The assay was performed as described in Simkin, et al., J. Exp. Bot. (2015) 66:4075-4090. Briefly, 20 μl of extract was added to 80 μl of assay buffer (50 mM Tris, pH 8.2; 15 mM MgCl2; 1.5 mM EDTA; 10 mM DTT; 7.5 mM fructose-1,6-bisphosphate) and incubated at 25 °C for 30 min. The reaction was stopped by the addition of 50 μl of 1 M perchloric acid. 300 μl of Biomol Green (Affiniti Research Products, Exeter, UK) was added, followed by 30 μl of sample or standard (PO at concentrations ranging from 0.125 nmol to 4 nmol). 3- 4) was incubated at room temperature for 30 minutes, and the absorbance at 620 nm (A620) was measured using a microplate reader (VERSAmax, Molecular Devices, Sunnyvale, CA). FBPase activity was normalized to transketolase activity (Zhao, et al., Biomed. Res. Int. (2014)2014:572915).
[0093] <Example 6: Chlorophyll fluorescence imaging screening in seedlings> 130μmol mol -2 s -2 and ambient CO2 concentration (400 μmol mol -1 Chlorophyll fluorescence imaging was performed on 2-3 week old tobacco seedlings grown in an environmental chamber controlled at 100°C. Chlorophyll fluorescence parameters were obtained using a chlorophyll fluorescence (CF) imaging system (Technologica, Colchester, UK (Barbagallo, et al., Plant Physiol. (2003)132:485-493; von Caemmerer, et al., J. Exp. Bot. (2004)55:1157-1166)). Photosystem II (PSII) photochemistry, F q ' / F m The efficiency of operation is 6300 μmol m -2 s -1 After a saturating 800 ms pulse of PPFD, the following equation F q ' / F m '=(F m '-F') / F m ' to calculate the steady-state fluorescence in the light (F') and the maximum fluorescence (F m ') measurements. F q ' / F m ' image shows the results of 600 μmol m -2 s -2 under a stable PPFD of 650 μmol m for N. tabacum cultivar Samsun. -2 s -2 The experiments were carried out under stable PPFD (Baker, et al., Journal of Experimental Botany (2001)52:615-621; Oxborough, et al., Philos. Trans. R. Soc. Lond. B. Biol. Sci. (2000)355:1489-1498; Lawson, et al., J. Exp. Bot. (2008)59:3609-3619).
[0094] Example 7: Leaf gas exchange Photosynthetic gas exchange and chlorophyll fluorescence parameters were recorded using a portable infrared gas analyzer with a 6400-40 fluorometer head unit (LI-COR 6400; LI-COR, Lincoln, NE, USA). All measurements were performed using a LI-COR 6400 cuvette unless otherwise stated. For greenhouse-grown plants, conditions were: 400 μmol mol -1 The plants were maintained at a CO2 concentration of 400 μmol mol, a leaf temperature of 25 °C, and a vapor pressure deficit (VPD) of 1 ± 0.2 kPa. Plants grown under field conditions were maintained in the chamber at 400 μmol mol -1 CO2 concentration, the shutoff temperature was set at 2°C above ambient temperature (ambient air temperature was measured prior to generating each gas exchange response curve), and the VPD was maintained as close to 1 kPa as possible.
[0095] (A / C i Response curve (photosynthetic capacity) Intracellular CO2 concentration (C i The response of net photosynthesis (A) to 2000 μmol mol -2 s -1 Illumination was provided by a red-blue light source attached to the leaf cuvette. A measurements were taken at 400 μmol mol -1 Ambient CO2 concentration (C a ) and then C a is the lowest concentration of 50 μmol mol -1 Then, the upper concentration of 2000 μmol mol -1 The maximum saturated CO2 assimilation rate (A max ), maximum carboxylation rate (Vc max ) and maximum electron transport flux (J max To calculate the parameters of A / C, a C3 photosynthesis model (Farquhar, et al., Planta (1980) 149:78-90) was used with the spreadsheet provided by Sharkey, et al., Plant Cell Environ. (2007) 30:1035-1040. iIn addition, the PSII efficiency factor F q ' / F v The efficiency of PSII (F q ' / F m ') and the photochemical quenching coefficient (q P ) Chlorophyll fluorescence parameters were recorded at each time point.
[0096] (A / Q response curve) Photosynthesis as a function of light (A / Q response curve) is calculated by the A / C i The measurements were taken under the same cuvette conditions as for the curves. A and g s After measuring at light levels of 2200 μmol m -2 s -1 The irradiance was initially stabilized at a saturation irradiance of 2000 μmol m -2 s -1 , 1650 μmol m -2 s -1 , 1300 μmol m -2 s -1 , 1000 μmol m -2 s -1 , 750 μmol m -2 s -1 , 500 μmol m -2 s -1 , 400 μmol m -2 s -1 , 300 μmol m -2 s -1 , 200 μmol m -2 s -1 , 150 μmol m -2 s -1 , 100 μmol m -2 s -1 , 50 μmol m -2 s -1 , and 0 μmol m -2 s -1 After A reaches a new steady state (1 min to 3 min), g s Measurements were recorded before A and g changed to the new light level. s The intrinsic water use efficiency (iWUE = A / gs) was estimated using the values of
[0097] Example 8: Statistical analysis All statistical analyses were performed using Sys-stat, University of Essex, UK, and R (see website www.r-project.org). Analysis of variance (ANOVA) and post hoc Tukey tests were performed for harvest data, seedling chlorophyll imaging, and enzyme activities. For gas exchange curves, data were compared by linear mixed model analysis using the lmer function and type III ANOVA (Vialet-Chabrand, et al., Plant Physiol. (2017)173:2163-2179). Significant differences between treatments were identified using contrast analysis (lsmeans package).
[0098] Example 9: Promoting electron transport and RuBP regeneration enhances photosynthetic capacity in two different tobacco cultivars under greenhouse conditions. Transgenic lines selected based on the first selection above were cultured at 400 μmol m -2 s -1 ~1000 μmol m -2 s -1 The plants were grown in a greenhouse with natural light supplemented to provide 100% illumination. The net CO2 assimilation rates (A) and F q ' / F m ' was analyzed using mature and developing leaves of N. tabacum cultivars Samsun (S and SC6) and N. tabacum cultivars Petit Havana (S B , C6 and S B Intracellular CO2 concentration (C i ) was determined as a function of CO2 assimilation rate (Figures 7A-7B). The transgenic lines showed higher CO2 assimilation rates than the control plants (CN). A was approximately 300 μmol mol -1 C i was 15% higher than the control in mature leaves of SC6 (whereas the current ambient CO2 concentration was about 400 μmol-1 and the measured C iThe concentration of NF-kappa B is lower than that of the surroundings due to a number of factors, including stomatal limitation (Figure 7B). Also, the developing leaves of SC6 plants showed a significant decrease in PSII operation efficiency (F q ' / F m ') and PSII efficiency factor (F q ' / F v There was also a significant increase in the Q-terminal region of the oxidized state (Fig. 7B). A The rate of assimilation is determined by the ability of the photosynthetic apparatus to maintain photochemical quenching in comparison to control plants, and is therefore an indicator of photochemical quenching in comparison to control plants. Interestingly, in mature leaves of N. tabacum cv. Samsun transgenic plants, the difference in assimilation rate and efficiency of operation of PSII photochemistry between transgenic and control plants was smaller than in developing leaves. Only mature leaves of S transgenic plants showed a higher rate of assimilation and efficiency of operation of PSII photochemistry in all measured CO2 concentrations. q ' / F m ' and F q ' / F v ' was higher than that of the control plants (Fig. 7B). In contrast, mature leaves of SC6 plants showed a mean concentration of 300 μmol m -1 and 900 μmol m -1 Between i Only at the level higher than the control q ' / F v ' values are shown (Figure 7B).
[0099] A similar trend was observed for N. tabacum cv. Petit Havana transgenic plants, which showed significantly higher A, F, and H levels compared to the control. q ' / F m ', and F q ' / F v The mean value of S' was higher than that of S' (Figure 7A). B In mature leaves of C6 plants (N. tabacum cv. Petit Havana), these significant increases were similar to the trends shown for developing leaves of SC6 lines (N. tabacum cv. Samsun) (Figures 7A-7B).
[0100] Developing leaves of both S and SC6 plants (N. tabacum cv. Samsun) showed a significant increase in J when compared to control plants. max and A max In addition, mature leaves of SC6 transgenic plants showed a significant increase in Vc compared to control plants (Table 3). max , J max , and A max In contrast, the S B The leaves of a C6 plant (N. tabacum cultivar Petit Havana) were max and J. max Although a higher mean value of A was evident, max These results indicated that the simultaneous promotion of electron transport and RuBP regeneration by expression of cytochrome c6 in combination with FBP / SBPase or SBPase had a greater effect on photosynthesis than either single manipulation in all analyzed plants. [Table 3]
[0101] Example 10: Enhancement of electron transport and RuBP regeneration promotes growth of two different tobacco varieties under greenhouse conditions. In parallel experiments, FBP / SBPase (S B ), cytochrome c6 (C6), or FBP / SBPase + cytochrome c6 (S B N. tabacum cv. Petit Havana plants expressing SBPase (S) or SBPase + cytochrome c6 (SC6) were grown in controlled conditions for 4 weeks before harvesting, and N. tabacum cv. Samsun plants expressing SBPase (S) or SBPase + cytochrome c6 (SC6) were grown in controlled conditions for 6 weeks before harvesting. Height, leaf number, total leaf area and aboveground biomass were measured (Figures 8 and 9). All analyzed transgenic plants showed higher height compared to control plants. Cytochrome c6 (C6 and S BPlants expressing C6 = N. tabacum cv. Petit Havana; and SC6 = N. tabacum cv. Samsun) had a significant increase in leaf area, and stem and leaf biomass compared to the respective controls. B In the transgenic plants (N. tabacum cv. Petit Havana), only the stem biomass was greater than that in the control plants. B C6 and SC6 transgenics are the sole S B The total increase in aboveground biomass was greater in the S transgenic plants compared to the control plants. B The percentage of β-glucosidase-specific ... B C6 and SC6) consistently showed higher ground mass averages compared to the control group; B 52% higher in C6 and 32% higher in SC6 (Figs. 8 and 9).
[0102] Example 11: Co-expression of FBP / SBPase and cytochrome c6 increases growth and water use efficiency under field conditions To test whether the increase in biomass observed in transgenic plants under controlled greenhouse conditions could be replicated in a field environment, a subset of lines was selected for field testing. Transgenic N. tabacum cultivar Petit Havana lines showed a greater percentage increase in biomass, so these plants were selected and tested in three field experiments in two different years (one in 2016 and two in 2017).
[0103] In 2016, FBP / SBPase (S BA small scale replicated controlled experiment of lines expressing single gene constructs for S. cerevisiae (S. cerevisiae) and cytochrome c6 (C6) was performed to assess vegetative growth in the field. Plants were germinated and grown under controlled environmental conditions for 26 days before being transferred to the field. After 14 days in the field, plants were harvested at the early vegetative stage and plant height, total leaf area, and aboveground biomass were measured (Figure 10A). These data showed that S. cerevisiae (S. cerevisiae) and cytochrome c6 (C6) single gene constructs were significantly increased in the control compared to the control. B C6 plants showed a 27%, 35% and 25% increase in height, leaf area and aboveground biomass, respectively, compared to the control (Figure 10A). C6 plants also showed a 50%, 41% and 36% increase in height, leaf area and aboveground biomass, respectively, compared to the control (Figure 10A). In 2017, two large-scale, randomized block-design field experiments were conducted to compare the S B , C6, and S B The performance of C6 plants was evaluated. Plants were grown from seeds in a greenhouse for 31-13 days, then transferred to the field and grown until the onset of flowering (another 24-30 days) before harvesting. In Figures 10B-10C, S. cerevisiae harvested after the onset of flowering is shown. B It can be seen that C6 and C7 plants did not show a significant increase in height, leaf area or biomass. Interestingly, FBP / SBPase + cytochrome c6 (S B C6) plants showed significant increases in several growth parameters when compared to controls, with 13%, 17%, and 27% increases in height, leaf area, and aboveground biomass, respectively (Figure 10C).
[0104] Furthermore, in a field experiment in 2017, the saturation light (A / C i ) in C i In experiment 1 in 2017, the PSII operation efficiency (F q ' / F m ') no difference in S B A significant increase in A was observed in C6 and C7 plants (Figure 11A). However, in experiment 2 in 2017, when compared to the control plants, the C6 and SB There was no clear difference in the A value in C6 plants, and F q ' / F m No obvious differences were observed in the values of A' (Figure 11B). Analysis of A as a function of light (PPFD) showed either small or non-significant differences in A between genotypes (Figures 12A and 13A). Interestingly, S B Stomatal conductance (g S ) is 1000 μmol m -2 s -1 At light levels above 100 nm, the phenotypes of the C6 plants were significantly lower than those of the control plants (Figure 12B). B There was a significant increase in the potential water use efficiency (iWUE) of C6 plants (Figure 12D). B or C6 transgenic plants, no significant difference was observed in iWUE (Figures 12D and 13D).
[0105] The above examples describe the generation and analysis of transgenic plants with simultaneously increased electron transport and improved capacity for RuBP regeneration in two different tobacco varieties. These examples show that the independent promotion of electron transport (by expression of cytochrome c6) and promotion of RuBP regeneration (by expression of FBP / SBPase or overexpression of SBPase) increased photosynthesis and biomass in plants grown under controlled conditions. Furthermore, these examples demonstrate that the interaction of these two processes (S B We found that simultaneously targeting both β-lactams (C6 and SC6 plants) had an even greater impact in promoting photosynthesis and growth. Furthermore, in field studies, plants with simultaneous promotion of electron transport and RuBP regeneration showed increased iWUE and biomass.
[0106] Under greenhouse conditions, increases in photosynthetic parameters were observed in all analyzed transgenic plants, and these were found to be consistently correlated with increased biomass. The examples presented herein provide the first report of increased photosynthesis and biomass by simultaneous promotion of electron transport and RuBP regeneration. An increase in A was observed under greenhouse conditions in the leaves of all analyzed transgenic tobacco plants in both tobacco varieties tested here (N. tabacum cv. Petit Havana and N. tabacum cv. Samsun). i Analysis of the response curves revealed that the photosynthetic parameter Vc max , J max , and A max The average values of RuBP, RuBP, and RuB were increased by 17%, 14%, and 12%, respectively. These results indicate not only an increased maximum rate of electron transfer and increased RuBP regeneration, but also an increased rate of carboxylation by Rubisco. Although Rubisco activity was not directly targeted, the results are consistent with J max and V cmax This is consistent with a study by Wullschleger, et al., J. Exp. Bot. (1993) 44:907-920, which showed a linear correlation between SBPase and J. max Not only did it result in a significant increase in Vc max and has also previously been shown to result in an increase in Rubisco activation state.
[0107] In particular, in the greenhouse study, both electron transport and RuBP regeneration (S B The highest photosynthetic rates were observed from leaves of plants with increased A (C6 and SC6), indicating that co-expression of these genes has an additional effect on improving photosynthesis. In addition to increasing A, plants with simultaneous promotion of electron transport and RuBP regeneration showed higher F q ' / F m', indicating a higher quantum yield of linear electron flux through PSII compared to control plants. These results indicate that the reduction of PSI is promoted by substituting a more efficient electron donor for PSI (Chida, et al., Plant Cell Physiol. (2007) 48:948-957;Finazzi, et al., Proc. Natl. Acad. Sci. US A. (2005) 102:7031-7036). This is consistent with published data showing that introduction of cytochrome c6 and overexpression of the Riske iron-sulfur protein in Arabidopsis leads to an increase in the quantum yield of PSII and a more oxidized plastoquinone pool (Simkin, et al., Plant Physiol. (2017) 175:134-145;Chida, et al., Plant Cell Physiol. (2007) 48:948-957). In addition, S B In C6 and SC6 plants, F q ' / F m The increase in the PSII efficiency factor (F q ' / F v We found that the increase in efficiency in these plants was largely driven by an increase in PSII assimilation, suggesting that the increase in efficiency in these plants could occur through promotion of downstream processes of PSII, such as CO2 assimilation.
[0108] To provide further evidence of the applicability of targeting both electron transport and RuBP regeneration to improve crop yield, plants were tested in the field. Field results showed that expression of FBP / SBPase alone resulted in a 22%-40% increase in growth and biomass in field-grown plants in 2016 when harvested during early vegetative growth (before the onset of flowering). Interestingly, when plants with the same transgenic manipulation were harvested later in development, after the onset of flowering in the 2017 field trial, this benefit was no longer apparent and the single FBP / SBPase expressing lines were indistinguishable from control plants.
[0109] Transgenic plants expressing cytochrome c6 alone also showed enhanced growth and biomass when harvested early in development, but similar to the FBP / SBPase plants, this improvement was no longer evident when the plants were harvested after flowering. This phenotypic difference in biomass gain between early and late harvest was not observed in parallel experiments in which overexpression of the H protein was shown to increase biomass under field conditions in plants harvested during early development and in plants harvested after the onset of flowering (Lopez-Calcagno, et al., Plant Biotechnol. J. (2019) 17(1):141-151)). These results suggest that expression of FBP / SBPase or cytochrome c6 alone may provide advantages under certain defined conditions or at certain stages of plant development. This may be applicable for some crops where early harvest is desirable (e.g., some types of lettuce, spinach, and tender vegetables) (Ichikawa, et al., GM Crops (2010) 1:322-326). In contrast to the results of the single manipulations described above, plants expressing both cytochrome c6 and FBP / SBPase simultaneously showed a consistent increase in biomass after flowering under field conditions.
[0110] In field-grown transgenic lines, the correlation between increased photosynthesis and increased biomass was less consistent than that observed under greenhouse conditions. Transgenic lines with individual manipulations, i.e., FBP / SBPase (S B The transgenic lines with double sequence manipulation, i.e., FBP / SBPase + cytochrome c6 (S BC6) also increased biomass in experiment 2 in 2017, without significant differences in photosynthetic capacity. Across all experiments, the average A values of the transgenic plants were consistently higher than that of the controls. Even small increases in assimilation over the life of a plant are known to have cumulative effects that can translate into significant biomass accumulation, even if the differences are not consistently statistically different across all experiments (Simkin, et al., J. Exp. Bot. (2015) 66:4075-4090).
[0111] 1000 μmol m -2 s -1 At light levels above 100 nm, FBP / SBPase + cytochrome c6 (S B C6) showed lower stomatal conductance (gs) and C i The concentration of C was observed to be low (Figure 12C). i Lowering light would be expected to reduce photosynthesis, but interestingly, these plants were able to maintain CO2 assimilation rates equal to or greater than those of control plants, resulting in improved iWUE. A similar improvement in iWUE was seen in plants overexpressing the NPQ-related protein, PsbS (Glowacka, et al., Nat. Commun. (2018)9). These plants showed reduced light-induced stomatal opening and a more oxidized QA pool, which has been proposed to act as a signal for stomatal movement (Busch, et al., Photosynth. Res. (2014)119:131-140).
[0112] The results of these examples are B Increased photosynthetic capacity in C6 plants is iThis provides validation for the proposal to compensate for the decline of RuBP regeneration in transgenic plants. The fact that higher iWUE and higher productivity compared to controls have been reported in field studies with CO2 enrichment for transgenic lines with increased RuBP regeneration (Rosenthal et al., BMC Plant Biol. (2011)11:123; Ichikawa, et al., GM Crops (2010)1:322-326) highlights the possibility of manipulating electron transport and RuBP regeneration for the development of new plant varieties that can sustain photosynthesis and yield under climate change scenarios.
[0113] The results of these examples provide a clear demonstration that a combination of manipulations resulting in simultaneous promotion of electron transport and RuBP regeneration under the conditions investigated resulted in a significant increase in biomass over either manipulation alone, highlighting the potential of this strategy for the development of high-yielding crops. [Brief description of the drawings]
[0114] [Figure 1A]Figures 1A-1B show schematic diagrams of constructs used to generate transgenic N. tabacum lines. Figure 1A shows the constructs used to express FBP / SBPase (SynFBP / SBPase) in N. tabacum cv. Petit Havana (top, EC23083) and Porphyra umbilicalis cytochrome c6 (PuCytc6) (bottom, EC23028). Figure 1B shows the constructs (B2-C6) used to express cytochrome c6 (PuCytc6) in N. tabacum cv. Samsun. RB = T-DNA right border; pFMV = Figwort mosaic virus promoter; tNOS = nopaline synthase terminator; 35S = Cauliflower mosaic virus 35S promoter; HPT = A. thaliana heat shock protein 18.2 (HSP) terminator; LB = T-DNA left border; p2x35S = 2x Cauliflower mosaic virus 35S promoter; tHSP = A. thaliana heat shock protein 18.2 (HSP) terminator; pNos = nopaline synthase promoter; NPT II = neomycin phosphotransferase gene. [Figure 1B]Figures 1A-1B show schematic diagrams of constructs used to generate transgenic N. tabacum lines. Figure 1A shows the constructs used to express FBP / SBPase (SynFBP / SBPase) in N. tabacum cv. Petit Havana (top, EC23083) and Porphyra umbilicalis cytochrome c6 (PuCytc6) (bottom, EC23028). Figure 1B shows the constructs (B2-C6) used to express cytochrome c6 (PuCytc6) in N. tabacum cv. Samsun. RB = T-DNA right border; pFMV = Figwort mosaic virus promoter; tNOS = nopaline synthase terminator; 35S = Cauliflower mosaic virus 35S promoter; HPT = A. thaliana heat shock protein 18.2 (HSP) terminator; LB = T-DNA left border; p2x35S = 2x Cauliflower mosaic virus 35S promoter; tHSP = A. thaliana heat shock protein 18.2 (HSP) terminator; pNos = nopaline synthase promoter; NPT II = neomycin phosphotransferase gene. [Figure 2A]Figures 2A-2E show the screening of transgenic plants overexpressing FBP / SBPase, SBPase, and cytochrome c6. Figure 2A shows the transcript levels in SB lines (N. tabacum cv. Petit Havana lines expressing FBP / SBPase; SB lines 03, 06, 21, and 44), C6 lines (N. tabacum cv. Petit Havana lines expressing cytochrome c6; C6 lines 15, 41, 47, and 50), SBC6 lines (N. tabacum cv. Petit Havana lines expressing FBP / SBPase and cytochrome c6; SBC6 lines 1, 2, and 3), and control lines (CN; both WT and azygous plants). Figure 2B shows the transcript levels in S lines (N. tabacum cv. Samsun expressing SBPase; S lines 30 and 60), SC6 lines (N. tabacum cv. Samsun expressing SBPase and cytochrome c6; SC6 lines 1, 2 and 3), and control lines (CN; both WT and azygous plants). Figure 2C shows FBPase activity in SB and SBC6 lines relative to the control (CN; both WT and azygous plants). Figures 2D-2E show chlorophyll fluorescence imaging of plants grown under controlled environmental conditions that were used to measure Fq' / Fm' (maximum PSII actuation efficiency) at 600-650 μmol m-2 s-1 (PPFD). Figure 2D shows the maximum PSII actuation efficiency of the control (CN; both WT and azygous plants), SB lines, C6 lines and SBC6 lines (6 plants per line; 3-4 lines per run) at 600 PPFD. Figure 2E shows the maximum PSII actuation efficiency of the control (CN; WT plants), S and SC6 lines (CN = 11 plants per manipulation; S and SC6 lines = 6-7 plants per manipulation) at 650 PPFD. In Figures 2C-2E, asterisks indicate lines that are statistically different from the control group (*P<0.05). [Figure 2B]Figures 2A-2E show the screening of transgenic plants overexpressing FBP / SBPase, SBPase, and cytochrome c6. Figure 2A shows the transcript levels in SB lines (N. tabacum cv. Petit Havana lines expressing FBP / SBPase; SB lines 03, 06, 21, and 44), C6 lines (N. tabacum cv. Petit Havana lines expressing cytochrome c6; C6 lines 15, 41, 47, and 50), SBC6 lines (N. tabacum cv. Petit Havana lines expressing FBP / SBPase and cytochrome c6; SBC6 lines 1, 2, and 3), and control lines (CN; both WT and azygous plants). Figure 2B shows the transcript levels in S lines (N. tabacum cv. Samsun expressing SBPase; S lines 30 and 60), SC6 lines (N. tabacum cv. Samsun expressing SBPase and cytochrome c6; SC6 lines 1, 2 and 3), and control lines (CN; both WT and azygous plants). Figure 2C shows FBPase activity in SB and SBC6 lines relative to the control (CN; both WT and azygous plants). Figures 2D-2E show chlorophyll fluorescence imaging of plants grown under controlled environmental conditions that were used to measure Fq' / Fm' (maximum PSII actuation efficiency) at 600-650 μmol m-2 s-1 (PPFD). Figure 2D shows the maximum PSII actuation efficiency of the control (CN; both WT and azygous plants), SB lines, C6 lines and SBC6 lines (6 plants per line; 3-4 lines per run) at 600 PPFD. Figure 2E shows the maximum PSII actuation efficiency of the control (CN; WT plants), S and SC6 lines (CN = 11 plants per manipulation; S and SC6 lines = 6-7 plants per manipulation) at 650 PPFD. In Figures 2C-2E, asterisks indicate lines that are statistically different from the control group (*P<0.05). [Figure 2C]Figures 2A-2E show the screening of transgenic plants overexpressing FBP / SBPase, SBPase, and cytochrome c6. Figure 2A shows the transcript levels in SB lines (N. tabacum cv. Petit Havana lines expressing FBP / SBPase; SB lines 03, 06, 21, and 44), C6 lines (N. tabacum cv. Petit Havana lines expressing cytochrome c6; C6 lines 15, 41, 47, and 50), SBC6 lines (N. tabacum cv. Petit Havana lines expressing FBP / SBPase and cytochrome c6; SBC6 lines 1, 2, and 3), and control lines (CN; both WT and azygous plants). Figure 2B shows the transcript levels in S lines (N. tabacum cv. Samsun expressing SBPase; S lines 30 and 60), SC6 lines (N. tabacum cv. Samsun expressing SBPase and cytochrome c6; SC6 lines 1, 2 and 3), and control lines (CN; both WT and azygous plants). Figure 2C shows FBPase activity in SB and SBC6 lines relative to the control (CN; both WT and azygous plants). Figures 2D-2E show chlorophyll fluorescence imaging of plants grown under controlled environmental conditions that were used to measure Fq' / Fm' (maximum PSII actuation efficiency) at 600-650 μmol m-2 s-1 (PPFD). Figure 2D shows the maximum PSII actuation efficiency of the control (CN; both WT and azygous plants), SB lines, C6 lines and SBC6 lines (6 plants per line; 3-4 lines per run) at 600 PPFD. Figure 2E shows the maximum PSII actuation efficiency of the control (CN; WT plants), S and SC6 lines (CN = 11 plants per manipulation; S and SC6 lines = 6-7 plants per manipulation) at 650 PPFD. In Figures 2C-2E, asterisks indicate lines that are statistically different from the control group (*P<0.05). [Figure 2D]Figures 2A-2E show the screening of transgenic plants overexpressing FBP / SBPase, SBPase, and cytochrome c6. Figure 2A shows the transcript levels in SB lines (N. tabacum cv. Petit Havana lines expressing FBP / SBPase; SB lines 03, 06, 21, and 44), C6 lines (N. tabacum cv. Petit Havana lines expressing cytochrome c6; C6 lines 15, 41, 47, and 50), SBC6 lines (N. tabacum cv. Petit Havana lines expressing FBP / SBPase and cytochrome c6; SBC6 lines 1, 2, and 3), and control lines (CN; both WT and azygous plants). Figure 2B shows the transcript levels in S lines (N. tabacum cv. Samsun expressing SBPase; S lines 30 and 60), SC6 lines (N. tabacum cv. Samsun expressing SBPase and cytochrome c6; SC6 lines 1, 2 and 3), and control lines (CN; both WT and azygous plants). Figure 2C shows FBPase activity in SB and SBC6 lines relative to the control (CN; both WT and azygous plants). Figures 2D-2E show chlorophyll fluorescence imaging of plants grown under controlled environmental conditions that were used to measure Fq' / Fm' (maximum PSII actuation efficiency) at 600-650 μmol m-2 s-1 (PPFD). Figure 2D shows the maximum PSII actuation efficiency of the control (CN; both WT and azygous plants), SB lines, C6 lines and SBC6 lines (6 plants per line; 3-4 lines per run) at 600 PPFD. Figure 2E shows the maximum PSII actuation efficiency of the control (CN; WT plants), S and SC6 lines (CN = 11 plants per manipulation; S and SC6 lines = 6-7 plants per manipulation) at 650 PPFD. In Figures 2C-2E, asterisks indicate lines that are statistically different from the control group (*P<0.05). [Figure 2E]Figures 2A-2E show the screening of transgenic plants overexpressing FBP / SBPase, SBPase, and cytochrome c6. Figure 2A shows the transcript levels in SB lines (N. tabacum cv. Petit Havana lines expressing FBP / SBPase; SB lines 03, 06, 21, and 44), C6 lines (N. tabacum cv. Petit Havana lines expressing cytochrome c6; C6 lines 15, 41, 47, and 50), SBC6 lines (N. tabacum cv. Petit Havana lines expressing FBP / SBPase and cytochrome c6; SBC6 lines 1, 2, and 3), and control lines (CN; both WT and azygous plants). Figure 2B shows the transcript levels in S lines (N. tabacum cv. Samsun expressing SBPase; S lines 30 and 60), SC6 lines (N. tabacum cv. Samsun expressing SBPase and cytochrome c6; SC6 lines 1, 2 and 3), and control lines (CN; both WT and azygous plants). Figure 2C shows FBPase activity in SB and SBC6 lines relative to the control (CN; both WT and azygous plants). Figures 2D-2E show chlorophyll fluorescence imaging of plants grown under controlled environmental conditions that were used to measure Fq' / Fm' (maximum PSII actuation efficiency) at 600-650 μmol m-2 s-1 (PPFD). Figure 2D shows the maximum PSII actuation efficiency of the control (CN; both WT and azygous plants), SB lines, C6 lines and SBC6 lines (6 plants per line; 3-4 lines per run) at 600 PPFD. Figure 2E shows the maximum PSII actuation efficiency of the control (CN; WT plants), S and SC6 lines (CN = 11 plants per manipulation; S and SC6 lines = 6-7 plants per manipulation) at 650 PPFD. In Figures 2C-2E, asterisks indicate lines that are statistically different from the control group (*P<0.05). [Figure 3A]Figures 3A-3B show biochemical analysis of transgenic N. tabacum cv. Petit Havana and N. tabacum cv. Samsun plants. Figure 3A shows immunoblot analysis of protein extracts representative of multiple experiments from mature leaves of N. tabacum cv. Petit Havana lines expressing FBP / SBPase (SB lines 03, 06, 21, and 44) and FBP / SBPase + cytochrome c6 (SBC6 lines 1, 2, and 3) compared to extracts from wild-type (WT) control plants (CN) and blotted against FBP / SBPase antibodies. Expression of the H protein from the glycine cleavage system was used as a loading control. Figure 3B shows immunoblot analysis of protein extracts representative of multiple experiments from mature leaves of N. tabacum cultivar Samsun lines expressing SBPase (S lines S30 and S60) and SBPase + cytochrome c6 (SC6 lines 1, 2, and 3) compared to extracts from WT control plants (CN) and blotted against SBPase antibody. In Figures 3A-3B, expression of H protein from the glycine cleavage system (H protein), transketolase (TK), and Rubisco were used as loading controls. Immunoblot analysis was repeated for multiple sets of plants and results shown are representative of a typical blot. [Figure 3B]Figures 3A-3B show biochemical analysis of transgenic N. tabacum cv. Petit Havana and N. tabacum cv. Samsun plants. Figure 3A shows immunoblot analysis of protein extracts representative of multiple experiments from mature leaves of N. tabacum cv. Petit Havana lines expressing FBP / SBPase (SB lines 03, 06, 21, and 44) and FBP / SBPase + cytochrome c6 (SBC6 lines 1, 2, and 3) compared to extracts from wild-type (WT) control plants (CN) and blotted against FBP / SBPase antibodies. Expression of the H protein from the glycine cleavage system was used as a loading control. Figure 3B shows immunoblot analysis of protein extracts representative of multiple experiments from mature leaves of N. tabacum cultivar Samsun lines expressing SBPase (S lines S30 and S60) and SBPase + cytochrome c6 (SC6 lines 1, 2, and 3) compared to extracts from WT control plants (CN) and blotted against SBPase antibody. In Figures 3A-3B, expression of H protein from the glycine cleavage system (H protein), transketolase (TK), and Rubisco were used as loading controls. Immunoblot analysis was repeated for multiple sets of plants and results shown are representative of a typical blot. [Figure 4]Figure 4 shows the complete data set of FBPase enzyme assay in analyzed N. tabacum cv. Petit Havana plants shown in Figure 2C. Bars represent FBPase activity in the tested transgenic lines relative to FBPase activity in the control (both WT and azygous plants). Each bar is an individual plant from an SB line expressing FBP / SBPase (SB03, SB06, SB21, SB44; shown in the center and labeled "SB"), an SBC6 line expressing FBP / SBPase+cytochrome c6 (SBC1, SBC2, SBC3; shown on the right and labeled "SBC6"), and a control line (CN; both WT and azygous plants; shown in black on the left). The average control activity is represented by a black bar at 1.0 of the relative FBPase activity and labeled "CN". [Figure 5A] Figures 5A-5B show biochemical analysis of transgenic N. tabacum cv. Petit Havana plants expressing cytochrome c6. Figure 5A shows immunoblot analysis of protein extracts from pools of developing leaves of C6 lines (C15, C41, and C47), a WT control line, and a null segregant (A) control line, as well as Porphyra umbilicalis crude protein extract (P). Figure 5B shows Ponceau stain of the immunoblot membrane in Figure 5A, revealing similar loading levels as the plant leaf extracts in Figure 5A. [Figure 5B]Figures 5A-5B show biochemical analysis of transgenic N. tabacum cv. Petit Havana plants expressing cytochrome c6. Figure 5A shows immunoblot analysis of protein extracts from pools of developing leaves of C6 lines (C15, C41, and C47), a WT control line, and a null segregant (A) control line, as well as Porphyra umbilicalis crude protein extract (P). Figure 5B shows Ponceau stain of the immunoblot membrane in Figure 5A, revealing similar loading levels as the plant leaf extracts in Figure 5A. [Figure 6A] Figures 6A-6B show average environmental conditions during the 2017 field experiments (i.e., experiments evaluating field-grown plants). Figure 6A shows the average daily light intensity (μmol m-2 s-1) from the 2017 field experiment. Figure 6B shows the temperature (°C) from the 2017 field experiment. In Figures 6A-6B, black = 2017 experiment 1, and grey = 2017 experiment 2. [Figure 6B] Figures 6A-6B show average environmental conditions during the 2017 field experiments (i.e., experiments evaluating field-grown plants). Figure 6A shows the average daily light intensity (μmol m-2 s-1) from the 2017 field experiment. Figure 6B shows the temperature (°C) from the 2017 field experiment. In Figures 6A-6B, black = 2017 experiment 1, and grey = 2017 experiment 2. [Figure 7A]7A-7B show the photosynthetic response of transgenic plants grown under controlled conditions (i.e., in a greenhouse (GH)). Figures 7A-7B show the photosynthetic carbon fixation rate (A (µmol m-2 s-1)), the actual operating efficiency of PSII in light (Fq' / Fm'), the electron sinks drawn from PSII (Fq' / Fv'), and the maximum efficiency of PSII (Fv' / Fm'). The parameters were determined as a function of increasing CO2 concentration (Ci (µmol m-2)) at saturating light levels (natural light levels in the greenhouse oscillated between 400 µmol m-2 s-1 and 1000 µmol m-2 s-1; supplemental light was provided as needed to maintain a minimum irradiance level of 400 µmol m-2 s-1). Figure 7A shows the photosynthetic response of mature leaves of N. tabacum cv. Petit Havana lines expressing FBP / SBPase (SB), cytochrome c6 (C6), FBP / SBPase + cytochrome c6 (SBC6), and the control (CN; both WT and azygous plants). Figure 7B shows the photosynthetic response of mature leaves (left column) and developing leaves (i.e., 11-13 cm long; right column) of N. tabacum cv. Samsun lines expressing SBPase (S), SBPase + cytochrome c6 (SC6), and the control (CN; both WT and azygous plants). In Figures 7A-7B, three to four individual plants from three to four independent transgenic lines were evaluated. Asterisks indicate significance between transgenic and control groups as determined using a linear mixed-effects model and type III ANOVA, *P<0.05, **P<0.01, ***P<0.001. [Figure 7B]7A-7B show the photosynthetic response of transgenic plants grown under controlled conditions (i.e., in a greenhouse (GH)). Figures 7A-7B show the photosynthetic carbon fixation rate (A (µmol m-2 s-1)), the actual operating efficiency of PSII in light (Fq' / Fm'), the electron sinks drawn from PSII (Fq' / Fv'), and the maximum efficiency of PSII (Fv' / Fm'). The parameters were determined as a function of increasing CO2 concentration (Ci (µmol m-2)) at saturating light levels (natural light levels in the greenhouse oscillated between 400 µmol m-2 s-1 and 1000 µmol m-2 s-1; supplemental light was provided as needed to maintain a minimum irradiance level of 400 µmol m-2 s-1). Figure 7A shows the photosynthetic response of mature leaves of N. tabacum cv. Petit Havana lines expressing FBP / SBPase (SB), cytochrome c6 (C6), FBP / SBPase + cytochrome c6 (SBC6), and the control (CN; both WT and azygous plants). Figure 7B shows the photosynthetic response of mature leaves (left column) and developing leaves (i.e., 11-13 cm long; right column) of N. tabacum cv. Samsun lines expressing SBPase (S), SBPase + cytochrome c6 (SC6), and the control (CN; both WT and azygous plants). In Figures 7A-7B, three to four individual plants from three to four independent transgenic lines were evaluated. Asterisks indicate significance between transgenic and control groups as determined using a linear mixed-effects model and type III ANOVA, *P<0.05, **P<0.01, ***P<0.001. [Figure 8]FIG. 8 shows that increasing expression of SBPase or increasing expression of FBP / SBPase+cytochrome c6 increases biomass in plants grown under controlled conditions (i.e., greenhouse (GH)). The left column of the graphs shows the mean ± SE of plant height, leaf area, and aboveground biomass dry weight expressed as a percentage of control values for 40-day-old N. tabacum cv. Petit Havana lines expressing FBP / SBPase (SB), cytochrome c6 (C6), and FBP / SBPase+cytochrome c6 (SBC6). The right column of the graphs shows the mean ± SE of plant height, leaf area, and aboveground biomass dry weight expressed as a percentage of control values for 56-day-old N. tabacum cv. Samsun lines expressing SBPase (S) and SBPase+cytochrome c6 (SC6). Five to six individual plants from two to four independent transgenic lines were evaluated. Values obtained for the control group containing both WT and azygous plants are shown as shades of grey set at 100% and overlaid on the graphs. Asterisks indicate significance between transgenic and control groups or between genotypes determined using ANOVA with Tukey's post-hoc test, *P<0.05, **P<0.01, ***P<0.001. [Figure 9]FIG. 9 shows that increased expression of SBPase or increased expression of FBP / SBPase + cytochrome c6 causes increased biomass in GH-grown plants. The left column of the graphs shows the mean ± SE of leaf number, leaf dry weight, and stem dry weight expressed as a percentage of control values for 40-day-old N. tabacum cv. Petit Havana lines expressing FBP / SBPase (SB), cytochrome c6 (C6), and FBP / SBPase + cytochrome c6 (SBC6). The right column of the graphs shows the mean ± SE of leaf number, leaf dry weight, and stem dry weight expressed as a percentage of control values for 56-day-old N. tabacum cv. Samsun lines expressing SBPase (S) and SBPase + cytochrome c6 (SC6). Five to six individual plants from two to four independent transgenic lines were evaluated. Values obtained for the control group containing both WT and azygous plants are shown as shades of grey set at 100% and overlaid on the graphs. Asterisks indicate significance between transgenic and control groups or between genotypes determined using ANOVA with Tukey's post-hoc test, *P<0.05, **P<0.01, ***P<0.001. [Figure 10A]Figures 10A-10C show that co-expression of FBP / SBPase + cytochrome c6 increases biomass in field-grown plants. Figure 10A shows the mean ± SE of plant height, leaf area, and aboveground biomass dry weight, expressed as a percentage of control values, for 40-day-old (i.e., young) 2016 field-grown N. tabacum cv. Petit Havana plants expressing cytochrome c6 (C6) or FBP / SBPase (SB). Figure 10B shows the mean ± SE of plant height, leaf area, and aboveground biomass dry weight, expressed as a percentage of control values, for 57-day-old field-grown N. tabacum cv. Petit Havana plants expressing FBP / SBPase (SB line; light gray bars) or cytochrome c6 (C6 line; dark gray bars). Figure 10C shows the mean ± SE of plant height, leaf area, and aboveground biomass dry weight, expressed as a percentage of control values, for 61-day-old (i.e., flowering stage) field-grown N. tabacum cv. Petit Havana plants expressing cytochrome c6 (C6 line; dark grey bars) or FBP / SBPase + cytochrome c6 (SBC6 line; white bars). Six individual plants from 2–3 independent transgenic lines (Figure 10A) or 24 individual plants from 2–3 independent transgenic lines (Figures 10B–10C) were evaluated. Values obtained for the control group, containing both WT and azygous plants, are shown as grey shades set at 100% and overlaid on the graph. Asterisks indicate significance between transgenic and control groups or between genotypes using ANOVA with Tukey's post-hoc test, *P<0.05, **P<0.01, ***P<0.001. [Figure 10B]Figures 10A-10C show that co-expression of FBP / SBPase + cytochrome c6 increases biomass in field-grown plants. Figure 10A shows the mean ± SE of plant height, leaf area, and aboveground biomass dry weight, expressed as a percentage of control values, for 40-day-old (i.e., young) 2016 field-grown N. tabacum cv. Petit Havana plants expressing cytochrome c6 (C6) or FBP / SBPase (SB). Figure 10B shows the mean ± SE of plant height, leaf area, and aboveground biomass dry weight, expressed as a percentage of control values, for 57-day-old field-grown N. tabacum cv. Petit Havana plants expressing FBP / SBPase (SB line; light gray bars) or cytochrome c6 (C6 line; dark gray bars). Figure 10C shows the mean ± SE of plant height, leaf area, and aboveground biomass dry weight, expressed as a percentage of control values, for 61-day-old (i.e., flowering stage) field-grown N. tabacum cv. Petit Havana plants expressing cytochrome c6 (C6 line; dark grey bars) or FBP / SBPase + cytochrome c6 (SBC6 line; white bars). Six individual plants from 2–3 independent transgenic lines (Figure 10A) or 24 individual plants from 2–3 independent transgenic lines (Figures 10B–10C) were evaluated. Values obtained for the control group, containing both WT and azygous plants, are shown as grey shades set at 100% and overlaid on the graph. Asterisks indicate significance between transgenic and control groups or between genotypes using ANOVA with Tukey's post-hoc test, *P<0.05, **P<0.01, ***P<0.001. [Figure 10C]Figures 10A-10C show that co-expression of FBP / SBPase + cytochrome c6 increases biomass in field-grown plants. Figure 10A shows the mean ± SE of plant height, leaf area, and aboveground biomass dry weight, expressed as a percentage of control values, for 40-day-old (i.e., young) 2016 field-grown N. tabacum cv. Petit Havana plants expressing cytochrome c6 (C6) or FBP / SBPase (SB). Figure 10B shows the mean ± SE of plant height, leaf area, and aboveground biomass dry weight, expressed as a percentage of control values, for 57-day-old field-grown N. tabacum cv. Petit Havana plants expressing FBP / SBPase (SB line; light gray bars) or cytochrome c6 (C6 line; dark gray bars). Figure 10C shows the mean ± SE of plant height, leaf area, and aboveground biomass dry weight, expressed as a percentage of control values, for 61-day-old (i.e., flowering stage) field-grown N. tabacum cv. Petit Havana plants expressing cytochrome c6 (C6 line; dark grey bars) or FBP / SBPase + cytochrome c6 (SBC6 line; white bars). Six individual plants from 2–3 independent transgenic lines (Figure 10A) or 24 individual plants from 2–3 independent transgenic lines (Figures 10B–10C) were evaluated. Values obtained for the control group, containing both WT and azygous plants, are shown as grey shades set at 100% and overlaid on the graph. Asterisks indicate significance between transgenic and control groups or between genotypes using ANOVA with Tukey's post-hoc test, *P<0.05, **P<0.01, ***P<0.001. [Figure 11A]Figures 11A-11B show the photosynthetic capacity of field-grown transgenic plants. Figure 11A shows the photosynthetic carbon fixation rate (A (μmol m-2 s-1)) and PSII operation efficiency (Fq' / Fm') as a function of increasing CO2 concentration (Ci (μmol m-2)) at saturating light levels in mature leaves from field-grown N. tabacum cultivar Petit Havana lines expressing FBP / SBPase (SB), cytochrome c6 (C6), and control plants (CN; both WT and azygous plants). The inset bar graphs show the maximum carbon fixation rate (Amax) in mature leaves from field-grown SB and C6 N. tabacum cultivar Petit Havana lines, as well as CN lines. FIG. 11B shows the photosynthetic carbon fixation rate (A (μmol m-2 s-1)) and PSII operation efficiency (Fq' / Fm') as a function of increasing CO2 concentration (Ci (μmol m-2)) at saturating light levels in mature leaves from field-grown N. tabacum cv. Petit Havana lines expressing cytochrome c6 (C6), FBP / SBPase + cytochrome c6 (SBC6), and control plants (CN; both WT and azygous plants). Inset bar graphs show the carbon fixation rate (A (μmol m-2 s-1)) and PSII operation efficiency (Fq' / Fm') as a function of increasing CO2 concentration (Ci (μmol m-2)) at saturating light levels in mature leaves from field-grown C6 and SBC6 N. tabacum cv. Petit Havana lines expressing cytochrome c6 (C6), FBP / SBPase + cytochrome c6 (SBC6), and control plants (CN; both WT and azygous plants). The maximum carbon fixation rate (Amax) of mature leaves from Havana and CN lines is shown. In Figures 11A-11B, the mean ± SE of 4-5 individual plants from 2-3 independent transgenic lines is shown. Asterisks indicate significance between transgenic and control groups, *P<0.05, as determined by linear mixed-effects model and type III ANOVA. [Figure 11B]Figures 11A-11B show the photosynthetic capacity of field-grown transgenic plants. Figure 11A shows the photosynthetic carbon fixation rate (A (μmol m-2 s-1)) and PSII operation efficiency (Fq' / Fm') as a function of increasing CO2 concentration (Ci (μmol m-2)) at saturating light levels in mature leaves from field-grown N. tabacum cultivar Petit Havana lines expressing FBP / SBPase (SB), cytochrome c6 (C6), and control plants (CN; both WT and azygous plants). The inset bar graphs show the maximum carbon fixation rate (Amax) in mature leaves from field-grown SB and C6 N. tabacum cultivar Petit Havana lines, as well as CN lines. FIG. 11B shows the photosynthetic carbon fixation rate (A (μmol m-2 s-1)) and PSII operation efficiency (Fq' / Fm') as a function of increasing CO2 concentration (Ci (μmol m-2)) at saturating light levels in mature leaves from field-grown N. tabacum cv. Petit Havana lines expressing cytochrome c6 (C6), FBP / SBPase + cytochrome c6 (SBC6), and control plants (CN; both WT and azygous plants). Inset bar graphs show the carbon fixation rate (A (μmol m-2 s-1)) and PSII operation efficiency (Fq' / Fm') as a function of increasing CO2 concentration (Ci (μmol m-2)) at saturating light levels in mature leaves from field-grown C6 and SBC6 N. tabacum cv. Petit Havana lines expressing cytochrome c6 (C6), FBP / SBPase + cytochrome c6 (SBC6), and control plants (CN; both WT and azygous plants). The maximum carbon fixation rate (Amax) of mature leaves from Havana and CN lines is shown. In Figures 11A-11B, the mean ± SE of 4-5 individual plants from 2-3 independent transgenic lines is shown. Asterisks indicate significance between transgenic and control groups, *P<0.05, as determined by linear mixed-effects model and type III ANOVA. [Figure 12A]Figures 12A-12D show that co-expression of FBP / SBPase + cytochrome c6 increases water use efficiency under field conditions: Figure 12A shows the mean ± SE net CO2 assimilation rate (A(μmol m-2 s-1)), Figure 12B shows the mean ± SE stomatal conductance (gs(mol m-2 s-1)), Figure 12C shows the mean ± SE intercellular CO2 concentration (Ci(μmol m-2)), and Figure 12D shows the mean ± SE potential water use efficiency (iWUE(A / gs)). Parameters shown in Figures 12A-12D are provided as a function of light (PPFD (µmol m-2 s-1)) in field-grown N. tabacum cultivar Petit Havana lines expressing cytochrome c6 (C6), FBP / SBPase + cytochrome c6 (SBC6), and control plants (CN; both WT and azygous plants). Four to five individual plants from two to three independent transgenic lines were evaluated. Asterisks indicate significance between transgenic lines and control groups determined using a linear mixed-effects model and type III ANOVA, *P<0.05, **P<0.01, ***P<0.001. [Figure 12B]Figures 12A-12D show that co-expression of FBP / SBPase + cytochrome c6 increases water use efficiency under field conditions: Figure 12A shows the mean ± SE net CO2 assimilation rate (A(μmol m-2 s-1)), Figure 12B shows the mean ± SE stomatal conductance (gs(mol m-2 s-1)), Figure 12C shows the mean ± SE intercellular CO2 concentration (Ci(μmol m-2)), and Figure 12D shows the mean ± SE potential water use efficiency (iWUE(A / gs)). Parameters shown in Figures 12A-12D are provided as a function of light (PPFD (µmol m-2 s-1)) in field-grown N. tabacum cultivar Petit Havana lines expressing cytochrome c6 (C6), FBP / SBPase + cytochrome c6 (SBC6), and control plants (CN; both WT and azygous plants). Four to five individual plants from two to three independent transgenic lines were evaluated. Asterisks indicate significance between transgenic lines and control groups determined using a linear mixed-effects model and type III ANOVA, *P<0.05, **P<0.01, ***P<0.001. [Figure 12C]Figures 12A-12D show that co-expression of FBP / SBPase + cytochrome c6 increases water use efficiency under field conditions: Figure 12A shows the mean ± SE net CO2 assimilation rate (A(μmol m-2 s-1)), Figure 12B shows the mean ± SE stomatal conductance (gs(mol m-2 s-1)), Figure 12C shows the mean ± SE intercellular CO2 concentration (Ci(μmol m-2)), and Figure 12D shows the mean ± SE potential water use efficiency (iWUE(A / gs)). Parameters shown in Figures 12A-12D are provided as a function of light (PPFD (µmol m-2 s-1)) in field-grown N. tabacum cultivar Petit Havana lines expressing cytochrome c6 (C6), FBP / SBPase + cytochrome c6 (SBC6), and control plants (CN; both WT and azygous plants). Four to five individual plants from two to three independent transgenic lines were evaluated. Asterisks indicate significance between transgenic lines and control groups determined using a linear mixed-effects model and type III ANOVA, *P<0.05, **P<0.01, ***P<0.001. [Figure 12D]Figures 12A-12D show that co-expression of FBP / SBPase + cytochrome c6 increases water use efficiency under field conditions: Figure 12A shows the mean ± SE net CO2 assimilation rate (A(μmol m-2 s-1)), Figure 12B shows the mean ± SE stomatal conductance (gs(mol m-2 s-1)), Figure 12C shows the mean ± SE intercellular CO2 concentration (Ci(μmol m-2)), and Figure 12D shows the mean ± SE potential water use efficiency (iWUE(A / gs)). Parameters shown in Figures 12A-12D are provided as a function of light (PPFD (µmol m-2 s-1)) in field-grown N. tabacum cultivar Petit Havana lines expressing cytochrome c6 (C6), FBP / SBPase + cytochrome c6 (SBC6), and control plants (CN; both WT and azygous plants). Four to five individual plants from two to three independent transgenic lines were evaluated. Asterisks indicate significance between transgenic lines and control groups determined using a linear mixed-effects model and type III ANOVA, *P<0.05, **P<0.01, ***P<0.001. [Figure 13A]Figures 13A-13D show the response of gas exchange parameters to absorbed light in N. tabacum cv. Petit Havana plants expressing FBP / SBPase or cytochrome c6 in field experiment 1 in 2017. Figure 13A shows the net CO2 assimilation rate (A(μmol m-2 s-1)), Figure 13B shows the stomatal conductance (gs(mol m-2 s-1)), Figure 13C shows the intercellular CO2 concentration (Ci(μmol m-2)), and Figure 13D shows the potential water use efficiency (iWUE(A / gs)). Parameters shown in Figures 13A-13D are provided as a function of light (PPFD (µmol m-2 s-1)) in field-grown N. tabacum cultivar Petit Havana lines expressing FBP / SBPase (SB), cytochrome c6 (C6), and control plants (CN; both WT and azygous plants). Four to five individual plants from two to three independent transgenic lines were evaluated and the mean ± SE is shown. Asterisks indicate significance between groups determined using a linear mixed-effects model and type III ANOVA, *P<0.05, **P<0.01, ***P<0.001. [Figure 13B]Figures 13A-13D show the response of gas exchange parameters to absorbed light in N. tabacum cv. Petit Havana plants expressing FBP / SBPase or cytochrome c6 in field experiment 1 in 2017. Figure 13A shows the net CO2 assimilation rate (A(μmol m-2 s-1)), Figure 13B shows the stomatal conductance (gs(mol m-2 s-1)), Figure 13C shows the intercellular CO2 concentration (Ci(μmol m-2)), and Figure 13D shows the potential water use efficiency (iWUE(A / gs)). Parameters shown in Figures 13A-13D are provided as a function of light (PPFD (µmol m-2 s-1)) in field-grown N. tabacum cultivar Petit Havana lines expressing FBP / SBPase (SB), cytochrome c6 (C6), and control plants (CN; both WT and azygous plants). Four to five individual plants from two to three independent transgenic lines were evaluated and the mean ± SE is shown. Asterisks indicate significance between groups determined using a linear mixed-effects model and type III ANOVA, *P<0.05, **P<0.01, ***P<0.001. [Figure 13C]Figures 13A-13D show the response of gas exchange parameters to absorbed light in N. tabacum cv. Petit Havana plants expressing FBP / SBPase or cytochrome c6 in field experiment 1 in 2017. Figure 13A shows the net CO2 assimilation rate (A(μmol m-2 s-1)), Figure 13B shows the stomatal conductance (gs(mol m-2 s-1)), Figure 13C shows the intercellular CO2 concentration (Ci(μmol m-2)), and Figure 13D shows the potential water use efficiency (iWUE(A / gs)). Parameters shown in Figures 13A-13D are provided as a function of light (PPFD (µmol m-2 s-1)) in field-grown N. tabacum cultivar Petit Havana lines expressing FBP / SBPase (SB), cytochrome c6 (C6), and control plants (CN; both WT and azygous plants). Four to five individual plants from two to three independent transgenic lines were evaluated and the mean ± SE is shown. Asterisks indicate significance between groups determined using a linear mixed-effects model and type III ANOVA, *P<0.05, **P<0.01, ***P<0.001. [Figure 13D]Figures 13A-13D show the response of gas exchange parameters to absorbed light in N. tabacum cv. Petit Havana plants expressing FBP / SBPase or cytochrome c6 in field experiment 1 in 2017. Figure 13A shows the net CO2 assimilation rate (A(μmol m-2 s-1)), Figure 13B shows the stomatal conductance (gs(mol m-2 s-1)), Figure 13C shows the intercellular CO2 concentration (Ci(μmol m-2)), and Figure 13D shows the potential water use efficiency (iWUE(A / gs)). Parameters shown in Figures 13A-13D are provided as a function of light (PPFD (µmol m-2 s-1)) in field-grown N. tabacum cultivar Petit Havana lines expressing FBP / SBPase (SB), cytochrome c6 (C6), and control plants (CN; both WT and azygous plants). Four to five individual plants from two to three independent transgenic lines were evaluated and the mean ± SE is shown. Asterisks indicate significance between groups determined using a linear mixed-effects model and type III ANOVA, *P<0.05, **P<0.01, ***P<0.001. [Figure 14A]14A to 14D show the enzyme activities of Chlamydomonas reinhardtii (C_reinhardtii_SBPase_XP_001691997.1 (SEQ ID NO: 13); C reinhardtii_SBPase_P46284.1 (SEQ ID NO: 14)), Zea mays (Z_mays_SBPase_NP_001148402.1 (SEQ ID NO: 10); Z_mays_SBPase_ONM36378.1 SEQ ID NO: 11)), Brachypodium distachyon (SEQ ID NO: 9), Triticum aestivum (T_aestivum_SBPase_P46285.1 (SEQ ID NO: 7); T_aestivum_SBPase_CBH32512.1 (SEQ ID NO: 8)), Arabidopsis thaliana (SEQ ID NO: 1), Brassica napus (SEQ ID NO: 2), Ananas comosus (SEQ ID NO: 6), Glycine max (SEQ ID NO: 12), Solanum lycopersicum (SEQ ID NO: 3), and Nicotiana tabacum (N_tabacum_SBPase_016455125.1 (SEQ ID NO: 4); N_tabacum_SBPase_016497321.1 (SEQ ID NO: 5)). FIG. 14A shows an alignment of the N-terminal parts of the SBPase polypeptides. FIG. 14B shows an alignment of the first part of the central part of the SBPase polypeptides (box indicates the cysteine residue to be mutated to produce a plant with a non-TRx (redox)-activated SBPase). FIG. 14C shows an alignment of the second part of the central part of the SBPase polypeptides. FIG. 14D shows the C-terminal part of the SBPase polypeptides. [Figure 14B]14A to 14D show the enzyme activities of Chlamydomonas reinhardtii (C_reinhardtii_SBPase_XP_001691997.1 (SEQ ID NO: 13); C reinhardtii_SBPase_P46284.1 (SEQ ID NO: 14)), Zea mays (Z_mays_SBPase_NP_001148402.1 (SEQ ID NO: 10); Z_mays_SBPase_ONM36378.1 SEQ ID NO: 11)), Brachypodium distachyon (SEQ ID NO: 9), Triticum aestivum (T_aestivum_SBPase_P46285.1 (SEQ ID NO: 7); T_aestivum_SBPase_CBH32512.1 (SEQ ID NO: 8)), Arabidopsis thaliana (SEQ ID NO: 1), Brassica napus (SEQ ID NO: 2), Ananas comosus (SEQ ID NO: 6), Glycine max (SEQ ID NO: 12), Solanum lycopersicum (SEQ ID NO: 3), and Nicotiana tabacum (N_tabacum_SBPase_016455125.1 (SEQ ID NO: 4); N_tabacum_SBPase_016497321.1 (SEQ ID NO: 5)). FIG. 14A shows an alignment of the N-terminal parts of the SBPase polypeptides. FIG. 14B shows an alignment of the first part of the central part of the SBPase polypeptides (box indicates the cysteine residue to be mutated to produce a plant with a non-TRx (redox)-activated SBPase). FIG. 14C shows an alignment of the second part of the central part of the SBPase polypeptides. FIG. 14D shows the C-terminal part of the SBPase polypeptides. [Figure 14C]14A to 14D show the enzyme activities of Chlamydomonas reinhardtii (C_reinhardtii_SBPase_XP_001691997.1 (SEQ ID NO: 13); C reinhardtii_SBPase_P46284.1 (SEQ ID NO: 14)), Zea mays (Z_mays_SBPase_NP_001148402.1 (SEQ ID NO: 10); Z_mays_SBPase_ONM36378.1 SEQ ID NO: 11)), Brachypodium distachyon (SEQ ID NO: 9), Triticum aestivum (T_aestivum_SBPase_P46285.1 (SEQ ID NO: 7); T_aestivum_SBPase_CBH32512.1 (SEQ ID NO: 8)), Arabidopsis thaliana (SEQ ID NO: 1), Brassica napus (SEQ ID NO: 2), Ananas comosus (SEQ ID NO: 6), Glycine max (SEQ ID NO: 12), Solanum lycopersicum (SEQ ID NO: 3), and Nicotiana tabacum (N_tabacum_SBPase_016455125.1 (SEQ ID NO: 4); N_tabacum_SBPase_016497321.1 (SEQ ID NO: 5)). FIG. 14A shows an alignment of the N-terminal parts of the SBPase polypeptides. FIG. 14B shows an alignment of the first part of the central part of the SBPase polypeptides (box indicates the cysteine residue to be mutated to produce a plant with a non-TRx (redox)-activated SBPase). FIG. 14C shows an alignment of the second part of the central part of the SBPase polypeptides. FIG. 14D shows the C-terminal part of the SBPase polypeptides. [Figure 14D]14A to 14D show the enzyme activities of Chlamydomonas reinhardtii (C_reinhardtii_SBPase_XP_001691997.1 (SEQ ID NO: 13); C reinhardtii_SBPase_P46284.1 (SEQ ID NO: 14)), Zea mays (Z_mays_SBPase_NP_001148402.1 (SEQ ID NO: 10); Z_mays_SBPase_ONM36378.1 SEQ ID NO: 11)), Brachypodium distachyon (SEQ ID NO: 9), Triticum aestivum (T_aestivum_SBPase_P46285.1 (SEQ ID NO: 7); T_aestivum_SBPase_CBH32512.1 (SEQ ID NO: 8)), Arabidopsis thaliana (SEQ ID NO: 1), Brassica napus (SEQ ID NO: 2), Ananas comosus (SEQ ID NO: 6), Glycine max (SEQ ID NO: 12), Solanum lycopersicum (SEQ ID NO: 3), and Nicotiana tabacum (N_tabacum_SBPase_016455125.1 (SEQ ID NO: 4); N_tabacum_SBPase_016497321.1 (SEQ ID NO: 5)). FIG. 14A shows an alignment of the N-terminal parts of the SBPase polypeptides. FIG. 14B shows an alignment of the first part of the central part of the SBPase polypeptides (box indicates the cysteine residue to be mutated to produce a plant with a non-TRx (redox)-activated SBPase). FIG. 14C shows an alignment of the second part of the central part of the SBPase polypeptides. FIG. 14D shows the C-terminal part of the SBPase polypeptides. [Figure 15A]15A-15D show Chlamydomonas reinhardtii (SEQ ID NO:26), Arabidopsis thaliana (SEQ ID NO:17), Brassica napus (SEQ ID NO:18), Solanum lycopersicum (SEQ ID NO:15), Nicotiana tabacum (SEQ ID NO:16), Glycine max (G_max_FBPA_NP_001347079.1 (SEQ ID NO:22), G_max_FBPA1_XP_003522841.1 (SEQ ID NO:23)), Ananas comosus (SEQ ID NO:24), Zea mays (Z_mays_FBPA_ACG36798.1 (SEQ ID NO:19), Z_mays_FBPA_PWZ45921.1 (SEQ ID NO:20)), Triticum aestivum (SEQ ID NO:21), and Brachypodium Figure 15A shows an alignment of the N-terminal portions of the FBPA polypeptides. Figure 15B shows an alignment of a first portion of the central portions of the FBPA polypeptides. Figure 15C shows an alignment of a second portion of the central portions of the FBPA polypeptides. Figure 15D shows an alignment of the C-terminal portions of the FBPA polypeptides. [Figure 15B]15A-15D show Chlamydomonas reinhardtii (SEQ ID NO:26), Arabidopsis thaliana (SEQ ID NO:17), Brassica napus (SEQ ID NO:18), Solanum lycopersicum (SEQ ID NO:15), Nicotiana tabacum (SEQ ID NO:16), Glycine max (G_max_FBPA_NP_001347079.1 (SEQ ID NO:22), G_max_FBPA1_XP_003522841.1 (SEQ ID NO:23)), Ananas comosus (SEQ ID NO:24), Zea mays (Z_mays_FBPA_ACG36798.1 (SEQ ID NO:19), Z_mays_FBPA_PWZ45921.1 (SEQ ID NO:20)), Triticum aestivum (SEQ ID NO:21), and Brachypodium Figure 15A shows an alignment of the N-terminal portions of the FBPA polypeptides. Figure 15B shows an alignment of a first portion of the central portions of the FBPA polypeptides. Figure 15C shows an alignment of a second portion of the central portions of the FBPA polypeptides. Figure 15D shows an alignment of the C-terminal portions of the FBPA polypeptides. [Figure 15C]15A-15D show Chlamydomonas reinhardtii (SEQ ID NO:26), Arabidopsis thaliana (SEQ ID NO:17), Brassica napus (SEQ ID NO:18), Solanum lycopersicum (SEQ ID NO:15), Nicotiana tabacum (SEQ ID NO:16), Glycine max (G_max_FBPA_NP_001347079.1 (SEQ ID NO:22), G_max_FBPA1_XP_003522841.1 (SEQ ID NO:23)), Ananas comosus (SEQ ID NO:24), Zea mays (Z_mays_FBPA_ACG36798.1 (SEQ ID NO:19), Z_mays_FBPA_PWZ45921.1 (SEQ ID NO:20)), Triticum aestivum (SEQ ID NO:21), and Brachypodium Figure 15A shows an alignment of the N-terminal portions of the FBPA polypeptides. Figure 15B shows an alignment of a first portion of the central portions of the FBPA polypeptides. Figure 15C shows an alignment of a second portion of the central portions of the FBPA polypeptides. Figure 15D shows an alignment of the C-terminal portions of the FBPA polypeptides. [Figure 15D]15A-15D show Chlamydomonas reinhardtii (SEQ ID NO:26), Arabidopsis thaliana (SEQ ID NO:17), Brassica napus (SEQ ID NO:18), Solanum lycopersicum (SEQ ID NO:15), Nicotiana tabacum (SEQ ID NO:16), Glycine max (G_max_FBPA_NP_001347079.1 (SEQ ID NO:22), G_max_FBPA1_XP_003522841.1 (SEQ ID NO:23)), Ananas comosus (SEQ ID NO:24), Zea mays (Z_mays_FBPA_ACG36798.1 (SEQ ID NO:19), Z_mays_FBPA_PWZ45921.1 (SEQ ID NO:20)), Triticum aestivum (SEQ ID NO:21), and Brachypodium Figure 15A shows an alignment of the N-terminal portions of the FBPA polypeptides. Figure 15B shows an alignment of a first portion of the central portions of the FBPA polypeptides. Figure 15C shows an alignment of a second portion of the central portions of the FBPA polypeptides. Figure 15D shows an alignment of the C-terminal portions of the FBPA polypeptides. [Figure 16A]Figures 16A-16D show alignments of FBPase polypeptide sequences from Chlamydomonas reinhardtii (SEQ ID NO: 37), Zea mays (SEQ ID NO: 35), Brachypodium distachyon (SEQ ID NO: 33), Triticum aestivum (SEQ ID NO: 36), Arabidopsis thaliana (SEQ ID NO: 27), Brassica napus (SEQ ID NO: 34), Glycine max (G_max_FBPase_NP_001238269.2 (SEQ ID NO: 28); G_max_FBPase_XP_003552216.1 (SEQ ID NO: 29)), Nicotiana tabacum (SEQ ID NO: 30), and Solanum lycopersicum (SEQ ID NO: 32). Figure 16A shows an alignment of the N-terminal parts of the FBPase polypeptides. Figure 16B shows an alignment of the first part of the central part of the FBPase polypeptides. Figure 16C shows an alignment of the central second portion of the FBPase polypeptides. Figure 16D shows an alignment of the C-terminal portion of the FBPase polypeptides. In Figures 16B-16C, the boxes indicate the cysteine residues that should be mutated to produce plants with non-TRx (redox)-activated FBPase. [Figure 16B]Figures 16A-16D show alignments of FBPase polypeptide sequences from Chlamydomonas reinhardtii (SEQ ID NO: 37), Zea mays (SEQ ID NO: 35), Brachypodium distachyon (SEQ ID NO: 33), Triticum aestivum (SEQ ID NO: 36), Arabidopsis thaliana (SEQ ID NO: 27), Brassica napus (SEQ ID NO: 34), Glycine max (G_max_FBPase_NP_001238269.2 (SEQ ID NO: 28); G_max_FBPase_XP_003552216.1 (SEQ ID NO: 29)), Nicotiana tabacum (SEQ ID NO: 30), and Solanum lycopersicum (SEQ ID NO: 32). Figure 16A shows an alignment of the N-terminal parts of the FBPase polypeptides. Figure 16B shows an alignment of the first part of the central part of the FBPase polypeptides. Figure 16C shows an alignment of the central second portion of the FBPase polypeptides. Figure 16D shows an alignment of the C-terminal portion of the FBPase polypeptides. In Figures 16B-16C, the boxes indicate the cysteine residues that should be mutated to produce plants with non-TRx (redox)-activated FBPase. [Figure 16C]Figures 16A-16D show alignments of FBPase polypeptide sequences from Chlamydomonas reinhardtii (SEQ ID NO: 37), Zea mays (SEQ ID NO: 35), Brachypodium distachyon (SEQ ID NO: 33), Triticum aestivum (SEQ ID NO: 36), Arabidopsis thaliana (SEQ ID NO: 27), Brassica napus (SEQ ID NO: 34), Glycine max (G_max_FBPase_NP_001238269.2 (SEQ ID NO: 28); G_max_FBPase_XP_003552216.1 (SEQ ID NO: 29)), Nicotiana tabacum (SEQ ID NO: 30), and Solanum lycopersicum (SEQ ID NO: 32). Figure 16A shows an alignment of the N-terminal parts of the FBPase polypeptides. Figure 16B shows an alignment of the first part of the central part of the FBPase polypeptides. Figure 16C shows an alignment of the central second portion of the FBPase polypeptides. Figure 16D shows an alignment of the C-terminal portion of the FBPase polypeptides. In Figures 16B-16C, the boxes indicate the cysteine residues that should be mutated to produce plants with non-TRx (redox)-activated FBPase. [Figure 16D]Figures 16A-16D show alignments of FBPase polypeptide sequences from Chlamydomonas reinhardtii (SEQ ID NO: 37), Zea mays (SEQ ID NO: 35), Brachypodium distachyon (SEQ ID NO: 33), Triticum aestivum (SEQ ID NO: 36), Arabidopsis thaliana (SEQ ID NO: 27), Brassica napus (SEQ ID NO: 34), Glycine max (G_max_FBPase_NP_001238269.2 (SEQ ID NO: 28); G_max_FBPase_XP_003552216.1 (SEQ ID NO: 29)), Nicotiana tabacum (SEQ ID NO: 30), and Solanum lycopersicum (SEQ ID NO: 32). Figure 16A shows an alignment of the N-terminal parts of the FBPase polypeptides. Figure 16B shows an alignment of the first part of the central part of the FBPase polypeptides. Figure 16C shows an alignment of the central second portion of the FBPase polypeptides. Figure 16D shows an alignment of the C-terminal portion of the FBPase polypeptides. In Figures 16B-16C, the boxes indicate the cysteine residues that should be mutated to produce plants with non-TRx (redox)-activated FBPase. [Figure 17A] Figures 17A-17B show an alignment of FBP / SBPase polypeptide sequences from Synechocystis sp. PCC6803 (SEQ ID NO: 38), Synechocystis sp. PCC6714 (SEQ ID NO: 39) and Microcystis aeruginosa (SEQ ID NO: 40). Figure 17A shows an alignment of the N-terminal parts of the FBP / SBPase polypeptides. Figure 17B shows an alignment of the C-terminal parts of the FBP / SBPase polypeptides. [Figure 17B]Figures 17A-17B show an alignment of FBP / SBPase polypeptide sequences from Synechocystis sp. PCC6803 (SEQ ID NO: 38), Synechocystis sp. PCC6714 (SEQ ID NO: 39) and Microcystis aeruginosa (SEQ ID NO: 40). Figure 17A shows an alignment of the N-terminal parts of the FBP / SBPase polypeptides. Figure 17B shows an alignment of the C-terminal parts of the FBP / SBPase polypeptides. [Figure 18A] Figures 18A-18E show alignments of transketolase polypeptide sequences from Brachypodium distachyon (B_distachyon_TK_XP_003557240.1 (SEQ ID NO: 46); B_distachyon_TK_XP_003581128.1 (SEQ ID NO: 47)), Zea mays (SEQ ID NO: 45), Nicotiana tabacum (SEQ ID NO: 43), Solanum lycopersicum (SEQ ID NO: 44), Arabidopsis thaliana (A_thaliana_TK1 (SEQ ID NO: 41); A_thaliana_TK2 (SEQ ID NO: 48)), and Brassica napus (SEQ ID NO: 42). Figure 18A shows an alignment of the N-terminal parts of the transketolase polypeptides. Figure 18B shows an alignment of the first part of the central part of the transketolase polypeptides. Figure 18C shows an alignment of the second part of the central portion of the transketolase polypeptide. Figure 18D shows an alignment of the third part of the central portion of the transketolase polypeptide. Figure 18E shows an alignment of the C-terminal part of the transketolase polypeptide. [Figure 18B]Figures 18A-18E show alignments of transketolase polypeptide sequences from Brachypodium distachyon (B_distachyon_TK_XP_003557240.1 (SEQ ID NO: 46); B_distachyon_TK_XP_003581128.1 (SEQ ID NO: 47)), Zea mays (SEQ ID NO: 45), Nicotiana tabacum (SEQ ID NO: 43), Solanum lycopersicum (SEQ ID NO: 44), Arabidopsis thaliana (A_thaliana_TK1 (SEQ ID NO: 41); A_thaliana_TK2 (SEQ ID NO: 48)), and Brassica napus (SEQ ID NO: 42). Figure 18A shows an alignment of the N-terminal parts of the transketolase polypeptides. Figure 18B shows an alignment of the first part of the central part of the transketolase polypeptides. Figure 18C shows an alignment of the second part of the central portion of the transketolase polypeptide. Figure 18D shows an alignment of the third part of the central portion of the transketolase polypeptide. Figure 18E shows an alignment of the C-terminal part of the transketolase polypeptide. [Figure 18C]Figures 18A-18E show alignments of transketolase polypeptide sequences from Brachypodium distachyon (B_distachyon_TK_XP_003557240.1 (SEQ ID NO: 46); B_distachyon_TK_XP_003581128.1 (SEQ ID NO: 47)), Zea mays (SEQ ID NO: 45), Nicotiana tabacum (SEQ ID NO: 43), Solanum lycopersicum (SEQ ID NO: 44), Arabidopsis thaliana (A_thaliana_TK1 (SEQ ID NO: 41); A_thaliana_TK2 (SEQ ID NO: 48)), and Brassica napus (SEQ ID NO: 42). Figure 18A shows an alignment of the N-terminal parts of the transketolase polypeptides. Figure 18B shows an alignment of the first part of the central part of the transketolase polypeptides. Figure 18C shows an alignment of the second part of the central portion of the transketolase polypeptide. Figure 18D shows an alignment of the third part of the central portion of the transketolase polypeptide. Figure 18E shows an alignment of the C-terminal part of the transketolase polypeptide. [Figure 18D]Figures 18A-18E show alignments of transketolase polypeptide sequences from Brachypodium distachyon (B_distachyon_TK_XP_003557240.1 (SEQ ID NO: 46); B_distachyon_TK_XP_003581128.1 (SEQ ID NO: 47)), Zea mays (SEQ ID NO: 45), Nicotiana tabacum (SEQ ID NO: 43), Solanum lycopersicum (SEQ ID NO: 44), Arabidopsis thaliana (A_thaliana_TK1 (SEQ ID NO: 41); A_thaliana_TK2 (SEQ ID NO: 48)), and Brassica napus (SEQ ID NO: 42). Figure 18A shows an alignment of the N-terminal parts of the transketolase polypeptides. Figure 18B shows an alignment of the first part of the central part of the transketolase polypeptides. Figure 18C shows an alignment of the second part of the central portion of the transketolase polypeptide. Figure 18D shows an alignment of the third part of the central portion of the transketolase polypeptide. Figure 18E shows an alignment of the C-terminal part of the transketolase polypeptide. [Figure 18E]Figures 18A-18E show alignments of transketolase polypeptide sequences from Brachypodium distachyon (B_distachyon_TK_XP_003557240.1 (SEQ ID NO: 46); B_distachyon_TK_XP_003581128.1 (SEQ ID NO: 47)), Zea mays (SEQ ID NO: 45), Nicotiana tabacum (SEQ ID NO: 43), Solanum lycopersicum (SEQ ID NO: 44), Arabidopsis thaliana (A_thaliana_TK1 (SEQ ID NO: 41); A_thaliana_TK2 (SEQ ID NO: 48)), and Brassica napus (SEQ ID NO: 42). Figure 18A shows an alignment of the N-terminal parts of the transketolase polypeptides. Figure 18B shows an alignment of the first part of the central part of the transketolase polypeptides. Figure 18C shows an alignment of the second part of the central portion of the transketolase polypeptide. Figure 18D shows an alignment of the third part of the central portion of the transketolase polypeptide. Figure 18E shows an alignment of the C-terminal part of the transketolase polypeptide. [Figure 19A] Figures 19A-19B show an alignment of the Liske iron-sulfur polypeptide sequences from Chlamydomonas reinhardtii (SEQ ID NO: 80), Ananas comosus (SEQ ID NO: 74), Zea mays (SEQ ID NO: 78), Oryza sativa (SEQ ID NO: 76), Triticum aestivum (SEQ ID NO: 75), Brachypodium distachyon (SEQ ID NO: 77), Arabidopsis thaliana (SEQ ID NO: 70), Brassica napus (SEQ ID NO: 71), Glycine max (SEQ ID NO: 79), Solanum lycopersicum (SEQ ID NO: 72), and Nicotiana tabacum (SEQ ID NO: 73). Figure 19A shows an alignment of the N-terminal portions of the Liske iron-sulfur polypeptides. Figure 19B shows an alignment of the C-terminal portions of the transketolase polypeptides. [Figure 19B]Figures 19A-19B show an alignment of the Liske iron-sulfur polypeptide sequences from Chlamydomonas reinhardtii (SEQ ID NO: 80), Ananas comosus (SEQ ID NO: 74), Zea mays (SEQ ID NO: 78), Oryza sativa (SEQ ID NO: 76), Triticum aestivum (SEQ ID NO: 75), Brachypodium distachyon (SEQ ID NO: 77), Arabidopsis thaliana (SEQ ID NO: 70), Brassica napus (SEQ ID NO: 71), Glycine max (SEQ ID NO: 79), Solanum lycopersicum (SEQ ID NO: 72), and Nicotiana tabacum (SEQ ID NO: 73). Figure 19A shows an alignment of the N-terminal portions of the Liske iron-sulfur polypeptides. Figure 19B shows an alignment of the C-terminal portions of the transketolase polypeptides. [Figure 20A]20A-20C show Chlamydomonas reinhardtii (SEQ ID NO: 49), Oscillatoria acuminata (SEQ ID NO: 68), Chamaesiphon polymorphus (SEQ ID NO: 69), Pyropia tenera (SEQ ID NO: 53), Porphyra umbilicalis (SEQ ID NO: 95), Porphyra purpurea (SEQ ID NO: 51), Bangia fuscopurpurea (SEQ ID NO: 50), Pyropia pulchra (SEQ ID NO: 52), Ulva fasciata (SEQ ID NO: 64), Thorea hispida (SEQ ID NO: 55), Gracilaria ferox (SEQ ID NO: 58), Gracilariopsis mclachlanii (SEQ ID NO: 62), Ahnfeltia plicata (SEQ ID NO: 56), Porolithon onkodes (SEQ ID NO: 57), Saccharina japonica (SEQ ID NO: 67), Sargassum confusum (SEQ ID NO: 59), Fucus vesiculosus var. FIG. 20A shows an alignment of the cytochrome c6 polypeptide sequences from Pseudomonas spiralis (SEQ ID NO: 65), Porphyridium purpureum (SEQ ID NO: 54), Trachydiscus minutus (SEQ ID NO: 60), Nannochloropsis oculata (SEQ ID NO: 66), Vischeria species CAUP Q (SEQ ID NO: 61), and Monodopsis species MarTras21 (SEQ ID NO: 63). FIG. 20A shows an alignment of the N-terminal part of the cytochrome c6 polypeptide. FIG. 20B shows an alignment of the central part of the cytochrome c6 polypeptide. FIG. 20C shows an alignment of the C-terminal part of the cytochrome c6 polypeptide. [Figure 20B]20A-20C show Chlamydomonas reinhardtii (SEQ ID NO: 49), Oscillatoria acuminata (SEQ ID NO: 68), Chamaesiphon polymorphus (SEQ ID NO: 69), Pyropia tenera (SEQ ID NO: 53), Porphyra umbilicalis (SEQ ID NO: 95), Porphyra purpurea (SEQ ID NO: 51), Bangia fuscopurpurea (SEQ ID NO: 50), Pyropia pulchra (SEQ ID NO: 52), Ulva fasciata (SEQ ID NO: 64), Thorea hispida (SEQ ID NO: 55), Gracilaria ferox (SEQ ID NO: 58), Gracilariopsis mclachlanii (SEQ ID NO: 62), Ahnfeltia plicata (SEQ ID NO: 56), Porolithon onkodes (SEQ ID NO: 57), Saccharina japonica (SEQ ID NO: 67), Sargassum confusum (SEQ ID NO: 59), Fucus vesiculosus var. FIG. 20A shows an alignment of the cytochrome c6 polypeptide sequences from Pseudomonas spiralis (SEQ ID NO: 65), Porphyridium purpureum (SEQ ID NO: 54), Trachydiscus minutus (SEQ ID NO: 60), Nannochloropsis oculata (SEQ ID NO: 66), Vischeria species CAUP Q (SEQ ID NO: 61), and Monodopsis species MarTras21 (SEQ ID NO: 63). FIG. 20A shows an alignment of the N-terminal part of the cytochrome c6 polypeptide. FIG. 20B shows an alignment of the central part of the cytochrome c6 polypeptide. FIG. 20C shows an alignment of the C-terminal part of the cytochrome c6 polypeptide. [Figure 20C]20A-20C show Chlamydomonas reinhardtii (SEQ ID NO: 49), Oscillatoria acuminata (SEQ ID NO: 68), Chamaesiphon polymorphus (SEQ ID NO: 69), Pyropia tenera (SEQ ID NO: 53), Porphyra umbilicalis (SEQ ID NO: 95), Porphyra purpurea (SEQ ID NO: 51), Bangia fuscopurpurea (SEQ ID NO: 50), Pyropia pulchra (SEQ ID NO: 52), Ulva fasciata (SEQ ID NO: 64), Thorea hispida (SEQ ID NO: 55), Gracilaria ferox (SEQ ID NO: 58), Gracilariopsis mclachlanii (SEQ ID NO: 62), Ahnfeltia plicata (SEQ ID NO: 56), Porolithon onkodes (SEQ ID NO: 57), Saccharina japonica (SEQ ID NO: 67), Sargassum confusum (SEQ ID NO: 59), Fucus vesiculosus var. FIG. 20A shows an alignment of the cytochrome c6 polypeptide sequences from Pseudomonas spiralis (SEQ ID NO: 65), Porphyridium purpureum (SEQ ID NO: 54), Trachydiscus minutus (SEQ ID NO: 60), Nannochloropsis oculata (SEQ ID NO: 66), Vischeria species CAUP Q (SEQ ID NO: 61), and Monodopsis species MarTras21 (SEQ ID NO: 63). FIG. 20A shows an alignment of the N-terminal part of the cytochrome c6 polypeptide. FIG. 20B shows an alignment of the central part of the cytochrome c6 polypeptide. FIG. 20C shows an alignment of the C-terminal part of the cytochrome c6 polypeptide.
Claims
1. 1. A genetically modified plant, plant part, or plant cell, comprising: the plant, plant part, or plant cell comprises one or more genetic modifications that improve RuBP regeneration and one or more genetic modifications that improve photosynthetic electron transport, which increase the activity of a Calvin-Benson cycle (CB) protein compared to an unmodified plant, plant part, or plant cell grown under the same conditions; the one or more genetic modifications that improve photosynthetic electron transport include overexpression of one or more photosynthetic electron transport proteins; the one or more photosynthetic electron transport proteins include a cytochrome c 6 protein, a Rieske iron-sulfur protein (FeS protein), or a cytochrome c 6 protein and a Rieske iron-sulfur protein; the one or more genetic modifications that improve RuBP regeneration include overexpression of a CB protein; the CB protein comprises sedoheptulose-1,7-bisphosphatase (SBPase), fructose-1,6-bisphosphate aldolase (FBPA), chloroplast fructose-1,6-bisphosphatase (FBPase), bifunctional fructose-1,6-bisphosphatase / sedoheptulose-1,7-bisphosphatase (FBP / SBPase), or transketolase (TK); A genetically modified plant, plant part, or plant cell, wherein said plant has improved water use efficiency compared to an unmodified WT plant when grown under conditions having a light intensity greater than 1000 μmol m −2 s −1 .
2. The cytochrome c 6 2. The genetically modified plant, plant part, or plant cell of claim 1, wherein the protein comprises an amino acid sequence having at least 90% sequence identity, at least 95% sequence identity, or at least 99% sequence identity to SEQ ID NO:
102.
3. 3. The genetically modified plant, plant part, or plant cell of claim 1 or 2, wherein the Liske iron-sulfur protein comprises an amino acid sequence having at least 90% sequence identity, at least 95% sequence identity, or at least 99% sequence identity to SEQ ID NO:
101.
4. The cytochrome c 6 3. The genetically modified plant, plant part, or plant cell of claim 1 or 2, wherein the protein is localized in the thylakoid lumen of at least one chloroplast in the cell of the genetically modified plant.
5. The cytochrome c 6 The cytochrome c protein is present in the thylakoid lumen. 6 a transit peptide that localizes the protein; 5. The genetically modified plant, plant part, or plant cell of claim 4, wherein the transport peptide comprises a chlorophyll a / b binding protein 6 transport peptide, a light-harvesting complex I chlorophyll a / b binding protein 1 transport peptide, or a plastocyanin signal peptide.
6. 4. The genetically modified plant, plant part, or plant cell of claim 2 or claim 3, wherein the Liske iron-sulfur protein is localized in the thylakoid membrane of at least one chloroplast within a cell of the genetically modified plant.
7. the Liske iron-sulfur protein comprises a transit peptide that localizes the Liske iron-sulfur protein to the thylakoid membrane; 7. The genetically modified plant, plant part, or plant cell of claim 6, wherein the transport peptide comprises a cytochrome f transport peptide, a cytochrome b6 transport peptide, a PetD transport peptide, a PetG transport peptide, a PetL transport peptide, a PetN transport peptide, a PetM transport peptide, or a plastoquinone transport peptide.
8. The cytochrome c 6 a plant promoter operably linked to the nucleic acid sequence encoding the protein or said Liske iron-sulfur protein; 8. The genetically modified plant, plant part, or plant cell of any one of claims 1 to 7, wherein the plant promoter comprises a constitutive promoter, an inducible promoter, a tissue or cell type specific promoter, or an inducible tissue or cell type specific promoter.
9. 2. The genetically modified plant, plant part, or plant cell of claim 1, wherein the SBPase comprises an amino acid sequence having at least 90% sequence identity, at least 95% sequence identity, or at least 99% sequence identity to SEQ ID NO:
96.
10. 2. The genetically modified plant, plant part, or plant cell of claim 1, wherein the FBPA comprises an amino acid sequence having at least 90% sequence identity, at least 95% sequence identity, or at least 99% sequence identity to SEQ ID NO:
97.
11. 2. The genetically modified plant, plant part, or plant cell of claim 1, wherein the FBPase comprises an amino acid sequence having at least 90% sequence identity, at least 95% sequence identity, or at least 99% sequence identity to SEQ ID NO:
98.
12. 2. The genetically modified plant, plant part, or plant cell of claim 1, wherein the FBP / SBPase comprises an amino acid sequence having at least 90% sequence identity, at least 95% sequence identity, or at least 99% sequence identity to SEQ ID NO:
99.
13. 2. The genetically modified plant, plant part, or plant cell of claim 1, wherein the transketolase comprises an amino acid sequence having at least 90% sequence identity, at least 95% sequence identity, or at least 99% sequence identity to SEQ ID NO:
100.
14. the SBPase, the FBPA, the FBPase, the FBP / SBPase, or the transketolase is localized in the chloroplast stroma of at least one chloroplast in a cell of the genetically modified plant; 14. The genetically modified plant, plant part, or plant cell of any one of claims 1 to 13, wherein the SBPase, the FBPA, the FBPase, the FBP / SBPase, or the transketolase comprises a transit peptide that localizes the SBPase, the FBPA, the FBPase, the FBP / SBPase, or the transketolase to the chloroplast stroma of the plant.
15. further comprising a plant promoter operably linked to the nucleic acid sequence encoding the SBPase, the FBPA, the FBPase, the FBP / SBPase, or the transketolase; 15. The genetically modified plant, plant part, or plant cell of any one of claims 1 to 14, wherein the plant promoter comprises a constitutive promoter, an inducible promoter, a tissue or cell type specific promoter, or an inducible tissue or cell type specific promoter.
16. 16. The genetically modified plant of any one of claims 1 to 15, wherein the plant has an increased biomass compared to an unmodified wild-type (WT) plant.
17. 17. A method for producing a genetically modified plant according to any one of claims 1 to 16, comprising: (a) introducing into a plant cell, tissue, or other explant both one or more genetic modifications that improve RuBP regeneration and one or more genetic modifications that improve photosynthetic electron transport, which increase the activity of a CB protein; (b) regenerating the plant cell, tissue, or other explant into a genetically modified plantlet; and (c) growing the genetically modified plantlet into a genetically modified plant having both one or more genetic modifications that improve RuBP regeneration and one or more genetic modifications that improve photosynthetic electron transport, which increase the activity of a CB protein.
Citation Information
Patent Citations
How to improve plant productivity through chloroplast engineering
JP2007525974A
Method for producing new higher plant and method for promoting growth of higher plant
JP2012110330A
Method of constructing novel higher plant and mehtod of promoting the growth of higher plant
WO2006082992A1
Enhancing photosynthesis
WO2017144901A1
